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Abstract 
 
Fusobacterium necrophorum an obligate Gram-negative anaerobe has been 
implicated in the cause of persistent severe throat infections and the systemic life-
threatening Lemierre’s syndrome; a potentially fatal periodontal disease, which 
results in abscess formation in the tonsils. The use of antibiotics had led to 
decreased incidence of F. necrophorum infections to a point that the bacterium 
became a forgotten pathogen; however, there has recently been a rise in interest. 
F. necrophorum is thought to survive the aerobic oropharynx by biofilm formation. 
Studies of optimal conditions for biofilm formation could be useful in improving 
therapeutic options. This current study determined that strains ARU 01 and JCM 
3718 formed the most biofilm at 37 °C, with reduction in biofilm observed at 26 °C 
and 42 °C.  Strain JCM 3724 on the other hand, formed most biofilm at 26 °C and 
42 °C; this is an indication that strain JCM 3724 but not JCM 3718 or ARU 01 was 
able to survive in extreme temperatures by forming biofilms; all strains produced 
more biofilm at pH 4.  Biofilm formation was observed in both mono and dual 
species culture of F. necrophorum, in dual culture the organisms became resistant 
to penicillin and ciprofloxacin.  
As glycans are implicated in biofilm formation, bacterial adhesion to host cells and 
pathogenicity, the cell surface glycans and cell extracts of F. necrophorum were 
investigated using enzyme-linked lectin assays (ELLA) and lectin histochemical 
staining.  No significant differences were seen in the staining patterns, but a 
patchy and variable staining was noted for Sambucus nigra that detects sialic acid. 
A surface lectin, the Galactose binding protein was identified and characterised 
as binding to unsubstituted beta galactosyl residues of the type carried by many 
bacteria suggesting a role in biofilm formation. Subsequent molecular and 
bioinformatic studies identified all but one key component of the lipid A pathway; 
lpxI was shown to substitute for lpxH in the pathway. The component genes 
required for expression of sialic acid on the cell surface of the organism were 
determined; a polymorphism, the presence or absence of siaA, suggested some 
but not all strains had the ability to express this sugar on the cell surface. Further 
studies are required to determine whether this is linked to pathogenicity.  
Genomic and proteomic studies on type strains and clinical isolates revealed 
significant differences between subsp. necrophorum and funduliforme that will be 
useful in developing a simple molecular based subspeciation test. The subsp. 
funduliforme was split into 3 clusters (A, B and C) based on the genomic data; 
proteomic studies were used to determine the impact of the non-synonymous 
SNPs seen; two clusters were observed at the protein level, A and B+C. Most of 
the amino acid replacements that differentiated the clusters A from B +C were 
conservative or semi- conservative; more differences were noted between the two 
subspecies and these also included non-conservative changes that could affect 
protein structure and function. Clearly, there is scope for further work to elucidate 
the evolution of these clusters and their relevance to pathogenicity. 
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Chapter 1 
 
1 Historical Introduction  
 
 General introduction 
Fusobacterium necrophorum is an obligate anaerobic Gram-negative rod known 
to colonise the mouth and respiratory tract in humans (as reviewed by Brazier, 
2006).  The most severe clinical presentation of infections due to F. necrophorum 
is septic jugular thrombophlebitis (also known as Lemierre’s syndrome).  Findings 
include sore throat, persistent fever, soft tissue or neck swelling and bacteremia 
(Handler et al., 2011).  F. necrophorum is implicated as a cause of endemic 
pharyngitis in adolescents and young adults, accounting for more than 20 % of 
acute pharyngitis and may also be the cause of intra-abdominal infections, 
peritonitis, septic arthritis, brain abscesses and infrequently, infective endocarditis 
(IE).  There is strong evidence that F. necrophorum is also responsible for more 
than 20 % of recurrent, persistent or chronic sore throats known as persistent sore 
throat syndrome (PSTS), without resulting in full systemic infection. This 
bacterium is also implicated in otitis media in children, peritonsillar abscesses in 
adolescents and young adults and sinusitis in adults aged between 30-50 years; 
it has also been connected recently with tonsillitis (Jensen et al., 2007).  Studies 
by Batty et al., (2005) and others have revealed that pharyngitis can progress to 
develop into Lemierre’s syndrome, a severe and life-threatening infection, 
estimated to have a higher incidence, mortality and morbidity compared to 
rheumatic fever in adolescents and young adults in the Western world (Bank et 
al., 2010).  The disease progresses in several steps: primary infection, which is 
usually pharyngitis, local invasion of the lateral pharyngeal space and internal 
jugular vein (IJV) septic thrombophlebitis, and finally metastatic complications. 
 
F. necrophorum infections were first noted in humans in 1898 by Hallé who 
examined a female with genitourinary tract infection and discovered that the 
bacteriological infection showed cocci shaped organisms.  Further studies 
examining samples from patients suffering from otitis showed that they all had 
Gram-negative coccobacilli, and this led to Hallé naming the organisms as 
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‘Bacillus funduliformis’ (now referred to as F. necrophorum subsp. funduliforme 
(as cited by Brazier, 2006; Riordan, 2007).  
 
In 1930, Lemierre, a French physician showed the association of Bacillus 
funduliformis with systemic infection (as cited by Brazier, 2006).  Studies carried 
out by Lemierre in 1936 involving cases of anaerobic septicaemia, noted that the 
infected group consisted mainly of young adults.  Their mortality rate from the 
onset of the infection was 7- 15 days, with symptoms ranging from mild fever to 
metastatic embolic pulmonary abscesses (as cited by Kristensen and Prag, 2000). 
This led Lemierre to provide a clear clinical description of postanginal septicaemia 
associated with F. necrophorum.  In the late 1980s, the names necrobacillosis and 
postanginal septicaemia were replaced with Lemierre’s syndrome (LS). 
 
 History of F. necrophorum   
F. necrophorum was first described in animals, as it is a much more common and 
important pathogen in animals than in humans. This organism was first recognised 
in 1884 by Loeffler as the cause of dipththeria infection in a calf.  He identified    
stained sections of dipththeric samples as negative rods with filamentous forms. 
This material was injected into mice, generating purulent lesions which were foul-
smelling and contained similar bacilli.  The isolate from calf serum broth could not 
be further sub-cultured.  Flugge named the organism Bacillus necrophorus and 
coined the term necrobacillosis for the disease.  The organism was first isolated 
in culture by Bang from liver abscess of cattle, and identified as the cause of hog 
cholera as cited by Riordan, (2007).  Schmorl in 1891 described the first human 
infections involving an animal strain.  Schmorl and his assistant working on rabbits 
with necrobacillosis developed abscesses on their fingers.  Once resected, 
stained and analysed microscopically, the results demonstrated the characteristic 
filamentous Gram-negative bacilli that he observed earlier (as reviewed by 
Riordan, 2007). 
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 Issues associated with the detection of F. necrophorum in Humans 
Isolation and identification of obligate anaerobes such as F. necrophorum from 
the normal microbiota of the throat is difficult and time-consuming (Aliyu et al., 
2004).  In diagnostic microbiology laboratories, isolating this bacterium requires 
adherence to the principles of good anaerobic bacteriology, due to its fastidious 
and strict growth requirements.  Studies have shown that strict anaerobic 
conditions need to be adhered to when working with F. necrophorum with 
minimum exposure to air.  The Centers for Disease Control and Prevention (CDC), 
USA, indicated that this microorganism may not survive exposure to air for more 
than 30 minutes (CDC, 2002).   
 
This bacterium accounts for only a small proportion of cases of human infection 
compared to other non-sporing anaerobes, therefore is not well studied.  However, 
there has been an increase in the isolation of the organism, which has stimulated 
research of this bacterium in microbiology laboratories in the UK (Brazier et al., 
2002; Brazier, 2006; Jones et al., 2001).  This increase may be due to increasing 
awareness, improved anaerobic diagnostic facilities and advice to general 
practitioners (GPs) not to prescribe empiric antibiotics for simple sore throats 
(Jones et al., 2001; Hagelskjaer et al., 1998; Brazier et al., 2002; Department of 
Health Standing Medical Advisory Committee, 1998). 
 
 Animal infections with F. necrophorum 
F. necrophorum is the cause of necrobacillosis in animals and is implicated in liver 
abscesses and footrot in cattle and sheep (Langworth, 1977; Zhou et al., 2009a). 
The first description of F. necrophorum infection in animals was in 1876 by 
Dammann then studying calf dipththeria.  He believed that the infection manifested 
due to Bacillus diphtheria, until Loeffler in 1884 analysed necrotic tissue of stained 
diphtheria material and labelled the causative agent as F. necrophorum (as cited 
by Brazier, 2006).  F. necrophorum is a recognised opportunistic animal pathogen, 
causing a variety of diseases, including dipththeria in calf and mastitis in cattle, 
hepatic (liver) abscesses and foot rot.  Liver abscesses have been described as 
the most common outcome of F. necrophorum infection found in cattle, and these 
infections are thought to start in the rumen and spread through septic emboli to 
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the liver.  Footrot is a necrotic infection of the soft tissues on the foot and 
surrounding skin, and this can often lead to fever and lameness in cattle and other 
hooved animals.  Predisposing factors include walking on damp ground and old 
injuries to the interdigital skin, with faecal secretions being the primary source of 
infection (Tan et al., 1996).  The incidence of hepatic abscesses reached up to 32 
% in most feed yards (Brink et al., 1990).  Simon and Stovell, (1971) demonstrated 
that F. necrophorum was present in 97 % all of liver abscesses assessed.  A total 
of 67 % of F. necrophorum were isolated in pure culture and 30 % isolated with 
other microorganisms such as streptococci.   
 
These infections of livestock have a major economic impact on the farming 
industry as well as on the animals’ welfare and this has led to the research on F. 
necrophorum mainly focused on the animal pathogen.  The bacterium was initially 
described as more common and important in animals, but others later described 
it as a historical view due to the increasing importance of the infection in humans 
(Nagaraja and Chengappa, 1998; Riordan, 2007; Wright et al., 2012). 
 
 F. necrophorum subspecies 
F. necrophorum is taxonomically divided into two subspecies: F. necrophorum 
subsp. necrophorum (FNSN) and F. necrophorum subsp. funduliforme (FNSF).  
The necrophorum subspecies is the more virulent form associated mostly with 
infections in animals, whereas subsp. funduliforme infects mainly humans 
(Brazier, 2006; Zhang et al., 2006; Jensen et al., 2007). 
  
 Phenotypic Identification of the organism 
F. necrophorum is a non-motile, non-sporing slow growing pleomorphic rod-
shaped anaerobe.  A few different agars can be used for culturing F. necrophorum, 
these include brain-heart infusion (BHI) agar, Columbia blood agar enriched with 
vitamin K, hemin and yeast extract (Brazier et al., 1990).  Studies by Batty and 
Wren (2005) and Brazier (2006) suggested that fastidious anaerobe agar (FAA) 
supplemented with 5 - 10% defribinated horse blood is best for culturing F. 
necrophorum.  FAA which has cysteine as a growth promoting agent provides all 
the nutritious medium for the growth of organism.  Commercial kits such as the 
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API 20A, API Rapid ID 32A and RapID-ANA II strip tests can be used to identify 
F. necrophorum, although as many of the tests on each strip are negative, 
excluding the indole and alkaline phosphatase tests, it is often better to use 
specific tests when F. necrophorum is suspected (Batty et al., 2005; Riordan, 
2007). 
The catalase test demonstrates the presence of the enzyme catalase which 
catalyses the release of oxygen from hydrogen peroxide (H2O2).  This test 
differentiates bacteria that produces catalase enzyme from non-catalase 
producing bacteria.  This enzyme breakdown hydrogen peroxide into oxygen and 
water, thus bacteria can protect themselves from the lethal effect of hydrogen 
peroxide which accumulates as end product of aerobic carbohydrate metabolism.  
Obligate anaerobes would be negative for catalase as they would die in the 
presence of oxygen.  They do not produce this enzyme, as they do not use 
oxygen, so would not need to break it down.  Although some obligate anaerobes 
produce these enzymes in very small quantities, they are totally absent in others 
(Hentges, 1996).  
Anaerobic bacteria can be classified by the presence and absence of lipase 
among other things.  One readily detectable feature of F. necrophorum is the 
production of lipase on egg yolk agar.  Lipases are enzymes catalysing the 
breakdown of triglycerides (triacylglycerols) into glycerol and long chain fatty 
acids.  Egg yolk agar is a differential and enriched medium used for the isolation 
and differentiation of different species based on their lipase and lecithinase 
activity.  This non-selective egg yolk supplemented medium supplies lecithin and 
free fats, which are required for the detection of lipase and lecithinase production.  
If the enzyme is present, the microorganism hydrolyses the free fats pesent in the 
medium, forming glycerol and free fatty acids.  The insoluble free fatty acids that 
is released, forms an iridescent sheen (oil on water) seen on the surface of the 
plate when angled at a light source (Tille, 2013).  F. necrophorum subsp. 
funduliforme is less strongly positive for lipase than subsp. necrophorum. 
Tryptophanase enzymes which produce indole as a metabolite from tryptophan is 
also produced by F. necrophorum.  The test for this uses spot indole reagent which 
produces a greenish-blue colour when positive for indole (Batty et al., 2005).  F. 
necrophorum colonies fluoresce a greenish-yellow under long wavelength Ultra-
violet (UV) light of 365 nm (Barrow and Feltham, 2004). 
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 Antimicrobial susceptibility 
F. necrophorum is kanamycin and metronidazole sensitive and generally 
susceptible to penicillins, colistin, tetracyclines, lincosamides and macrolides, but 
resistant to vancomycin, gentamycin, neomycin and streptomycin (Nagaraja et al., 
1998). 
 
 Molecular identification 
The use of molecular typing techniques to characterise bacterial strains is a very 
powerful tool, which contributes to our understanding and control of outbreaks and 
recurrent infections (Hollis et al., 1999).  F. necrophorum is thought to have a 
complex and unusual virulence and pathogenesis, which is poorly understood at 
present. In a small study in humans, 17 isolates from cases of systemic disease 
and from cases of persistent sore throat syndrome were compared using 
enterogenic repetitive intergenic consensus (ERIC) - PCR to determine whether 
strains of similar or different types were responsible for throat and systemic 
disease; similar strains were found in both diseases (Batty et al., 2005). They 
identified at least twelve different band patterns and hence types.  Interestingly, 
four proposed types were shared amongst clinical presentations (CPs) including 
a large proportion demonstrating the same band patterns as the type culture strain 
(JCM 3724), but the results also showed seven types that were exclusive to either 
persistent sore throat syndrome or Lemierre’s syndrome samples. 
Molecular typing studies by Okwumabua et al., (1996)  investigated differences 
between bovine strains of both subspecies of F. necrophorum using ribotyping.  
Narayanan et al. (1997) expanded on the work and discovered different strains 
and subspecies from different lesions in the same animal, indicating different 
strains actively causing independent lesions. They also identified the same strain 
in different sites, possibly suggesting that only certain strains are able to colonise 
and spread, which indicates a potential route of pathogenesis of the bacterium. 
This work has not been carried out for the human pathogen. 
 
 Evidence for biofilm formation 
Fusobacteria are likely to reside in biofilms alongside other microbes that can 
decrease the available oxygen and provide a stable anaerobic environment.  
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Biofilms are defined as structured communities of bacterial cells enclosed in a self-
produced polymeric matrix. They are ubiquitous masses of cells capable of 
surviving on a wide range of surfaces by adhering to an inert or living surface such 
as water pipes and chronic wounds. This mode of growth is a strategy used by 
microorganisms to survive harsh growth conditions and exposure to antimicrobial 
agents (Stewart and Costerton, 2001). Biofilms are surrounded with self-
generated exopolysaccharides known as the extracellular polymeric substance 
(EPS).  The EPS is made up of polysaccharide biopolymer, protein and DNA, but 
the structural components vary among different bacterial species and strains 
(Branda et al., 2005). These are tightly attached to the underlying surface and 
inactivate the defence molecules, thus contributing to the persistence of the biofilm 
and difficulty in treatment (Vu et al., 2009).  There is evidence that biofilms play 
an important role in the development of antimicrobial resistance. Since their 
complex structure provides a barrier to the penetration of antimicrobial agents. 
The EPS protects the bacteria from killing by antimicrobial agents and enables 
evasion from the host immune response, resulting in chronic upper respiratory 
infections and in the case of F. necrophorum biofilm and antibiotic resistance 
(Mohammed et al., 2013).  It has been shown that the resultant biofilms have 
altered phenotypes with respect to growth, gene expression and protein 
production.  This is as a result of communication among the bacteria in this sessile 
environment known as quorum sensing (QS) (Donlan et al., 2002). Most bacteria 
during stressful changes in the environment, secrete small QS signalling 
molecules also called autoinducers, at a concentration (threshold) corresponding 
to the density of cells (Raina et al., 2009; Jang et al., 2012). Stress response gene 
expression is triggered at a threshold causing a change in cell surface proteins, 
which increases cell surface hydrophobicity (Stanley and Lazazzera, 2004). QS is 
implicated in the regulation of processes such as antibiotic resistance, antibiotic 
production, biofilm formation, bioluminescence and virulence expression 
(Engebrecht and Silverman, 1984; Haas et al., 2002). 
The human upper respiratory tract has abundant oxygen, yet facultative and 
obligate anaerobes have been shown to thrive in this niche (Ahn and Burne, 
2007).   Anaerobes such as F. necrophorum are thought to survive in this oxygen 
rich environment by forming polymicrobial biofilms, where oxygen is consumed by 
aero-tolerant species; this creates an oxygen gradient in the biofilm, allowing 
anaerobes to survive deep within (Bradshaw et al., 1998).  It is unusual to find a 
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single bacterial species in an infection and the microbes tend to form biofilms that 
act synergistically, affecting, for example, the antibiotic sensitivity of the organisms 
involved.  Biofilms have been associated with a wide variety of microbial infections 
in the body, estimated to be as high as 80% of all infections according to the 
National Institutes of Health (NIH) (Davies, 2003; Joo and Otto, 2012; Jamal et 
al., 2018).   
Many biofilms are detrimental to humans, the clinically important ones are formed 
in response to stresses from the host defence mechanisms and antibiotics 
(Anderson and O’Toole, 2008).  Biofilms have increased resistance to 
antimicrobials and are more resistant to host defence mechanisms than free-living  
planktonic cells; indeed bacteria in a biofilm growth state can be up to 1000 times 
more resistant than their planktonic counterparts (Mah and O’Toole, 2001; López 
et al., 2010).  Thus, biofilm formation is a mechanism that promotes bacterial 
attachment to host surfaces. Bacteria within biofilms communicate with one 
another through soluble signalling molecules to optimize gene expression for 
survival and live in conditions of limited nutrients in a dormant state, in which 
defence molecules produced by the immune system and pharmacologic 
antibiotics are less effective.  Research into the formation of F. necrophorum 
biofilms may shed light on the behaviour and requirements of this obligate 
anaerobe. 
Bacteria in biofilms usually use surface proteins and sugars for attachment to each 
other, host cells or to the extracellular matrix. Oligosaccharide residues on cells, 
such as surface proteoglycans, glycoproteins and glycolipids, are specific to 
different cells.  Fimbriae and other cell surface appendages expressed by bacteria 
such as Escherichia coli are involved in providing structural stability during biofilm 
formation (López et al., 2010; Donlan, 2002). Bacterial lectins are carbohydrate-
binding proteins first described in 1970 by Nathan Sharon and colleagues.  They 
specifically identify and bind to sugar moieties to help in the process of cell-cell or 
cell-matrix attachments during biofilm formation; these lectins also bind with 
glycan ligands on host surface receptors.  Lectins are also useful as primary 
diagnostic tools for the identification of bacterial glycans (Afrough et al., 2007; 
Munoz et al., 1999; Munoz et al., 2003; Slifkin and Doyle, 1990).  
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 The role of glycans in biofilm formation 
In the last 15 years, interest in the glycans of bacteria has increased substantially. 
These glycans can be found in polysaccharides, glycoproteins glycolipids, 
lipopolysaccarides and peptidoglycans (reviewed by Comstock and Kasper, 
2006).  The lipopolysaccharides and peptidoglycans have been well documented 
but more recently the focus has moved towards glycolipds and glycoproteins 
(Zhou and Wu, 2009), some of which carry sugars identical to those of the host 
implying that molecular mimicry could be a colonisation strategy (reviewed by 
Varki et al., 2009).  Additionally, bacterial glycans can facilitate binding to other 
bacteria or to host cells via glycan-lectin interactions.  A number of pathogens 
have been investigated and the data supporting the role of glycans and lectins in 
colonisation, adherence and biofilm formation is compelling (Esko and Sharon, 
2009).  
 
Glycan-lectin binding plays a role in biofilm formation with for example, lectins on 
organisms binding to host glycans, lectins on the host binding bacterial glycans 
and lectin-glycan binding between organisms of the same or different species.  
The understanding of the mechanisms of biofilm formation in F. necrophorum 
infection could lead to the development of ways of inhibiting biofilm formation and 
potential therapeutic strategies based on glycan and biofilm formation (Lesman-
Movshovich et al., 2003; Ofek et al., 2003; Wu et al., 2007; Rachmaninov et al., 
2012).  
Oligosaccharides containing N-acetylneuraminic acid (sialic acid) on the cell 
surface of some pathogenic bacteria are known to be important for host-microbe 
interactions.  Studies have shown N-acetylneuraminic acid (Neu5Ac) has a major 
role in the pathogenicity of bacterial pathogens, such as cell surface 
sialyloligosaccharide moieties of the human pathogen Haemophilus influenzae 
which are involved in virulence and adhesion to host cells.  Little is known about 
glycosylation of F. necrophorum; indeed, bacterial glycosylation is a fairly novel 
area and glycans have not yet been given a definitive function.   However, many 
discoveries have been made on appendages of pathogenic bacteria indicating 
glycans may influence pathogenicity (Vimr, 2004; Vimr et al., 2013). 
By imitating the carbohydrates of human host cells, which are crucial for self/non-
self-recognition, a bacterial pathogen can escape the host immune system. The 
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terminal oligosaccharide moieties of some bacteria are identical to those of 
gangliosides, which are compounds composed of a glycosphingolipid with one or 
more sialic acid linked to the sugar chains; these moieties are thought to be 
involved in virulence and adhesion to host cells (Yuki et al., 2004).  Important 
information in the understanding of the role of bacteria in chronic infections will be 
obtained from an investigation of the mechanisms of glycan-lectin interactions 
during biofilm formation. The inhibition of glycan-lectin interactions and quorum 
sensing have been considered as alternative strategies to antibiotic treatment that 
can be useful in the treatment of chronic infections through the prevention and 
disruption of biofilm formation (Brackman et al., 2011). 
 
Extracellular products such as lipopolysaccharide (LPS) endotoxins confer 
pathogenicity to Fusobacteria; LPS is the major component of the outer 
membrane of Gram-negative bacteria. In the late 19th century Richard Pfeiffer 
discovered a heat-resistant toxic component released from Vibrio cholerae only 
after the destruction of the bacterial cell wall (as cited by Lerner et al., 2003).  This 
structure is essential for the majority of Gram-negative organisms and confers 
protection in hostile environments and antibiotic resistance (Dong et al, 2014).  
LPS is the most powerful natural immunogen able to trigger strong immune 
response in animals. This complex molecule of about 30 KDa is composed of 
three different regions: O-antigen, core oligosaccharide and lipid A.  
 
The O-antigen or O-polysaccharide is the most heterogenous part of the LPS 
consisting of many sugar unit repeats, and it is bound to the core oligosaccharide. 
It is the outer part of the LPS that is the first target of the host immune system and 
is also important in serological classification of bacteria strains (Atlas, 1997).  The 
core part of the LPS is the hetero-oligosaccharide containing sugars such as: acid 
2-keto-3-deoxyoctulosonate (KDO), L-glycerol-D-manno-heptose, D-galactose 
and D-glucose; this connects the O-antigen repeats with lipid A (Henderson, 
2013). 
 
Lipid A is hydrophobic and allows anchorage of the whole molecule to the bacterial 
outer membrane.  It is highly conserved in Gram-negative bacteria and is the toxic 
component of the LPS.  This structure and the biosynthetic pathway of lipid A is 
widely researched and studied; it is the most conserved part of the LPS in bacteria 
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and responsible for endotoxic activity and growth.  Studies in Escherichia coli have 
shown involvement of enzymes and genes in lipid A biosynthesis which are shared 
by many Gram-negative bacteria (Wang and Quinn, 2010).  The elucidation of the 
lipid A pathway in F. necrophorum would help clarify its importance in bacteria 
expressing the endotoxin. 
 
 Sialic acid 
Sialic acids are important components of carbohydrate chains, they commonly 
occur at the terminal position to form glycoconjugates, including glycoproteins and 
glycolipids (Vimr et al., 2004).  A major sialic acid linked to glycoconjugates, and 
the sialyloligosaccharides of glycoconjugates is N-acetylneuraminic acid 
(Neu5Ac).  It plays important roles in many biological processes including cell–cell 
recognition, inflammatory and immunological responses, cancer metastasis and 
viral infection.  Lipopolysaccharides, lipooligosaccharides, and glycoproteins are 
among the glycoconjugates located on the surface of bacteria pathogenic to 
humans such as Haemophilus influenzae and Campylobacter jejuni, and their 
sugar chain structures have been determined (Kajiwara et al., 2010). 
 
 Galactose binding lectin 
F. necrophorum surface is decorated with many glycan-binding proteins, which, 
as well as helping with attachment to the host also protect them from host 
defences.  These glycan-binding proteins also known as lectins were first 
described in bacteria by Nathan Sharon and colleagues in 1970.  These lectins 
are adhesins, some of which have haemagglutination activity, and bind with glycan 
ligands on host receptor surface.  Scientists have analysed the structure of these 
adhesins in Gram-negative anaerobes; the main interest is in those adhesins 
(lectins) important for bacterial internalisation or for colonisation (Nobbs et al., 
2009).  Several studies have shown the expression adhesins of Fusobacterium 
nucleatum that mediate galactose-sensitive binding to various mammalian cells 
and lectin-like adhesins that enabled galactose-sensitive coaggregation with other 
periodontopathogenic bacteria (Shaniztki et al., 1997). 
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 Genome sequencing of Fusobacterium 
Kapatral et al., in 2002 completed a study to understand the genetic, metabolic 
and pathogenesis of Fusobacterium, by assembling the F. nucleatum strain ATCC 
25586 genome from shotgun sequences; this was the first determination of 
Fusobacterium species genome sequence.  From the genome analysis, they 
revealed several important pathways including amino acid, carbohydrate, organic 
acid and lipid metabolism.  They were able to predict for the first time some outer 
membrane proteins of very high molecular weight, and also identified several 
transporters which are used for uptake of different substrates including sugars, 
peptides, metal ions and cofactors.  
The annotated genome of F. nucleatum has been used to predict the genome of 
F. necrophorum, as they are both thought to occupy similar niches and may 
therefore share some virulence mechanisms.  The first genome for F. 
necrophorum was lodged in 2012 in the GenBank database, but now there are 
many more genomes available, which include strains from deer, bovine and 
human origin. 
 
  Biochemical research on Fusobacterium in the last decade 
A survey of the PubMed database (22/01/2019) using the interrogation terms 
“Fusobacterium necrophorum” and “human” and limiting the search to the past 
decade retrieved 280 publications.  Of these, the vast majority were medical case 
studies, and a few were epidemiological surveys.  This underlines a strong interest 
in the medical consequences of infection and the number of cases worldwide.  
Only one publication addressed biochemical aspects of the organism (Holm et al., 
2017).  In this study of 220 human isolates of F. necrophorum, the authors 
determined that there were 3 variants of the leukotoxin gene; 2 of which had not 
been previously described.  They also noted that the majority of isolates had novel 
sequence types and that these were related to the site of infection.  Clearly there 
is scope for in-depth biochemical and molecular analyses of the organisms to gain 
an understanding of metabolic processes, molecular diversity and the relationship 
to pathogenicity. 
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 Prevalence of F. necrophorum infection in the UK. 
There are issues surrounding determination of organism prevalence as this would 
rely on the reporting of all infections: this is not current practise in the UK.  A large 
retrospective study of symptomatic patients was carried out at the Royal 
Hampshire County Hospital (Pett et al., 2014).  They reported 18 patients 
diagnosed with Fusobacterial infections; 0.76 cases/100,000/year, of which half 
were infected with Fusobacterium necrophorum.  This study indicated a relatively 
low number of infections seen in the UK.  
 
The relative importance of F. necrophorum was highlighted by Centor et al., (2015) 
in a cross-sectional study of 312 university students in the USA aged 15-30 years 
who presented with acute sore throat and 180 asymptomatic controls. They 
isolated Fusobacterium necrophorum in 20.5 % of patients and 9.4 % of 
asymptomatic students; group A β-haemolytic Streptococcus in 10.3 % of patients 
and 1.1% of asymptomatic students; group C/G β-haemolytic Streptococcus in 9.0 
% of patients and 3.9 % of asymptomatic students and Mycoplasma pneumoniae 
in 1.9 % of patients and 0 % asymptomatic students.  Likewise, Klug et al., (2016) 
undertook a systematic literature search to investigate 498 records of patients with 
acute tonsillitis and associated controls.  Patients were found to be more likely to 
carry F. necrophorum than healthy controls (21 % vs 8 %).  
 
Holmes et al., (2016) reviewed the role of F. necrophorum in pharyngotonsillitis. 
Having determined that it was an important pathogen in 13 - 40 years old suffering 
from pharyngotonsillitis, he suggested that throat swabs from such patients should 
be routinely tested for the presence of the organism.  This is important given the 
reported cases of Lemierre’s disease in teenagers and yound adults. In a study of 
patients in Sweden, Dapefrid et al., (2017) also reported a high prevalence of 
Fusobacterium necrophorum in 126 patients in the age group 15-23 years 
diagnosed with chronic tonsillitis undergoing tonsillectomy. Interestingly, F. 
necrophorum was the most common pathogen (19 %) and was detected at both 
the surface and in the core of the tonsils; even though F. necrophorum is a strict 
anaerobe.  In the same age group of patients, streptococci group G and C were 
also detected (30 %). 
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In a study by Atkinson et al., (2018) a comprehensive microbiome analysis of 
students in the USA suffering from pharyngitis confirmed that F. necrophorum was 
a more common cause (18 patients) than Streptococcus pyogenes (Group A 
streptococci) (9 patients).  It was also noted that the development of a productive 
mucosal infection with F. necrophorum was associated with a significant decrease 
in the microbial diversity. Yusuf et al., (2015) investigated cultures from 230 
patients in Belgium (median age of 28 years, 61.7 % men).  F. necrophorum was 
found in 37/57 of patients suffering from acute tonsillitis or peritonsillar abscess, 
whilst Fusobacterium spp. other than F. necrophorum were found in 35/45 of 
patients with acute otitis.  
 
However, in a cohort of fifty-seven patients aged 15-52 years who were to undergo 
tonsillectomy due to recurrent or persistent throat pain, Björk et al., (2015) 
assessed oropharyngeal colonisation with F. necrophorum and β-haemolytic 
streptococci.  Follow-up samples were also assessed for bacterial colonisation 
post-surgery.  In the samples harvested pre-surgery, during surgery and at follow 
up, F. necrophorum was detected in 28, 30 and 16 % of the patients respectively. 
By comparison, the results for β-haemolytic streptococci were 5, 9 and 5 % 
respectively.  Interestingly, patients with and without colonisation with F. 
necrophorum at follow-up both reported relief from pain: this suggested that F. 
necrophorum was not the sole cause of the symptoms seen and hence further 
work is required to determine its’ role in pathogenicity. However, the reporting of 
the levels of pain is subjective and there were issues associated with storage of 
samples prior to testing.  In support, Hayawaka et al., (2018), studied 32 Japanese 
patients undergoing elective tonsillectomy between 2014 and 2015, and 
determined the prevalence of F. necrophorum by either culture or gyrB PCR.  F. 
necrophorum was not significantly different between patients with infectious and 
non-infectious indications.  However, the authors themselves raised issues on this 
study; the cohort number was too small for robust statistical analysis, qPCR was 
not performed, and the MIC determination was carried out in broth rather than on 
agar.  More importantly, exposure of the patients to recent antimicrobial therapy 
was collected retrospectively resulting in a likely underestimation of infection. 
 
There are some researchers who feel that F. necrophorum plays an important role 
in pathogenesis and others whose studies do not support this. It is difficult to 
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reconcile these views, however, the work of Björk et al., (2015) does suggest that 
in tonsillitis, symptoms were alleviated even when F. necrophorum was detected 
post-surgery suggesting that the organism is not the prime cause of the associated 
pain.  Differences noted in different racial groups (cohorts) may be due to ethnic 
variations in cell surface receptors required to enable attachment of the organism 
or differences in immune response.  
 
 Study Aims  
The aims of this research project were to: 
1. investigate biofilm formation in F. necrophorum, to determine optimal 
conditions, to assess antibiotic resistance of biofilm and confirm the 
organism present by DNA sequencing. 
2. analyse the glycan-lectin profiles of the organisms. 
3. investigate the LPS/lipid A pathways utilising in silico methods. 
4. sequence whole genomes of type strains and clinical isolates. 
5. analyse whole genome sequences (WGS) of clinical strains to confirm 
presence of genes involved in glycan pathways. 
6. determine sialic acid related metabolic pathways utilising in silico methods 
to interrogate WGS of Fusobacteria sp. 
7. to provide evidence for a future robust typing system for F. necrophorum. 
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Chapter 2   
 
2 Materials and Methods 
 
 Materials 
Materials used in this study were purchased from various selected companies 
including Sigma–Aldrich (Dorset, UK), VWR Ltd (East Grinstead, UK), Qiagen 
(Crawley, UK), and Fisher Scientific Ltd (Loughborough, UK). Solid media, 
including Fastidious anaerobe agar (FAA), Fastidious anaerobe broth (FAB), 
Brain Heart Infusion (BHI) broth, Luria–Bertani (LB) agar, and blood used for 
culturing bacterial strains were obtained from Sigma–Aldrich (Dorset, UK), VWR 
Ltd (East Grinstead, UK), LabM Ltd., Heywood, UK, Oxoid Ltd (Basingstoke, UK) 
and Fisher Scientific Ltd (Loughborough, UK).  Biofilm assays were performed 
using conventional microtitre plates (Nunc™, Denmark).  All PCR and DNA 
sequencing kits were obtained from Qiagen and Sigma–Aldrich Ltd, UK.  
 
 Bacterial isolates and type cultures  
Human isolates of Fusobacterium necrophorum harvested from patients with 
persistent sore throat were obtained from the HPA laboratory at University College 
Hospital London (UCLH), UK (Table 2.1); no clinical data was provided.  One 
clinical F. necrophorum isolate (ARU 01) from a human with Lemierre’s disease 
and two bovine (from bovine liver abscesses) reference strains from the Japanese 
Collection of microorganisms (JCM): F. necrophorum subsp. necrophorum (JCM 
3718) and F. necrophorum subsp. funduliforme (JCM 3724), were obtained from 
Mrs V. Hall, at the Anaerobe Reference Unit, Cardiff.  Whilst all cultures obtained 
had been sub-cultured and grown within an anaerobic cabinet, all the results 
presented in this thesis were obtained in experiments carried out in anaerobic gas 
jars (section 2.3.2.1), microtitre plates with oil overlay (section 2.4.4.4) or Hungate 
tubes (section 2.7.1). 
 
E. coli NCTC 10418 and S. aureus NCTC 6571 used in this study were obtained 
from stock cultures held at the University of Westminster, London.  At the time of 
this research, the cultivation of Clostridium perfringens, an anaerobic control, was 
not allowed at the University of Westminster. 
  17 
Table 2.1 Clinical strains/isolates of Fusobacteria from UCLH, London, UK. 
 
Collection Isolate numbers 
Clinical isolates of 
Fusobacterium 
necrophorum 
1, 5, 11, 21, 24, 30, 39, 40, 41, 42, 52, 59, 62, 
70, 80, 82, 86, 87, 88, 89, 90, 91, 92, 93, 94, 
95. 
  
 
 
 
 Table 2.2 Strains of Fusobacteria from Anaerobic Reference Unit,  
 Cardiff, UK. 
Strain/ 
Isolate Subspecies 
Source 
ARU 01 
Fusobacterium necrophorum subspecies 
funduliforme 
Human 
JCM 3718 
Fusobacterium necrophorum subspecies 
necrophorum 
Bovine liver 
JCM 3724 
Fusobacterium necrophorum subspecies 
funduliforme 
Bovine liver 
(JCM –Japan Collection of Microorganisms (Microbe Division (Riken Brc, 2015)) 
 
 Table 2.3 Control strains of bacteria used in this study. 
 
Culture Strain NCTC Number 
 
Escherichia coli NCTC 10418 
Staphylococcus 
aureus NCTC 6571 
(NCTC – National Collection of Type Cultures (Culture Collections, 2015) 
 
 
 Methods 
2.3.1 Preparation of media, buffers and stock solutions 
2.3.1.1 Solid media 
Solid media used in this study were prepared following the manufacturer’s 
instructions.  The desired amounts of the powdered agar were weighed and 
dissolved in deionised water and thoroughly mixed either by heating on a hot plate 
or gently stirring and swirling until all the powdered agar was dissolved.  The 
media were then sterilised by autoclaving at 121 °C for 15 minutes at 15 psi. For 
the preparation of solid media supplemented with blood, antibiotics or sugars, the 
autoclaved media were cooled to 50 °C after which the supplements were added. 
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Blood agar was normally prepared by the addition of horse, sheep or human blood 
(7 % (v/v)) Fastidious anaerobe agar (FAA). LB agar without supplements was 
used for growth of the control aerobic bacteria. 
2.3.1.2 Liquid media 
Liquid media were also prepared according to manufacturer’s instruction and 
sterilised by autoclaving at 121 °C for 15 minutes at 15 psi before use.  The same 
method as above was followed for the addition of supplements. Liquid media used 
included FAB, BHI broth and LB broth. 
2.3.1.3  Solutions 
All solutions used were prepared according to the manufacturer’s instructions and 
sterilised by autoclaving or where appropriate, by filtration.  Solutions included 1X 
phosphate buffered saline (PBS), TE (10 mM Tris–HCl, 1 mM EDTA, pH 8.0) 
buffer, 10X Tris–Borate–Ethylene–diamine–tetra–acetic acid (EDTA  0.5 M) 
(TBE), Elution buffer (10 mM Tris–HCl, pH 8.5, 10X Tris–Acetate–Ethylene–
diamine–tetra–acetic acid (EDTA 0.5 M) (TAE), physiological saline (0.85% NaCl), 
10% SDS, 4% formaldehyde, 8mM NaOH, 5M NaCl and 0.1M sodium citrate in 
10% ethanol. 
2.3.1.4 Preparation of antibiotics 
Antibiotics stock solutions used in this study were prepared using their respective 
solvents according to the manufacturer’s instructions.  These included ampicillin 
(AMP), ciprofloxacin (CIP), gentamicin (GM),) kanamycin (KAN), tetracycline 
(TET), vancomycin (VAN), levofloxacin (LEVO), ceftazidime (CEF), and 
chloramphenicol (CHL).  Stock solutions for all antibiotics used were prepared 
following the guidelines of Clinical Laboratory Standards Institute (CLSI, 
document M100–S24) and the British Society for Antimicrobial Chemotherapy 
(BSAC) methods for antimicrobial susceptibility testing guidelines, filter–sterilised 
and stored at –80 °C (Clinical Laboratory Standards Institute, 2014; British Society 
for Antimicrobial Chemotherapy, 2013). EUCAST (European Committee on 
Antimicrobial Susceptibility Testing) breakpoints were used where BSAC had no 
established breakpoints for the interpretation of zones of inhibition for some 
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antibiotics.  It is recommended that, as disc diffusion methods are not so robust in 
anaerobes, that in future work gradient strips (e.g. E-test) should be used.  
Working solutions of each antibiotic used for min mum inhibitory concentration 
(MIC) determination were prepared as 10, 100 and 1000–fold concentrations 
using the MIC range (512, 256, 128, 64, 32, 16, 8, 4, 2, 1, 0.5 and 0.25 µg/mL) as 
a guide and stored at –20 °C. Stock concentrates of each were prepared at 5120 
µg/ml; these were diluted with sterile LB broth to make working  concentrations. 
2.3.2 Identification of F. necrophorum isolates 
2.3.2.1 Bacterial culture  
Cultures were suspended in sterile 15 % (v/v) glycerol solution (Sigma, 
Gillingham) and frozen at -80 °C for long-term storage.  Using these stocks, all  F. 
necrophorum isolates were cultured on fastidious anaerobe agar (FAA) (LabM 
Ltd., Heywood, UK) supplemented with 5-7 % defibrinated horse, sheep blood 
(Oxoid Ltd., Basingstoke, UK) or whole human blood (NHS Blood Transfusion 
Lab, London, UK) and incubated anaerobically at 37 °C for 48 hours  in  an 
anaerobic jar (Oxoid Ltd., Basingstoke, UK) with AnaeroGen™ sachet (Oxoid Ltd., 
Basingstoke, UK) generating anaerobic growth conditions (oxygen level <1 % and 
9-13 % carbon dioxide and 85 % nitrogen).  An oxygen detector strip was used to 
monitor anaerobe conditions.  Colonies obtained were subsequently sub-cultured 
in Brain Heart Infusion (BHI) broth (Lab M Ltd., Heywood, UK) and grown 
anaerobically at 37 °C with shaking at 85 rpm in the Innova 42 incubator shaker 
(Eppendorf Inc., CT, USA) for 48 hours, until an optical density (OD) of 0.6 to 0.7 
at wavelength of 600 nm was achieved.  E. coli and S. aureus (provided by the 
University of Westminster, London, UK) were used as positive controls throughout 
this study.  E. coli and S. aureus were cultured on Luria Bertani (LB) agar under 
aerobic conditions at 37 °C overnight and sub-cultured in LB broth with shaking at 
200 rpm and 37 °C overnight. 
2.3.2.2 Biochemical identification of bacterial strains 
Identification tests were carried out on all the Fusobacterium strains isolated on 
the FAA. They were analysed macroscopically by observing the colony 
morphologies and microscopically by performing Gram staining on all cultured 
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isolates using the method described by Halebain et al., (1981).  Biochemical 
identifications included the Catalase Test (Sigma Aldrich Ltd, Dorset, UK), 
Oxidase Test using N, N, N’, N’- tetramethyl-p-phenylenediamine (TMPD) and 
Spot Indole Test (Remel™; Thermo Scientific, DE, USA).  Lipase production was 
tested by the egg yolk agar plate method. Briefly, egg yolk saline solution (1:1) 
was added to FAA (instead of GAM - Gifu Anaaerobe Medium agar) at a 
concentration of 10% and the strains were inoculated as streaks and incubated 
as described above.  The formation of an oily iridescent sheen over and 
immediately around growth indicated lipase production (Amoaka et al., 1993). 
Identification was also carried out on type strains used in this study even though 
they had been identified in previous studies.  Some, but not all cultures were 
examined under UV light for fluorescence.  The isolates had been analysed by 
API and fatty acid analysis by our collaborators. 
2.3.2.3 Primer design 
Primers were designed to target the gyrase B gene of Fusobacteria and for the 
highly conserved areas of bacterial 16S, 23S rRNA genes. Sequences were taken 
from the literature (Chakravorty et al., 2007) and BLASTN, CLUSTALW 
(www.ebi.ac.uk/Tools/msa/) were used to identify highly conserved areas suitable 
for primer design.  Primers were designed using Primer 3 (www.primer3.ut.ee) 
and synthesised by MWG Eurofin, Germany. 
2.3.3 Molecular Analysis 
2.3.3.1 16S rRNA gene identification 
Genotypic identification of microorganisms using 16S rRNA gene sequencing is a 
more objective, accurate and reliable method for identification of bacteria 
compared to phenotypic methods such as Gram staining and colony 
morphologies. The genotypic identification method enables defining the 
taxonomical relationships among bacteria (Petti et al., 2005). 
2.3.3.2 Bacterial culture for molecular analysis 
The F. necrophorum reference and clinical strain isolates were plated on FAA 
(LabM Ltd., Heywood, UK) supplemented with 5 % defibrinated horse blood.  The 
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plates were incubated anaerobically at 37 ºC for 48-72 hours as described above 
(see 2.2.2.1).  The resulting bacterial colonies were sub-cultured in brain heart 
infusion (BHI) broth (LabM Ltd., Heywood, UK) and grown overnight at 37 °C 
anaerobically in the Innova 42 incubator shaker (Eppendorf Inc., CT, USA) at 85 
rpm until the stationary phase, OD600 of 0.6 to 0.7.  E. coli and S. aureus cultures 
used as controls were grown on LB agar plates for 16 hours at 37 °C and sub-
cultured in LB broth aerobically.  DNA extraction was performed based on the 
boiling lysis method utilised by Millar et al., (2000). 
2.3.3.3 DNA extraction and amplification of 16S, 23S rRNA and gyrase B 
genes 
Bacterial cultures were centrifuged at 3000 rpm for 10 minutes and the liquid 
removed.  DNA was extracted from the bacterial pellets and frozen at -20 °C as 
described by Millar et al., (2000).  The pellets were re-suspended in 500 µl sterile 
distilled water and the tubes incubated at 100 ºC using boiling water or a heat 
block for 10 minutes.  The tubes with the suspensions were then centrifuged at 
10,000 rpm for 5 minutes.  The resulting supernatant contained the crude DNA 
extracts, whose concentrations were determined using the NanoDrop 1000 
spectrophotometer (Thermo Scientific, Loughborough, UK); these were used as 
templates for the PCR.  DNA template (1 µl) was mixed with 12.5 µl Master Mix 
(Qiagen, Crawley, UK; Sigma-Aldrich, MO, USA), 2.5 µl of each primer (0.5 µM) 
and 6.5 µl of sterile distilled water giving a total volume of 25 µl.  PCR 
amplifications were performed using either the Techne Touchgene Gradient 
thermal cycler (Barloworld Scientific Ltd, Stone, UK) or the Peltier thermal cycler, 
DNA Engine®, BIO-RAD using the Taq PCR Master Mix kit according to the 
manufacturer’s instructions (Qiagen, Crawley, UK).  PCR conditions were an initial 
denaturation step at 95 ºC for 5 minutes, followed by 35 cycles of denaturation at 
95 ºC for 30 seconds, annealing at 55 ºC for 30 seconds and extension at 72 ºC 
for 30 seconds, and a final extension step at 72 ºC for 5 minutes. 
2.3.3.4 Phenol-chloroform extraction 
Due to the growth of the isolates on blood agar plates, some of the extracted crude 
DNA was contaminated with haem; therefore, the samples were further purified 
using phenol-chloroform extraction. 
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The phenol-chloroform extraction procedure involved adding 500 µl phenol: 
chloroform: isoamylalcohol (25:24:1, v/v; Sigma-Aldrich, Dorset, UK) to an equal 
volume of bacterial suspension.  The mixtures were shaken vigorously and 
centrifuged at 10,000 rpm for 10 minutes to separate the aqueous and organic 
layers.  The upper aqueous layer was transferred to a clean microfuge tube and 
500 µl of chloroform was added. The mixtures were shaken vigorously and 
centrifuged at 10,000 rpm for 10 minutes to separate the aqueous and organic 
layers.  The upper aqueous layer was transferred to a clean microfuge tube.  The 
nucleic acids in the aqueous layer were precipitated with a 1:10 v/v solution of 3 
M NaOAc (Sigma-Aldrich, Dorset, UK) and 2 volumes of 100 % ethanol (Thermo 
Scientific, USA).  The samples were stored at -80 °C for 20 minutes and then 
centrifuged at 10,000 rpm for 10 minutes.  The DNA pellets were washed once 
with 70 % ethanol, air-dried at room temperature and then re-suspended in 50 µl 
of sterile distilled water.  The concentration of DNA was measured using the 
NanoDrop 1000 spectrophotometer. 
2.3.3.5 Gel Electrophoresis 
All amplified PCR products were resolved on 1% (w/v) agarose gels in 1 x TBE 
buffer. Agarose powder (Sigma–Aldrich, Dorset, UK) was dissolved in 1 x TBE 
buffer and heated in a microwave until fully dissolved; the mixture was allowed to 
cool to about 60°C and then poured in the gel cast.  PCR amplicons were mixed 
with loading dye, loaded onto the gel along with DNA marker in one of the wells, 
and electrophoresed with 1 x TBE buffer at 100 volts for about 60 minutes. The 
amplicons resolved on the gel were stained with ethidium bromide (20 µg/ml) and 
the bands visualised using the UVITEC PRO gel imaging system (UVITEC, 
Cambridge, UK). 
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Table 2.4 Primers used for 16S rRNA, 23S rRNA and gyrB genes PCR 
 
 
 
 
 
 
 
 
Where M = A, C; Y = C, T; R = A, G. 
The 16S rRNA primers were used for the confirmation of identity of all strains. 
These primers described by Chakravorty et al., (2007) are specific for the 
conserved regions of the 16S rRNA gene sequences in all bacteria and, following 
sequencing of the PCR products, BlastN analysis was used for identification 
purposes. 
  
Primer name Oligonucleotide sequence 
339F     5' ACT CCT ACG GGA GGC AGC AGT 3'  
907R 5' CCG TCA ATT AMT TTG AGT TT 3'} DEGENERATE 
533F 5' GTG CCA GCA GCC GCG GTAA 3'    
CDR 5' CTT GTG CGG GCC CCC GTC AAT TC 3'   
23S rRNA-F 5' GCG ATT TCY GAA TGG GGR AAC CC 3'} DEGENERATE 
23S rRNA-R 5' TTC GCC TTT CCC TCA CGG TAG 3' 
GyrB-F 5' AGG AAT TTC CGT CGT GAA TC 3' 
GyrB-R 5' TGG TTC CTG TTG TTT CTC CA 3' 
 
Table 2.5 List of primers used in the study of the function of Galactose 
(Gal) binding protein genes. 
 
Primer name Sequence 
Gal1F 5’ GGA TGC ATG GTT GTC AGG AC 3’  
Gal1R 5’ TTG CTT GAC CTT TTG CGT CA 3’   
Gal2F 5’ AAGCATGGCAAATCCT 3’  
Gal2R 5’ GTCCTGACAACCATGCATCC 3’ 
Gal3F 5’ GGCTATGATCCGTGGTTATG 3’  
Gal3R 5’ AGCACCCAATATGATTCCA 3' 
 
16S RRNA 
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Table 2.6 Primers for genes involved in the lipid IV A biosynthetic 
pathway 
 
LPX 
primers Sequence Gene 
Primer1-F 5’-GGCGGTTGTTCGAGGTTTAA-3’ LpxA-UDP-N-ACETYLGLUCOSAMINE-O-  
Primer1-R 5’ TTCCAAATTGCTCTTCCGCC-3’  ACYL TRANSFERASE 
Primer2-F 5’-TGAAGAGGCGGGAATACAAGA-3’  LpxC-UDP-3-O-[HYDROXYMYRISTOLYL]-N- 
Primer2-R 5’-AAGCCGAAAGTTCTTGCAGG-3’ ACETYLGLUCOSAMINE DEACETYLASE 
Primer3-F 5’-TCGGAGAAGGTGCTGTGATT-3’  LpxD-UDP-3-O-[3HYDROXYMYRISTOYL]   
Primer3-R 5’-TACAGTCGTATTTGCCCCGA-3’ GLUCOSAMINE-N-ACETYLTRANSFERASE 
Primer4-F 5’-GGATGTTCCGACTGTGGTTG-3’  LpxB-LIPID-A-DISACCHARIDE 
Primer4-R 5’-CTCTCACTGCCCGCAATTTT-3’ SYNTHETASE 
  
Table 2.7 Primers used for amplification of genes involved in glycosylation 
of F. necrophorum. 
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All products were analysed by agarose (1 %) gel electrophoresis in 1X TBE buffer 
with appropriate DNA ladders.  The amplicons resolved on the agarose gels were 
stained with ethidium bromide (20 µg/ml) for 5 minutes before being viewed on a 
UV transilluminator.  Results were recorded using the UVITEC PRO software.  
2.3.3.6 Gel/PCR purification and DNA Sequencing 
PCR products showing clear single bands were purified prior to sequencing using 
a QIAquick PCR purification kit (Qiagen, Crawley, UK) following the 
manufacturer’s instructions. Amplicons showing multiple bands were extracted 
and gel purified, by excising the band of interest and then purifying using the 
QIAquick Gel Extraction kit (Qiagen, Crawley, UK) following the manufacturer’s 
instructions with slight modifications. Briefly, PB buffer was used for the PCR 
products and QC buffer was used for the excised gel to provide optimal salt 
concentration and low pH necessary for the DNA to adsorb to the silica gel 
membrane. Samples were applied to the QIAquick silica-gel spin column and 
centrifuged at maximum speed (13,000 rpm (15,115 x g*)) for 1 minute to remove 
contaminants from the sample.  PE wash buffer was used to thoroughly wash the 
samples and the purified samples were finally eluted with sterile distilled water. 
The amplicons were then sequenced using dideoxy sequence methods by GATC 
Biotech AG, Constance, Germany. The resulting sequences were analysed using 
bioinformatics tools such as BLAST and CLUSTALW to determine similarities with 
strains in the databases. 
*Please refer to the appendix for conversion table of speed to rcf (g) for the centrifuge used. 
2.3.3.7 RNA Extraction 
The RNA was extracted using TRI Reagent® RNA Isolation Reagent (Sigma-
Aldrich, UK) combined with RNeasy kit (Qiagen, UK).  500 µl of TRI Reagent was 
added to frozen bacterial cell pellets (stored at -20 °C) and homogenised. 
Chloroform (500 µl) was then added and mixed using a vortex for 10 seconds. 
The mix was then centrifuged at 10,000 x g at 4 °C for 30 minutes. Approximately 
500 µl of the colourless upper aqueous phase of the supernatant was transferred 
to a new tube and an equal volume of 70 % ethanol was added, the sample was 
vortexed for 5 s. To precipitate the RNA, 500 µl of 80 % ethanol was added to the 
spin column before the sample was centrifuged at 10,000 x g for 2 minutes.  To 
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remove any carryover of ethanol, the lid of each tube with a sample was left 
opened, and the tubes were re-centrifuged at maximum speed for 5 minutes. To 
elute the RNA, 50 µl of RNase-free water were added to each sample and then 
the tubes centrifuged at maximum speed for 1 minute. The concentration and 
purity of the purified total RNA was measured with NanoDrop spectrophotometer 
at wavelengths of 260 and 280 nm (NanoDrop 1000, Thermo Scientific).  An 
accepted RNA yield is about 150-300 ng and accepted 260:280 and 260:230 
ratios is approximately 2.00 and 2.0-2.2 respectively.  The samples were either 
used directly to make complementary DNA (cDNA) or stored at -80 °C.  
2.3.3.8 DNase Treatment 
Using 5 µl of the extracted RNA from above, 1 µl of DNase (1 unit/µl) plus 1 µl of 
(10x) DNase buffer and 3 µl of sterile distilled water was added in a 0.5 ml 
microfuge tube. The mix was incubated for 30 minutes at 37 °C. The quality of the 
cleaned RNA was checked using agarose gel electrophoresis and the quantity 
and quality of the extracted RNA checked using NanoDrop spectrophotometer. 
Controls with no DNase, using water instead, were also set up. 
2.3.3.9 cDNA synthesis 
QuantiTect® Reverse Transcription protocol for cDNA synthesis was followed 
(Qiagen®, UK). Genomic DNA elimination reaction was first prepared. A 14 µl 
reaction volume in each tube contained: ~300 - 500 ng RNA. RNA (2 µl) was mixed 
with 2 µl of gDNA Wipeout buffer and 10 µl of sterile distilled water to give a total 
volume of 14 µl. The tubes were incubated at 42 °C for a minimum of 2 minutes 
(maximum 10 minutes), then immediately chilled on ice for 2 minutes. To clean 
1.5 ml tubes was added 1 µl of Reverse Transcriptase (RT), 4 µl RT buffer and 1 
µl RT primer mix. The template RNA from above (all 14 µl) was then added to 
each appropriately labelled tube. The tubes were incubated at 42 °C for 15 
minutes and then at 95 °C for 3 minutes to inactivate the enzyme. After this, the 
tubes were chilled on ice. Samples were then either used for real-time PCR mix 
or stored at -20 °C until ready to use. The cDNA was then stored at -80 °C until 
required for RT-qPCR. 
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2.3.4 RT-qPCR 
qPCR was performed in a 25 µl total volume comprising of 12.5 µl SYBR Green 
Master Mix (Qiagen, QuantiFast, UK), 2.5 µl of each forward and reverse primers 
(0.5 µM), 2 µl of cDNA template and 5.5 µl of sterile distilled water. Negative 
controls with samples with no cDNA and another with no reverse transcriptase 
were also set up.  The qPCR cycling using the Rotor GeneQ thermocycler 
(Qiagen, UK) was performed with an initial activation step at 95 ºC for 5 minutes, 
followed by 35 cycles of: denaturation at 95 ºC for 10 seconds; annealing at 55 ºC 
for 30 seconds and extension at 72 ºC for 30 seconds.  A melt curve analysis was 
also produced at the end of each run to check the specificity of the reaction.  
 
 Biofilm Formation Assays 
2.4.1 Microtitre plate assay (MTP) 
Formation and development of biofilm by bacteria have been studied using a 
variety of systems, which are categorised into static and continuous flow systems.  
The system of choice determines the kind of data that needs to be extracted from 
the study, and care is necessary in selection of the platform in order to fulfil the 
experimental requirements. All platforms have some advantages and 
disadvantages.  Biofilm formation using static systems like microtitre plates are 
common and useful for the study of early events during the formation of biofilms 
(Azeredo et al., 2017).  Originally developed by Madilyn Fletcher (1977) for the 
investigation of bacteria attachment and was also proved to be suitable for 
studying sessile development (Azeredo et al., 2017).  The polystyrene microtitre 
plate (static) biofilm system is simple to use, inexpensive and has a high-
throughput, therefore are easily adaptable for studying biofilms under difficult 
conditions. 
Formation of biofilm in this study was determined using the conventional microtitre 
plate (MTP) assay previously described (O’Toole et al., 1999; Stepanovic et al., 
2001; Merritt et al., 2011; O’Toole, 2011),with slight modifications. The technique 
used is suitable for growing biofilms in a wide range of bacteria. Water was 
replaced with 1X phosphate buffered saline (PBS) and 33 % (v/v) acetic acid was 
used as solubiliser in addition to 80 % and 95 % ethanol and 20 % acetone. Other 
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modifications include careful aspiration of unbound cells from the 24 or 48-hour-
old biofilm cultures before washing and fixing with 4 % formaldehyde then staining. 
2.4.2 Preliminary Biofilm growth with E. coli and S. aureus 
Initial experiments for biofilm formation were set up using E. coli and S. aureus to 
determine the biofilm thickness under different conditions. 
2.4.2.1 Temperature 
Overnight bacterial cultures in LB broth were diluted 1:100 in fresh LB broth.  200 
µl of single culture and 200 µl of mixed cultures of E. coli and S. aureus (100 µl of 
each culture) were plated into 3 sets of 96-well plates in duplicate and incubated 
at three different temperatures: 26 ºC, 37 ºC and 42 ºC for 24 hours. 
2.4.2.2  pH 
Using the method above, the ability to form biofilms under acidic and alkaline 
environmental conditions was tested.  The pH of the LB broth were adjusted to 4, 
7 and 10 without altering the nutrient strength of the growth media.  The bacterial 
cultures were inoculated as above and incubated for 24 hours at 37 ºC.  Growth 
at pH 7 was used as control for comparison of the extent of biofilm formation in 
normal, acidic and alkaline growth medium. 
2.4.2.3 Nutrient concentration 
The third condition to be tested was nutrient concentration of the LB broth media 
used for growth of the bacteria. The ability for biofilm formation with different 
concentration of nutrient: stock (full) concentration (25 g/L), half concentration 
(12.5 g/L) and quarter concentration (6.25 g/L) of LB broth were tested.  Except 
for the concentration of the LB broth used, the method was as above (see section 
2.2.1.2.). 
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2.4.3 The effect of different conditions on Fusobacteria  
2.4.3.1 pH 
The ability of the selected clinical isolates to form biofilm was tested in growth 
media with different pH.  F. necrophorum isolates were inoculated in FAB, BHI or 
LB broth respectively of pH 4, 7 and 10 and incubated anaerobically at 37 ⁰C. 
2.4.3.2 Temperature 
Biofilm assays were also performed under different incubation temperatures 
namely, 26 ⁰C, 37 ⁰C and 42 ⁰C. 
2.4.3.3 Nutrient concentration 
This test was performed to determine whether F. necrophorum had preference for 
specific media and/or could form biofilm in diluted concentrations of nutrients in 
the media used to support their growth.  The strains were grown in FAB, BHI and 
LB and their ability to form biofilms in these media were compared.  In the reduced 
nutrient concentration assay, stock concentration (full) (37 g/L) of BHI broth was 
diluted to (half) 18.5 g/L and (quarter) 9.25 g/L and used to grow biofilms. 
All the assays were performed in duplicate, repeated at least three times for 
reproducibility, and used the conventional MTP biofilm assay (O’Toole et al., 1999; 
Merritt et al., 2011; O’Toole 2011; Stepanovic et al., 2001).  Results were 
classified according to biofilm production described by Pye et al., (2013).  
Definition of biofilm producers: weak biofilm producers at OD570 were ≥ 0.05 but ˂ 
0.13, moderate producers at OD570 were ≥ 0.13 but ˂ 0.25 and strong producers 
at OD570 were ≥ 0.25. 
2.4.3.4 Inhibition of biofilm formation in F. necrophorum 
In this biofilm experiment, three species of bacteria were used: E. coli NCTC 
10418, S. aureus and F. necrophorum.  The control strain, E. coli, was chosen 
because it had been demonstrated to be a biofilm producer in previous studies 
(López et al., 2010).  The clinical and reference strains of F. necrophorum were 
checked for their ability to form biofilms under both normal and different 
environmental conditions such as change in pH and temperature, reduced nutrient 
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concentration in the environment and in the presence of increasing concentrations 
of antibiotics.  These conditions were studied using the 96-well microtitre plate. 
Culture media used to support the growth of the bacterial cells were fastidious 
anaerobe broth (FAB), BHI and LB broth (for aerobic cultures).  Briefly, broth 
culture of F. necrophorum strains harvested at the stationary growth phase and 
the control S. aureus (or E. coli) grown overnight with shaking at appropriate 
speeds were diluted 1:10 in BHI (or FAB) broth or LB broth respectively.  100 ul 
aliquots of each diluted strain, 8 replicates of each were pipetted into the wells of 
the 96-well microtitre plate (NUNC; Fisher Scientific Ltd., Loughborough, UK).  
The cells were then overlaid with 50 ul of mineral oil (F. necrophorum cultures 
only) to provide anaerobic conditions (Ahn and Burne, 2007).  Positive control for 
the biofilm assay was S. aureus.  Negative control with BHI broth only with no cells 
was also set up.  The plates with cultures were incubated statically at 37 °C for 48 
hours.  Unbound cells were aspirated, and the biofilm fixed with 4 % formaldehyde 
for 10 minutes.  The wells were washed with 1X PBS and stained with 0.1 % 
crystal violet (CV) for 10 minutes.  The stained biofilm was washed again with 1X 
PBS, allowed to air-dry and solubilised with the appropriate solvent, in this case 
33 % acetic acid.  Absorbance was measured at 600 nm with a microtitre plate 
reader.  All tests were performed and repeated for reproducibility as mentioned 
above. 
2.4.3.5 Biofilm estimation – Crystal violet assay  
Quantification of biofilm formation used the method demonstrated by Merritt et al., 
(2011).  The crystal violet assay provides a quantitative assessment of biofilm 
growth as well as allowing motile and non-motile cells to be distinguished by their 
adherence to plate wells.  Biofilm liquid containing planktonic (unbound) cells was 
carefully removed ensuring the biofilm itself was not disrupted.  The remaining 
biofilm was carefully washed 3 times with 1X PBS buffer and then fixed with 4 % 
formaldehyde for 15 minutes at room temperature.  A wash step with 100 µl 1X 
PBS buffer was carried out twice.  The PBS was removed and 125 µl 0.1 % crystal 
violet stain solution was added to each well using a multi-tip Gilson pipette.  The 
solution was left to stain the well contents at room temperature for 10 -15 minutes.  
The washing step was repeated, and the plate was allowed to air dry before 
solubilisation of the biofilm.  Acetic acid (150 µl of 33 %) was pipetted into each 
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well to elute the dye bound to the biofilm.  To allow solubilisation, the plate was 
covered and incubated at room temperature for 15 minutes.  A pipette was used 
to ensure the well contents were mixed.  Aliquots of 125 µl of the crystal 
violet/acetic acid solution from each well was transferred into a flat bottom 96-well 
plate (Sterilin; Barloworld Scientific Ltd, Stone, UK).  Optical density was 
measured at 570 nm and 600 nm with 33 % acetic acid as the blank, using a 
microtitre plate reader (Versamax; Molecular devices, CA, USA).  The amount of 
crystal violet bound to each well is proportional to the amount of biofilm produced 
(O’Toole, 2011). 
2.4.4 BSAC disc susceptibility determination of E. coli and S. aureus 
Bacterial cell cultures were grown in LB broth aerobically overnight and about 4 
colonies were picked and diluted 1:100 with sterile Iso-Sensitest broth (Oxoid, 
Basingstoke, UK), using direct colony suspension method according to the BSAC 
method for antimicrobial susceptibility testing (AST).  AST was performed on Iso-
Sensitest agar (Oxoid, Basingstoke, UK) by steaking the suspension of cells 
evenly on the entire plate using a sterile cotton swab to achieve a lawn of growth. 
Antibiotic discs were placed on the inoculated agar plate above and the plate was 
incubated aerobically at 37 ºC for 24 hours.  The zones of inhibition (ZOI) were 
determined to the nearest mm with a ruler and interpreted using the BSAC and 
EUCAST guidelines. 
 
 
Table 2.8 Bacterial strains and antibiotics used for disc diffusion test of 
aerobes. 
 
Bacteria 
Strains Antibiotic Used 
E. coli 
AK (30 µg), CAZ (30 µg), CHL (30 µg), CIP (5 µg), GM (10 
µg) 
S. aureus 
AMP (30 µg), CIP (5 µg), GM (10 µg), TET (30 µg), VAN (5 
µg), LEV (5 µg), KAN (30 µg) 
Key: AK (Amikacin), AMP (Ampicillin), CAZ (Ceftazidime), CHL (Chloramphenicol),  
CIP (Ciprofloxacin), GM (Gentamicin), KAN (Kanamycin), 
LEV (Levofloxacin), TET (Tetracycline), VAN (Vancomycin). 
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2.4.4.1 Antibiotic Susceptibility (Bacteriostatic) testing of Fusobacteria 
Disc diffusion method of Lakhssassi et al., (2005) was used for the testing of 
antibiotic susceptibility and determine zones of inhibition.  Blood agar plates were 
inoculated with diluted F. necrophorum cell culture as described above for E. coli 
and S. aureus.  The inoculum was spread over the entire plate and antibiotic discs 
were carefully place on the agar and the plates were incubated anaerobically at 
37 ºC for 48 hours. 
 
2.4.4.2 Antibiotic susceptibility testing on planktonic cells and biofilm  
E. coli and S. aureus (MIC determination). 
 
Overnight cultures of E. coli and S. aureus in LB broth were set up as described 
above and 100 µl of 1:100 fresh diluted cultures were plated into 96-well plates 
and then incubated at 37 ºC for 24 hours.  After the incubation period, 100 µl of 
diluted antibiotics were added to the cells and incubated at 37 ºC for another 24 
hours.  Antibiotics used were AMP, CIP, GM, TET and VAN for S. aureus and AK, 
CAZ, CHL, CIP, GM, and LEV for E. coli.  For mixed cultures of the two bacteria, 
AMP, CIP, GM, LEV and VAN were added.  Antibiotics were added at four different 
concentrations: 512, 256, 128 and 64 µg/ml, to test their effects on planktonic cells 
and biofilms produced. 
2.4.4.3 Antibiotic susceptibility testing on F. necrophorum biofilm 
2.4.4.3.1 Minimum inhibition concentration (MIC) test using MTP 
To determine the lowest antibiotic concentration that inhibits growth of F.  
necrophorum planktonic cells and biofilm formation, 96-well microtitre plates were 
used to set up the experiment.  Appropriate dilutions of the overnight (S. aureus) 
and stationary phase (F. necrophorum) cultures were diluted 1:100 in BHI 
corresponding to 0.5 McFarland (1.5 – 3.0 X 108 CFU/ml) and 100 µl of bacterial 
cell culture were aliquoted into each well of the 96-well plates.  Aliquots of 50 µl 
of the different antibiotics (ciprofloxacin, kanamycin, metronidazole and penicillin) 
were added to appropriate wells and each well was overlaid with 50 µl of sterile 
mineral oil to achieve an anaerobic environment.  A control was set up using 50 
µl of sterile 1X PBS instead of antibiotics.  The plate was sealed with parafilm and 
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incubated at 37 ºC for 48 hours.  After 48 hours, the plates were observed for the 
presence or absence of growth (turbidity of broth was indicative of cell growth).  
Optical density at OD600 was measured using a plate reader.  Antibiotics were 
added at four different concentrations: 512, 256, 128 and 64 µg/ml, to test the 
minimum antibiotic concentration required for inhibition or elimination of biofilms 
produced. 
2.4.4.4 Single and Dual-species biofilm formation 
The two reference strains (JCM 3718 and JCM 3724) and the clinical isolate (ARU 
01) were sub-cultured in BHI and diluted as describe above.  E. coli and S. aureus 
were subcultured in LB broth and diluted as above.  Single-species biofilm assays 
were set up in 96-well microtitre plates by aliquoting 100 µl of ARU 01, 3718 and 
3724 in duplicates into appropriate wells.  A negative control was BHI only, no 
added cells.  For dual-species biofilm assay, the volume of ARU 01, 3718 and 
3724 cell cultures were reduced to 50 µl per well and 50 µl of either E. coli or S. 
aureus were added to the Fusobacterium cultures.  The wells were overlaid with 
50 µl of sterile mineral oil to achieve an anaerobic environment.  The plates were 
sealed with parafilm and incubated at 37 ºC for 48 hours.  After 48 hours, the 
optical density at 600 nm wavelength (OD600) was determined using a plate 
reader.  Microtitre plates with bacterial species showing growth after overnight 
incubation with antibiotics were then quantified for residual biofilms.  The amount 
of biofilm formed was quantified using the crystal violet assay.  The percentage 
inhibition or antibiotic efficacy was estimated by comparison of the optical density 
of the residual biofilm of bacterial species that had been challenged with antibiotics 
to that of a positive control, i.e. the same species without antibiotics.  
2.4.4.5 Statistical analysis 
Each experiment was performed in 16 replicates and repeated 3 times at different 
time points and the results were averaged where necessary.  The mean 
absorbance of the negative control was subtracted from the mean absorbance 
values to determine the actual values.  In the current study, the main statistical 
used was one-way analysis of variance (ANOVA) followed by Bonferroni multiple 
comparison and was performed using GraphPad Prism® version 5.00 for 
Windows.  This test was used to determine whether there were any differences in 
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the degree of biofilm formation under different environmental conditions (three 
parameters compared each time).  A p value of <0.05 was considered statistic-
ally significant.  The mean value obtained for each strain forming single/dual-
species biofilm was determined using Microsoft Office Excel software.  The 
confidence interval of the mean was calculated by setting the significance limit to 
p = 0.05 at 95 % confidence interval.  
See Appendix V for the formulae for estimating percentage efficacy and residual 
biofilm of the antibiotics that inhibit biofilm.  Percentage residual biofilms of ≤ 0.05 
at OD600 were considered as complete inhibition. 
2.4.5 LIVE/DEAD BacLight Bacterial viability 
This method is a quantitative fluorescent microscopy technique for the 
determination of viability of bacterial cells.  The kits consist of SYTO 9, a green 
fluorescent nucleic acid dye which stains live cells and propidium iodide, a red 
fluorescent nucleic acid dye which stains dead or dying cells. 
2.4.5.1 Bacterial Viability assay 
LIVE/DEAD BacLight Bacterial Viability [Live/Dead®BacLightTM kit L7012] - 3.34 
mM SYTO 9 dye (component A), 20 mM Propidium iodide dye (PI-component B), 
mounting oil] (Life technologies, NY, USA & Molecular Probes, USA), is a 
fluorescent staining method which was applied to each of the bacterial samples to 
assess the ratio of viable to total cell counts.  The two fluorescent components are 
nucleic acid stains, which fluoresce depending on cell viability.  SYTO 9, a green 
fluorescent nucleic acid dye, penetrates all live bacterial cells, which produces the 
green colour.  PI, which is a red fluorescent nucleic acid dye, will only combine 
with SYTO 9 to form the red fluorescent colour if the cell has damaged 
membranes, i.e. dead or dying cells.  In preparing for the BacLight procedure, the 
cells had to be grown in broth cultures according to the manufacturer’s protocol 
with slight modifications.  100 µl of each bacterial sample extracted with 0.85 % 
NaCl to obtain the desired bacterial density, was pipetted into a labelled Eppendorf 
tube and an equal volume of component A (SYTO 9) and component B (PI) were 
vortexed in a new Eppendorf tube.  The dye mixture was covered in foil to avoid 
photodegradation.  Dye mixture (0.5 µl) was then added to each bacterial sample, 
ensuring minimal exposure to light.  Samples were incubated in the dark for 15 
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minutes at room temperature.  5 µl of each dye/bacteria solution sample was 
pipetted onto a separate glass slide.  The samples were covered in a layer of 
BacLight mounting oil (component C) before an 18 mm glass cover slip was 
applied.  Slides were viewed with Leica epifluorescence microscope (Leica 
Microsystems Ltd, Milton Keynes, UK). 
2.4.5.2 Cytospin procedure 
For the cytospin procedure, the dye mixture was prepared and added to the 
samples as mentioned above.  The sample were mounted into a cytocentrifuge 
and spun at 500 rpm for 3 minutes, to produce a discrete area of cells on the slide 
using a Shandon Cytospin 3 (Thermo Scientific, DE, USA).  BacLight mounting oil 
and glass cover slip were then applied as above. 
2.4.5.3 Viability of biofilm forming cells  
Planktonic cells from biofilms formed in 96-well plates were discarded, and 150 µl 
of 0.85 % NaCl was pipetted into each well.  The contents of each well were 
thoroughly mixed by pipetting up and down several times to extract the biofilm, 
and the content was transferred to appropriately labelled microfuge tubes.  The 
tubes and contents were centrifuged at 1000 rpm for 15 minutes and the 
supernatant discarded.  Bacterial suspensions were prepared following the 
manufacturer’s protocols with slight modifications. Isopropyl alcohol was omitted 
and only 0.85 % NaCl was used, also the amount of cell culture used was 1.2 ml 
instead of 25 ml.  Briefly, the two dyes (SYTO 9 and propidium iodide) were mixed 
in a 1:1 ratio, and 0.5 µl of the mixture added to 100 µl of each bacterial 
suspension.  The samples were thoroughly mixed, covered and incubated in the 
dark at room temperature for 15 minutes.   
For microscopy, the cells were then immobilised onto slides by cytocentrifugation 
at 500 rpm using a Shandon Cytospin 3 (Thermo Scientific, DE, USA).  A drop of 
BacLight mounting oil was applied to each slide and coverslips applied.  The stains 
were examined under epifluorescent microscope (Leica Microsystems Ltd, Milton 
Keynes, UK).  The percentage of Live/Dead cells was estimated. 
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 Analysis of the bacterial cell surface utilising lectin staining 
Biotinylated lectins used in this study were purchased from Vector Labs, UK and 
were chosen to cover a range of sugar specificities.  The lectins were (1 mg) were 
re-suspended following the manufacturer’s instructions to a stock concentration of 
1 mg/ml.  The assay used a final concentration of 0.6 µg/ml. 
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Table 2.9 Commonly used biotinylated lectins with their sugar specificity 
and abbreviations adapted from Afrough et al., (2007). 
 
Lectins   Abbreviation Source Carbohydrate 
Specificity  
Concanavalin A  Con A Jack bean Glucose/Mannose 
Peanut Agglutinin  PNA Peanuts Galactose 
Jacalin  JAC Jackfruit seed Galactose/GalNAca 
Erythrina cristagalli  ECA Erythrinacristagali 
seeds  
Galactose/GlcNAcb 
Sophora japonica  SJA Japanese pagoda 
seeds 
GalNAc/Galactose 
Ricinus communis 
Agglutinin I  
RCA-I Castor bean GalNAc/Galactose 
Griffonia 
simplicifolia Lectin 
I  
GSL-I Griffonia seeds GalNAc/Galactose 
Soybean 
Agglutinin  
SBA Soybean GalNAc 
Dolichos biflorus  DBA Horse gram seeds GalNAc 
Vicia villosa Lectin  VVA Hairy vetch seed GalNAc 
Griffonia 
simplicifolia Lectin 
II  
GSL-II Griffonia seeds GlcNAc 
Wheat Germ 
Agglutinin  
WGA Wheat gem GlcNAc/NANA (N-
Acetylglucosamine/N- 
Acetylneuraminic acid.  
Succinylated 
Wheat Germ 
Agglutinin  
SWGA Wheat gem GlcNAc 
Lycopersicon 
esculentum  
LEA Tomato fruit GlcNAc 
Solanum 
tuberosum  
 STA Tomato fruit GlcNAc/Sialic acid 
Lens culinaris 
Agglutinin  
LCA Lentil seeds Glucose/Mannose 
Sambucus nigra 
Agglutinin 
SNA Elder bark α –2,6 sialic acid  
Pisum sativum 
Agglutinin  
PSA Garden pea Glucose/Mannose 
Phaseolus vulgaris 
Leucoagglutinin  
PHA–L Red kidney beans Complex Sugars 
Phaseolus vulgaris 
Erythreoglubulin  
PHA–E Red kidney beans Complex Sugars 
Datura stramonium  DSA Thorn apple LacNAcc 
Ulex europaeus 
Agglutinin I  
UEA–I Furze seed Fucose 
a – GalNAc – N–acetyl D–galactosamine 
b – GlcNAc – N–acetyl D–glucosamine 
c – LacNAc – N–acetyllactosamine  
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2.5.1 Cytochemistry staining with biotinylated lectins 
Bacterial cell pellets were re-suspended in 50 µl of sterile distilled water and three 
small aliquots was smeared onto glass microscope slides (see below).  The slides 
were air –dried and a paraffin (PAP) pen was used to draw circles around the air-
dried spots to contain the reagents.  The cells were fixed with 4 % 
paraformaldehyde (PFA) at room temperature for 30 minutes, and the slides were 
washed 3 x 5 minutes with 1X PBS.  The fixed cells were then blocked using 4.5 
% human serum albumin (HSA) (Zenlab, UK) at room temperature 30 minutes.  
Slides were washed with IX PBS for 3 x 5 minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Set up of bacterial cells and biotinylated lectin on slides. 
Five lectins were used per strain of bacterium plus one lectin free control, containing 
cells only. 
 
Diluted lectin (50 µl of 6 µg/ml) was pipetted onto the bacteria on each slide.  The 
slides with the lectins were incubated for 1 hour at room temperature then rinsed 
with 1X PBS/Tween™20 (0.05 % v/v) (PBST).  Streptavidin-peroxidase (Sigma) 
was diluted according to the manufacturer’s instructions and 50 µl was placed on 
the bacteria on the slides for 1 hour at room temperature.  The slides were rinsed 
with solution of 1X PBST.  The substrate solution for peroxidase prepared as 
according to the manufacturer’s instructions (Vector Laboratories (SK-4200)), was 
then pipetted onto each circle and incubated at room temperature for 30 minutes 
and removed by tilting the slides.  Finally, the cells were counter stained with 
Mayer’s haematoxylin for 30 minutes at room temperature and then rinsed by 
 SBA             PNA        Control 
B 
Slide 
Con A          WGA            SNA 
A 
Slide 
Circle drawn around cells  
with paraffin pen. 
Circle drawn around cells  
with paraffin pen. 
  39 
pipetting PBST onto the slides.  Results were then observed using a light 
microscope. 
2.5.2 Lectin cytochemistry for epifluorescent microscopy 
The fluorescein isothiocyanine (FITC) conjugated lectins used in the staining 
include Concanavalin A (Con A), Wheat Germ Agglutinin (WGA), Peanut 
Agglutinin (PNA), Soybean Agglutinin (SBA) and Sambucus nigra Agglutinin 
(SNA). (Vector Laboratories, UK).  The staining protocols were similar to those 
described above for the biotinylated lectins with some modifications.  The slides 
with the fluorescent lectins were incubated for 1 hour in the dark at room 
temperature.  After incubation, the slides were rinsed with solution of 1X PBS and 
Tween™20 (0.05 % v/v) (TPBS).  Mounting medium was applied to the slides and 
coverslips placed on top.  The slides were viewed under an epifluorescent 
microscope with a FITC filter (Zeiss Axiovert).   
2.5.3 Lectin ELISA (ELLA) 
This enzyme –linked lectinsorbent assay (ELLA) procedure was used to highlight 
which glycans were present in the bacteria (intra and extracellular).  1 ml of each 
broth culture sample was centrifuged at 10,000 rpm for 3 minutes, the supernatant 
was discarded, and the pellet was mixed via vortex in 1.5 ml PE-LB buffer solution 
(G-biosciences Tissue PE LB™).  After a 30 minutes incubation period at room 
temperature, the samples were centrifuged at 10,000 rpm for 5 minutes.  The 
protein extract (supernatant) was pipetted into labelled centrifuge tubes.  50 µl 
was removed for spectrophotometric analysis (NanoDropTM) to assess the protein 
content of the extract. 100 µl of the extracts were pipetted into wells of the 96-well 
plate, with PE-LB buffer used as the negative control.  The plate was left in a fridge 
for at least 24 hours.  The extracts were removed, and the wells were washed by 
using 200 µl PBS buffer and shaking the plate for 10 minutes.  The PBS buffer 
was removed and 200 µl of 4.5 % human serum albumin (HSA) was added to 
each well as the blocking agent and left at room temperature for 60 minutes.  The 
blocking agent were then removed and 100 µl of the diluted biotinylated lectin 
solutions (6 µg/ml) were added to duplicate wells for each lectin (see Table 2.9). 
The plate was incubated at room temperature for 60 minutes before lectin 
solutions were removed and the washing step was repeated.  100 µl of 
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streptavidin-alkaline phosphatase (diluted as recommended by the manufacturer) 
was then added to each well and left for 60 minutes at room temperature before 
the washing step was repeated.  100 µl of pnp-phosphate solution (10 mM) was 
pipetted into each well and incubated for 60 minutes at room temperature.  50 µl 
of 3 M NaOH solution was added to stop the reaction and the plate was read at 
405 nm on a microtitre plate reader (VersaMax; Molecular devices, CA, USA).  
 Galactose binding protein – Study of function 
2.6.1 Primer design 
The FUS007_00675 gene sequence encoding the F. necrophorum D-galactose-
binding protein was obtained from the UniProt (Universal protein resource 
database) Knowledgebase, and the gene specificity was compared to all microbes 
using NCBI BLAST to evaluate all homology.  Clustal Omega was utilised to 
determine conserved areas suitable for primer design.  Using Primer3 software 
(Koressaar and Remm, 2007; Untergrasser et al., 2012), three primer sets for 
Galactose binding (Gal-binding) protein were designed for the candidate 
sequence: 
1) Forward: 5’ GGA TGC ATG GTT GTC AGG AC 3’ and the reverse: 5’ TTG CTT 
GAC CTT TTG CGT CA 3’.  
2) Forward: 5’ AAGCATGGCAAATCCT 3’ and the reverse: 
 5’ GTCCTGACAACCATGCATCC 3’. 
3) Forward: 5’ GGCTATGATCCGTGGTTATG 3’ and reverse:  
5’ AGCACCCAATATGATTCCA 3’. 
The above primers were based on nucleotide sequence of the FUS007_00675, 
FSEG_00004 gene and F. necrophorum D-12 strain on the BioCyc database.  All 
the primers were synthesised by MWG Eurofin, Germany.  DNA Extraction and 
PCR were as previously described (see section 2.2.3.3 in methods). 
2.6.2 Haemagglutination assay 
2.6.2.1 Blood typing 
Agglutination tests were carried out in 96-well microtitre plates using Human blood 
obtained from the National Blood Transfusion Services.  Anti-A and anti-B 
monoclonal antibodies were tested against blood group A, B, O and AB.  This was 
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used to demonstrate the appearance of positive and negative agglutination in 96-
well microtitre plate, which was rated from 0-4+, with 0 meaning no 
haemagglutination (cells homogenously distributed) and 4+ meaning 100 % 
haemagglutination (grape-like clusters of cells). 
Single drops of anti-A and anti-B monoclonal antibodies were added to individual 
wells of the microtitre plate and 50 µl of sterile 1X PBS was added.  Serial double 
dilution of the blood typing sera was conducted.  Red blood cells were diluted to 
2 % (v/v) with sterile PBS and 50 µl of the red cell suspension was added to each 
well containing the serially diluted antibodies.  The microtitre plate was incubated 
at 37 ºC for 1 hour before assessment of the results. 
2.6.2.2 Human erythrocyte agglutination by bacteria  
Several examples of haemagglutination of bacteria have been shown to involve 
appendages such as pili or flagella on the surface of the cells.  Some strains of E. 
coli were shown to attach to cells by means of pili.  Studies using electron 
microscopy of whole organisms of cell fragments did not show the presence of 
these appendages, thus have not associated haemagglutination of F. nucleatum 
with pili of flagella.  Others were able to show F. nucleatum can agglutinate A, B 
and O human erythrocytes and that of other species (Dehazya and Coles, 1980). 
To determine whether the Galactose binding protein bound to the alpha galactosyl 
residue on Human blood group B red cells, A, B, O and AB red cells were diluted 
to 1 % in PBS (v/v) and 100 ul of the diluted red blood cells was added to each 
well of a microtitre plate and incubated at room temperature for 1 hour.  Three 
different strains of F. necrophorum: ARU 01, JCM 3718 and JCM 3724 were each 
diluted to ratio of 1:1 in PBS and aliquoted into appropriate wells.  The strains 
were tested against each blood type.  The microtitre plate was incubated 
anaerobically in an anaerobic jar with an AnaeroGen sachet for 1 hour at 37 ºC.  
Agglutination was scored as above, i.e. from 0-4+. 
2.6.2.3 Sheep erythrocyte agglutination 
To determine whether the galactose binding protein bound to β-galactosyl 
residues, neuraminidase (Sialidase) type V from Clostridium perfringens diluted in 
PBS and was used to cleave the terminal sialic acid residues of sheep 
erythrocytes, so that the β-galactose molecules could be exposed.  5 % 
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erythrocyte suspension in PBS was added to a neuraminidase solution consisting 
of 1 µl neuraminidase in 49 µl of diluent (1X PBS) and incubated at room 
temperature for 1 hour.  After incubation, erythrocytes were washed by 
centrifugation with PBS at 3000 rpm for 5 minutes.  Strains of F. necrophorum 
were diluted 1:1 with PBS and used for serial doubling dilution or the bacteria. The 
microtitre plate was incubated anaerobically with an AnaeroGen sachet at 37 ºC 
for an hour.  The same criteria and scoring as above was used for observing 
haemagglutination under the microscope. 
2.6.2.4 Bead based lectin assay 
Galactose binding proteins play an important part in biofilm formation and 
attachment of bacteria to the host receptor cells.  To evaluate the specificity of the 
galactose binding protein, a series of immobilised glycans were investigated in an 
interaction assay. 
Five beads with attached sugars: P-Aminophenyl β-D-thiogalactopyranoside 
agarose (Thio-Gal), Glucose agarose, N-Acetyl-D-Glucosamine agarose 
(GlcNAc), P-Aminophenyl oxalic acid agarose (Sialic acid), N-
Acetylgalactosamine agarose (GalNAc) and two controls Sepharose CL and 
Sepharose 2B, which had no attached sugars (Sigma Aldrich, UK), were 
equilibrated in 0.15 M NaCl.  F. necrophorum samples used were ARU 01, JCM 
3718 and JCM 3724, which were grown until they were confluent.  In a further 
experiment, the following sugars, 0.1 M xylose, 0.01 M xylose, 0.1 M galactose 
and 0.01 M galactose were added to the bead to inhibit binding of bacteria to the 
beads.  In principal, the sugars would lead to competition for binding and therefore 
the bacterial binding to the beads would be reduced if inhibition occurred.  
2.6.2.5  Methodology for bead assay 
Agarose beads were suspended in 1 part beads and 5 parts of 0.15 M NaCl to a 
working volume of 1.5 ml in a 1.5 ml Eppendorf tube.  20 µl of the agarose beads 
were transferred into another 1.5 ml Eppendorf and 50 µl of the confluent bacterial 
cultured cells and 50 µl of 0.15 M NaCl were added to the tube.  50 µl of mineral 
oil was used to overlay the contents of the tube to create an anaerobic 
environment.  The samples were incubated at 37 ºC for 4 hours, with the tubes 
gently inverted every hour to re-suspend the beads.  After 4 hours, 1 ml of 0.15 
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NaCl was added to each tube and carefully mixed, then incubated undisturbed at 
room temperature for 30 minutes.  Most of the liquid above the agarose beads 
was removed leaving only about 100 µl to prevent the beads from drying out.  The 
beads were re-suspended and 50 µl were transferred into wells of a 96-well 
microtitre plate and observed under a light microscope.  The remaining bacterial 
cell cultures were stained with Live/Dead BacLight Bacterial Viability stain 
(Thermo Scientific) described above.  The result was observed under fluorescent 
microscope.  
2.6.3 Bioinformatics 
The nucleotide sequence of the enzymes were obtained from the BioCyc 
database (http://www.biocyc.org).  Primers for the genes were designed using 
‘Primer 3’ and the sequences were confirmed by BLAST (The Basic Local 
Alignment Search Tool).  
2.6.4 Sequence analysis 
F. necrophorum isolates grown on blood agar plates were used to extract 
bacterial DNA using the boiling method (section 2.2.2.4).  The resulting 
supernatants contain DNA templates used to validate the primers, by standard 
PCR and gel electrophoresis (section 2.2.2.4). 
2.6.5 PCR and Sequencing 
A PCR reaction was set up as described for 16S rRNA, with slight modifications. 
Aliquots of 2 µl of DNA template was used in a 25 ul PCR reaction mix.  5 µl of 
the PCR amplicon was run on a 1 % agarose gel (see section 2.2.3.3 and 2.2.3.5). 
The resulting gel was stained with ethidium bromide and the bands visualised 
under a UV transilluminator comparing the bands with DNA ladder with fragments 
of defined lengths (Peqlab, Erlangen, Germany) run on the same gel. 
The remaining PCR amplicon was purified using QIAquick PCR Purification kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions.   Purified 
samples were sequenced using Sanger sequencing by GATC Biotech Ag, 
Germany.  Using online alignment tool BLAST, each of the sequence obtained 
were compared with those in GenBank database.  CLUSTALW program was 
used to search similarity of sequence in the different isolates of F. necrophorum.  
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Sequences were translated with ExPASY (http://web.expasy.org/translate/) to 
confirm whether the nucleotide sequence differences resulted in changes to 
primary amino acid structures. 
Comparative studies were undertaken between E. coli K12 and F. necrophorum 
D12 using bioinformatics databases to see if there were differences in the 
amplified sequences and if these were conserved domains and located in the 
catalytic regions. 
The RaptorX server (http://raptorx.uchicago.edu/) was also used to predict the 3D 
structure of the enzymes involved in lipid A biosynthesis. 
 
 
 Whole genome sequencing 
2.7.1 Preparation of anaerobic broth using anaerobic Hungate culture 
tubes 
Brain heart infusion (BHI) broth was made following the manufacturer’s 
instructions, and resazurin solution at a concentration of 0.1 g/50 ml was added.  
This was heated to boiling and then L-cysteine hydrochloride (0.5 g/L) was added 
which changed the colour of the medium from pink to yellow.  The media were 
aliquoted into Hungate culture tubes, placed in a boiling water bath until the media 
turned from pink back to yellow.  The tubes were closed with the butyl rubber 
septum and the screw caps tightened to prevent leakage of the anaerobic 
atmosphere during autoclaving.  The samples were autoclaved at 121 °C for 15 
minutes at 15 psi.  The media undergoes further oxygen purging during 
autoclaving.  The samples were then allowed to cool and the stored at room 
temperature until ready to use. 
2.7.2 Growth of F. necrophorum in anaerobic BHI broth 
Single colonies of F. necrophorum cultures grown anaerobically on FAA blood 
agar plates as described above were subcultured in 10 ml of anaerobic BHI broth 
in Hungate tubes using aseptic microbiological techniques.  The tubes were tightly 
closed, and cultures grown anaerobically at 37 °C until mid-log phase (optical 
density (OD) of 0.6 to 0.7 at 600 nm) using ‘Ultrospec 10’ spectrophotometer.  A 
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Hungate tube containing only anaerobic BHI broth was used as a blank for 
calibration of the spectrophotometer. 
2.7.3 Preparation of Genomic DNA (gDNA) for NG Sequencing 
Genomic DNA was extracted using Sigma GenElute Bacterial Genomic DNA Kit 
(Sigma-Aldrich, UK), following the manufacturer’s instructions with some slight 
modifications.  F. necrophorum culture samples grown to mid log phase (OD of 
approximately 0.3 – 0.5) were aliquoted and the cells pelleted and stored at -20 
°C until they were used for preparation of gDNA.  The gDNA was eluted in 10 mM 
Tris-HCl buffer pH 8.5 (no EDTA).  Samples were then aliquoted and stored at -
20 °C to prevent degradation. 
The concentration of gDNA necessary for NGS library preparation was 1-30 ng/ul 
in 30 - 100 ul volume.  The concentrations of gDNA were quantified using a Qubit 
and NanoDrop spectrophotometer.  When NanoDrop was used for quantification, 
the minimum concentration of DNA required for NGS library preparation was 10 
ng/ul in 30 – 100 ul volume (as NanoDrop usually overestimates concentration of 
DNA, usually by 10-fold). 
The integrity of the gDNA was checked by electrophoresis on a 0.8 % agarose gel 
to verify that the gDNA was not degraded which may jeopardise the outcome of 
the NGS library preparation.  Non-degraded genomic DNA samples were then 
aliquoted into 1.5 ml microfuge tubes, prepared according to the company’s 
instructions and sent for sequencing. 
2.7.4 Next generation sequencing 
The two F. necrophorum reference strains, Lemierre’s syndrome (LS) isolate and 
17 other clinical isolates were commercially sequenced by microbesNG 
(Edgbaston, Birmingham, UK), using Illumina next generation sequencing 
technology (on the Illumina HiSeq.  The raw sequence data was processed with 
their automated analysis pipeline. 
They used Kraken (a taxonomic sequence classification system) to identify the 
closest available reference genome and the reads were mapped using Burrows-
Wheeler Aligner (BWA mem), a software package for mapping low-divergent 
sequences against a large reference genome, to assess the quality of the data. 
  46 
BWA-MEM is the latest of one of three algorithms, and is generally the one 
recommended for high-quality queries, it is also faster and more accurate as well 
as its use for longer sequences ranging from 70 bp to 1 Mbp. 
De novo assembly of the reads using SPAdes was also performed and these were 
mapped back to the resultant contigs using BWA mem to get more quality metrics. 
2.7.5 Phylogenetic analyses 
Information from assemblies obtained from microbesNG, NCBI and NCTC were 
used in the phylogenetic analysis, and genes encoded within genomes were 
predicted using Prokka 1.13 (Seemann, 2014). 
2.7.5.1 Preliminary phylogenetic analyses   
Prokka 1.13 (Seemann, 2014) software was used to predict genes encoded within 
genomes.  All protein sequences were analysed with PhyloPhlAn 0.99, to 
determine the placement of the whole-genome within the Fusobacterium genus 
(Segata, et al., 2013).  The resulting multiple-sequence alignment was imported 
into R and phangorn v.2.3.1 (Schliep, 2011) was used to construct a neighbour-
joining tree.  FigTree v1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/) was used to 
visualize the phylogenetic tree and annotated using Adobe Illustrator. 
2.7.6 16S rRNA gene sequence analysis of strain F88   
Using RNAmmer 1.2 (Lagesen et al., 2007) the 16S rRNA gene sequence of strain 
F88 was predicted, with a partial (1229 nt) sequence recovered that was extended 
to 1514 nt by comparison with other Fusobacterium spp.  Accession numbers for 
16S rRNA gene sequences of type strains of the genus Fusobacterium were 
obtained from the List of Prokaryotic Names With Standing In Nomenclature 
(http://www.bacterio.net/fusobacterium.html) and De Witte et al., (2017).  The 
sequences were imported into Geneious 8.1.4.  A multiple-sequence alignment 
was created using CLUSTAL W, and this used to create a neighbour-joining tree 
(Jukes Cantor).  Bootstrap values were generated from 1000 replicates. 
2.7.7  Quality control checks on genome sequence data 
For all Fusobacterium necrophorum genomes listed in Table 1, the size of 
genome, number of CDS and number of scaffolds were examined.  Potential 
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contaminants within genomes were identified by running the questionable 
Fusobacterium necrophorum assemblies against the nt (NCBI non-redundant 
nucleotide) database (created 3 March 2018) of Centrifuge 1.0.3 (Kim et al., 
2016). 
2.7.8 Determination of average nucleotide identity (ANI) 
This was determined between pairs of genomes using OrhtoANI implemented in 
OAT 0.93 (≤10 sequences to compare) or OAT_cmd 1.30 (Lee et al., 2016). 
Outputs from OAT_cmd were imported into R to generate a heatmap (heatmap.2 
function in package gplots). 
2.7.9 Comparative and pangenome analyses of Fusobacterium 
necrophorum strains.  
The 49 whole-genome sequences identified as Fusobacterium necrophorum 
sensu stricto were subject to further analyses.  ANI was determined for the 49 
genome sequences and other Fusobacterium species using OAT_cmd 1.3.0.  A 
pangenome analysis was carried out on the 49 Fusobacterium necrophorum 
strains using Roary (Page et al., 2015). 
Using Roary, coding sequences (CDSs) were extracted from the input files and 
translated to protein sequences, filtered to remove partial sequences and 
iteratively pre-clustered using CD-HIT (Fu et al., 2012).  This resulted in a 
substantially smaller dataset of protein sequences, which were then clustered with 
TRIBE-MCL (Enright, et al., 2002).  Finally, results from CD-HIT and TRIBE-MCL 
were merged together and used to make a core gene alignment with MAFFT 
(Katoh, et al., 2002), outputting a core cluster alignment file.  A maximum-
likelihood tree (GTR model) was created using FastTree with the core alignment 
file.  The phylogenetic tree was visualized using FigTree v1.4.2. phandango 
(Hadfield, et al., 2017) was used to visualize pangenome data.  Single nucleotide 
polymorphism (SNP) sites in the core cluster alignment file generated by Roary 
were identified using SNP-sites (Page et al., 2016).  Principal component analysis 
(PCA) of the presence/absence of accessory genes within Fusobacterium 
necrophorum subsp. funduliforme genomes was done using the R package 
FactoMineR (Lê et al., 2008).  Representative sequences of the 6819 genes 
detected in the Roary analysis were submitted to eggNOG-mapper v4.5.1 
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http://eggnogdb.embl.de/#/app/home; Huerta-Cepas, et al., (2016) to obtain 
additional functional information.  progressiveMauve (Darling, et al., 2010) was 
used to visualize genome arrangements, using the .gbk files produced by Prokka. 
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Chapter 3  
 
3 Typing and Subtyping of F. necrophorum strains and clinical isolates 
 
 Introduction 
The two major subspecies of F. necrophorum are biotype A, F. necrophorum 
subsp. necrophorum and biotype B, F. necrophorum subsp. funduliforme (Shinjo 
et al., 1991).  In the past, F. necrophorum has been divided into three biotypes: 
the two mentioned above and the third biotype C which has been placed in a new 
species as Fusobacterium pseudonecrophorum.  Biotype A is the virulent form of 
F. necrophorum, and is predominantly isolated from bovine hepatic abscesses, 
biotype B is benign and is isolated mainly from ruminal contents, but also from 
lesions caused by a mix of biotypes.  Biotype C is non-pathogenic and can be 
isolated from abscesses and faecal material.  There is also a fourth intermediate 
biotype known as AB: this is mainly isolated from ovine and bovine foot lesions 
(Nicholson et al., 1994).  Their classifications were based on cellular and colonial 
morphology, characteristic growth in broth medium, toxin production, their ability 
to agglutinate chicken erythrocytes and virulence in mice. Differences in 
production of certain extracellular enzymes such as lipase, DNase and alkaline 
phosphatase have been demonstrated, however, these have not been shown to 
be useful to distinguish between the two major subspecies (Okwumabua et al., 
1996).  Narongwanichgarn et al., (2001) were able to characterise nineteen strains 
of F. necrophorum using the API 20A test kit for identification of anaerobes, which 
had been previously identified as F. necrophorum by the VPI method.  Of the 19 
strains tested, only 7 of them were identified as having haemagglutinating activity; 
these were classified as F. necrophorum subspecies necrophorum.  Those strains 
lacking haemagglutinating activity were classified as F. necrophorum subspecies 
funduliforme.   All the strains tested were shown to be β-haemolytic on blood agar 
plates (Narongwanichgarn et al., 2001).  
Both cellular morphology and total DNA homology data have provided convincing 
evidence for relatedness of F. necrophorum subspecies, but it has been shown 
that comparing 16S rRNA sequences is a better and more sensitive method for 
verification of the taxonomic identity.  Over the years, the increasing use of PCR, 
rapid template purification and automated DNA sequencing has dramatically 
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reduced the time necessary to yield a high-quality sequence.  The use of 16S 
rRNA gene sequencing to identify strains and to study the relatedness of 
prokaryotic species is well established and this has resulted in increased 
availability of 16S rRNA databases.  Reports have shown that subtle differences 
in the 16S rRNA gene can be used for species identification and for subtyping and 
identifying hypervirulent bacterial clones (Gee et al., 2003). 
Molecular techniques such as 16S and 23S rRNA intergenic spacer region 
sequence analysis, random amplified polymorphic DNA-PCR and ribotyping 
analysis are used to discriminate between the two F. necrophorum subspecies.  
Random Amplified Polymorphic DNA PCR (RAPD-PCR) using a 10-mer 
oligonucleotide primer, W1L-2 has also been used for discriminatory tests 
(Narongwanichgarn et al. 2001). 
A real-time quantitative PCR assay was developed by Jensen, et al., (2007) for 
the detection of F. necrophorum subspecies.  For confirmation that the strains 
were indeed F. necrophorum, they initially identified colonies on agar plate by 
colony morphology, odour, Gram stain, green fluorescence with UV light 
irradiation, β-haemolysis on blood agar plates and antimicrobial susceptibility 
testing. This was followed by targeting the gyraseB (gyrB) gene of both 
subspecies using subspecies-specific PCR primers, which amplified a region of 
306 bp.  Results of the gyrB species assay were verified with TaqMan-based 
quantitative PCR-probe assay to bind within the amplified region.  The assay used 
was based on the RNA polymerase β-subunit (rpoB) gene, consisting of PCR 
primers and a single probe specific to F. necrophorum.   All the F. necrophorum 
strains tested were amplified with the primers-probe set, resulting in the correct 
subspecies assignment of the isolates, based on previous records of the strains 
(Jensen et al., 2007). 
 
The aim of this chapter was: 
1. To identify, based on biochemical and PCR/Sanger sequencing-based 
analysis of F. necrophorum isolates from clinical samples.  
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 Methods 
3.2.1 Identification methods 
3.2.1.1 Colony morphology and macroscopic appearance 
Initial identification of F. necrophorum was based on colony morphology.  Isolates 
were cultured on fastidious anaerobe agar (FAA) (LabM Ltd., Heywood, UK) 
supplemented with 5 % (v/v) defibrinated horse blood (Oxoid Ltd., Basingstoke, 
UK) and incubated anaerobically at 37 °C for 48 hours in an anaerobic jar (Oxoid 
Ltd., Basingstoke, UK) with AnaeroGen™ sachet (Oxoid Ltd., Basingstoke, UK) 
generating anaerobic growth conditions (oxygen level <1 % and 9-13 % carbon 
dioxide and 85 % nitrogen).  β-haemolysis was recorded, where present, on the 
blood agar plates. 
3.2.1.2 Biochemical tests 
The methods for these tests, including Gram staining and tests for catalase, 
oxidase, indole and lipase are presented in the Appendix I. 
3.2.1.3 Molecular Analysis  
Methods for bacterial growth, harvesting, DNA extraction, PCR, DNA sequencing, 
RNA extraction, cDNA synthesis and rt-qPCR are described in the Methods 
sections 2.3.3.9 and 2.3.4 (chapter 2).  
 
 Results 
3.3.1 Identification of isolates 
3.3.1.1 Morphology and Biochemical tests 
F. necrophorum isolates were incubated anaerobically for 48 hours as described 
above, and the colonies macroscopically observed.  All strains produced colonies 
that were either translucent or opaque cream colour with waxy or matt 
appearance. The size of the colonies varied with some being very small, and 
others medium to large.  Most were β-haemolytic on 5 % blood agar, even though 
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this was not always clear with some of the isolates. They all produced a 
characteristic, offensive ‘boiled cabbage’ odour. 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Colony identification of F. necrophorum on FAA blood agar 
plates after 48 hours incubation under anaerobic conditions at 37 °C. 
A) ARU 01, B) JCM 3718 and C) JCM 3724 
 
   
 
 
Figure 3.2 Gram stain images of F. necrophorum strains, A-ARU 01, B-JCM 
3718 and C-JCM 3724 
Showing pink Gram-negative rods with characteristic pleomorphic morphology 
consisting of short rods, long filaments and coccoid elements.  Under the light 
microscope, ARU 01 and JCM 3718 strains displayed long and short rods, while 
JCM 3724 had coccoid forms (Magnification x1000). 
 
 
 
All the strains tested were Gram-negative, pleomorphic in nature consisting of 
mainly short rods and longer filamentous coccoid elements when examined under 
the microscope (Figure 3.2).  The pleomorphism is likely to be a consequence of 
stress reaction to oxygen in the media. They were all catalase negative as they 
gave off little or no oxygen with hydrogen peroxide. The strains were mainly 
negative for the oxidase test (52 isolates out of the initial 80 isolates tested), but 
A B C 
A                                     B                                      C 
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a few of the isolates appeared to be positive; as an obligate anaerobe, F. 
necrophorum is unable to produce energy aerobically and should not express 
oxidase enzyme.  Some of the positive results were noted after 30 seconds (data 
not shown) and thus were classified as false positive and inconclusive.  S. aureus 
was used as a control for most of the tests, and despite the fact that it prefers 
aerobic respiration, was oxidase negative, confirming studies that have shown 
that the enzyme is not expressed by this species (Baker, 1984).  The indole test 
was positive for all of the isolates, which was in agreement with results from 
previous studies (Bennett & Eley, 1993); El-Hadedy and El-Nour, 2012).  Studies 
have shown indole to be an important molecule in cell signalling (quorum sensing) 
that controls biofilm formation (Hu et al., 2010).  Some isolates produced lipase 
on egg yolk agar: this test has been used in some studies to differentiate 
subspecies of F. necrophorum (Morgenstein et al., 1981; Amoako et al., 1993).  
3.3.1.2 16S and 23S rRNA analysis 
Genotypic identification of microorganisms using 16S rRNA gene sequencing is 
known to be a more objective, accurate and reliable method for identification of 
bacteria compared to phenotypic methods such as Gram staining and colony 
morphologies. The genotypic identification method has the added capability of 
defining the taxonomical relationships among bacteria.  Phenotypic methods have 
many strengths but may fail because the phenotype can inherently be mutated, 
and interpretations can be biased (Petti et al., 2005).  
In the current study, microbiological and biochemical identification results were 
confirmed by 16S rRNA PCR and DNA sequencing, 21 isolates were selected for 
future research.16S (533F/CDR) and 23S (universal) primers (Rudi et al., 1997) 
were used to amplify rRNA from F. necrophorum strains JCM 3718, JCM 3724 
and ARU 01.  The results for 10 isolates amplified using 16S rRNA primers are 
shown in Figure 3.3. Amplicons were the expected 425-450 bp and about 400 bp 
with the 23S rRNA primers (results not shown).  
Biochemical tests had only confirmed that the isolates were F. necrophorum 
species, but 16S rRNA PCR and sequencing of the amplicons produced was able 
to identify different species and subspecies of Fusobacterium after sequence 
analysis using the BlastN function at the NCBI.  The gyrase B primers amplified 
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the expected amplicons of 125bp (results not shown) and amplicons were 
identified BlastN.
  55 
 
  Table 3.1 Characteristics of F. necrophorum isolates selected for future research 
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Figure 3.3 Electrophoretic separation pattern of amplicons of F. 
necrophorum DNA with 16S rRNA primers. 
Lane M 100 bp marker, lane- 1 Empty, lane 2- ARU 01, lane 3- JCM 3718, lane 4- 
JCM 3724, lane 5- F1, lane 6- F5, lane 7- F11, lane 8- F21, lane 9- F24, lane 10- 
F30, lane 11- F40, lane 12- S. aureus and lane 13- negative control. 
 
 
 
3.3.1.3 Real-time PCR (RT-PCR/qPCR)  
 
Table 3.2 Results of RT-PCR of F. necrophorum strains ARU 01, JCM 3718, 
JCM 3724 and E. coli with gyrase B and 16S rRNA primers:  
ARU 01; JCM 3718; JCM 3724; E. coli, +ve (positive control) and -ve (no template 
control). 
  
Samples CT Values Melting Temperature 
ARU 01 22.72 77.2 
JCM 3718 27.31 77.3 
JCM 3724 26.55 77.5 
E. coli 27.79 77.5 
GyraseB -ve 31.68 77.5 
16S rRNA +ve 19.22 90 
16S rRNA -ve 30.05 90.2 
 
 
 
 
 
 
 M     1     2     3     4     5     6     7     8     9    10   11    12    13 
425bp 
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3.4   Discussion 
 
The strains obtained from the UK Anaerobe Reference Unit (UKARU), Cardiff, 
consisted of two reference type strains (one subsp. funduliforme and the other 
necrophorum) and a clinical isolate from a Lemierre’s patient identified to 
subspecies level as F. necrophorum subsp. funduliforme.  The results in the 
current study fully supported their findings.  Of the 80 clinical samples available 
for the current studies (obtained from University College Hospital, London), due 
to financial constraints, only 21 were selected for further study based on 
biochemical and molecular methods; these were unequivocally F. necrophorum.   
 
The PCR based methods used to confirm the biochemical identification tests used 
16S rRNA, 23S rRNA and gyrase B primers.  The primers used successfully 
validated most of the 80 isolates as F. necrophorum, but there were some isolates 
that were not F. necrophorum, suggesting contamination.  The issues with these 
isolates were not picked up by the biochemical tests used in this study, therefore 
additional tests would have been required if molecular techniques had not been 
used.  Primers targeting the rpoB gene specific for F. necrophorum could have 
been used instead of 16S rRNA primers which target 16S ribosomal RNA genes 
found in all bacteria (Aliyu et al., 2004).  Jensen et al., (2007) used a gyrB TaqMan 
probe-based method to sub-speciate F. necrophorum type strains ATCC 25286 
and ATCC 51357 (JCM 3718 and JCM 3724 respectively): these strains 
subsequently served as positive and negative controls for their differentiating 
probes in further studies. 
 
Care taken in the validation of isolate identity is key to successful research, though 
it will become apparent in subsequent chapters that, during the Whole Genome 
Sequencing work, one isolate was found to have been misidentified.  
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Chapter 4   
 
4 Biofilms 
 
 Introduction 
The oral environment exposes bacteria to various physio-chemical challenges 
such as nutrient limitation, variation in oxygen tension, fluctuations in temperature 
and pH. Biofilms are sessile architecturally complex communities of 
microorganisms (Vlamakis et al., 2008) adhering to each other and to solid 
surfaces. They are enclosed in a self-produced hydrated matrix of extracellular 
polysaccharide, protein and DNA (Stewart & Costerton, 2001; Bassler & Losick, 
2006; Hadju et al., 2010). Almost all microorganisms (nearly 99 %) exist as 
biofilms in their natural habitats due to environmental stresses such as hostile 
environmental conditions and exposure to antimicrobial substances (Stewart and 
Costerton, 2001).  Studies have shown the importance of appendages such as 
flagella, fimbriae and pili which influence the rate of attachment to temporary 
surfaces until a permanent mechanism is achieved (Donlan, 2002; López et al., 
2010). Most bacteria secrete small signalling molecules known as auto-inducers 
for cell to cell signalling that mediate quorum sensing (QS) (Jang et al., 2012). 
Stress response gene expression is triggered when these molecules reach a 
threshold, causing a change in cell surface proteins, increasing cell surface 
hydrophobicity (Stanley & Lazazzera, 2004).  This leads to induction of the first 
stage of the biofilm cycle where the primary reversible adherence between cells 
and attachment of the cell to a surface occurs. This is followed by secretion of the 
extracellular matrix, which is associated with a decrease in hydrophobicity 
resulting in irreversible attachment (Jefferson, 2004). Finally, the biofilm matures 
giving rise to complex micro-colonies and the dispersal of very motile planktonic 
(free-floating) cells under unfavourable conditions (McDougald et al., 2012). The 
detached planktonic cells are then free to infect other areas, playing a key role in 
systemic infection, which is also dependent on the host immune response 
(Donlan, 2001; Taj et al., 2011). 
Bacteria in biofilms are protected from being killed by antimicrobial agents by their 
extracellular polymeric substances (EPS), that help them to evade the host 
immune responses, leading to  chronic infections such as those of the upper 
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respiratory tract in the case of F. necrophorum biofilm (Mohammed et al., 2013).  
Bacteria of the same strain existing in a biofilm growth state are 10 - 1000 times 
more resistant to antibiotics than their planktonic counterparts. Suggestions for 
this antibiotic resistance include: slow growth rate, nutrient limitation, poor 
antibiotic penetration, stress responses and formation of persister cells (Mah & 
Toole, 2001).  Biofilms are reported to be responsible for up to 80 % of human 
bacterial infections, including dental plaques, upper respiratory tract infections and 
medical implant associated infections (Schachter, 2003b; Römling & Balsalobre, 
2012).  
Research into biofilm has focused mainly on mono-species biofilms, but this is not 
the normal occurrence in nature; biofilms are often made up of many bacterial 
species, and sometimes contain algae, protozoa and fungi (Burmølle et al., 2014). 
Several studies have investigated ways of preventing biofilm formation including 
the use of enzymes to dissolve the biofilm matrix and compounds such as 
furanones (Licking, 1999). 
The study in this project included in vitro examination of mono-species biofilm 
production of the three F. necrophorum strains under various conditions of nutrient 
concentration, temperature and pH and dual-species biofilm assays of F. 
necrophorum and Staphylococcus aureus.   Any findings in this study could help 
in the understanding of the behaviour of F. necrophorum biofilms and in finding 
novel antimicrobial treatment. 
 
Aims of this study included:  
1. the determination of the optimal conditions for biofilm formation by F. 
necrophorum in mono-species culture. 
2.  the investigation of F. necrophorum biofilm formation in dual culture with 
S. aureus an aerobic bacterium using the MTP assay. 
3. the determination of the impact of biofilm formation on antibiotic resistance. 
 
 Methods 
All methods are described in methods sections 2.4.1, 2.4.2, 2.4.3, 2.4.4.2, 2.4.4.3 
and 2.4.4.4 (chapter 2). 
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 Results 
4.3.1 Biofilm formation  
At 37 ºC under anaerobic conditions F. necrophorum formed biofilms in both 
mono- and dual-culture. Using absorbance in the MTP assay as a measure of 
adherent and planktonic cells in biofilm formation (Table 4.1), S. aureus grown in 
mono-cultures without mineral oil yielded more biofilm than S. aureus with mineral 
oil, 0.108 and 0.701 respectively, demonstrating that although S. aureus was able 
to generate ATP in both conditions as it is a facultative anaerobe, its growth was 
decreased slightly by the anaerobic environment created by the mineral oil.  The 
mean growth value for the F. necrophorum was higher than that obtained for S. 
aureus grown under aerobic conditions; 1.17 and 0.701 respectively. The highest 
mean biofilm growth was seen in the co-culture of S. aureus with the reference 
JCM 3724 strain, the dual-culture of S. aureus and the ARU 01 strain had a slightly 
lower mean biofilm when compared to the dual culture of S. aureus and JCM 3724, 
but JCM 3718 exhibited the least biofilm growth; 1.23, 1.20 and 1.14 respectively.  
Mono-cultures formed less biofilm than dual-cultures; (volume corrected). The 
reference strain JCM 3724 in co-culture generated the greatest mean biofilm 
growth, with JCM 3718 showing the least mean biofilm growth (Table 4.2).   
Using crystal violet (CV) as a measure of adherent cells in the biofilm (Table 4.2), 
whilst the F. necrophorum mono-cultures gave higher absorbance than did S. 
aureus, the difference (0.132 vs 0.129) was not as pronounced as that seen by 
MTP absorbance measurements (1.17 vs 0.701), which are for both planktonic 
cells and biofilms. Although there was a difference between the measurement for 
S. aureus in the presence and absence of mineral oil, this was not as pronounced 
in the CV assay.  The highest absorbance in dual culture was for JCM 3724 and 
S. aureus, whilst the co-culture of ARU 01 with S. aureus yielded the lowest value 
in the CV assay whereas, in the MTP absorbance assay the poorest biofilm 
producing dual cultures were JCM 3718 and S. aureus.  In both assays, the 
absorbance obtained in dual culture was significantly higher than the additive 
absorbances of the single strains (volume corrected) with the exception of the 
ARU 01 co-culture assayed by the CV assay.  
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As the MTP assay was assessing both planktonic and sessile cells, true biofilm 
formation can only be determined by the CV assay; hence, all subsequent results 
presented refer to the CV assay.  
 
 
 
Table 4.1 Comparisons of biofilm mean absorbance (MTP assay); adherent 
and planktonic cells 
 
Bacteria - conditions 
Mean absorbance (nm) ± standard 
deviation (SD) 
JCM 3718 + S. aureus 1.14 ± 0.040 
JCM 3724 + S. aureus 1.23 ± 0.047 
ARU 01 + S. aureus 1.20 ± 0.140 
S. aureus + mineral oil 0.701 ± 0.179 (0.35*) 
F. necrophorum strains + mineral oil 1.17 ± 0.313 (0.585*) 
S. aureus  1.08 ± 0.258 (0.54*) 
*corrected to 50µL         n=36 
 
 
Table 4.2 Comparisons of crystal violet mean absorbance: adherent cells 
 
Bacteria - conditions 
Mean absorbance (nm) ± standard 
deviation (SD) 
JCM 3718 + S. aureus 0.134 ± 0.033 
JCM 3724 + S. aureus 0.168 ± 0.034 
ARU 01 + S. aureus 0.103 ± 0.003 
S. aureus + mineral oil 0.119 ± 0.018 (0.060*) 
F. necrophorum strains + mineral oil 0.132 ± 0.041(0.065*) 
S. aureus  0.129 ± 0.066 (0.065*) 
*corrected to 50µL          n=36 
 
4.3.2 F. necrophorum and S. aureus biofilm formation under different 
conditions 
All three F. necrophorum isolates (JCM 3718, JCM 3724 and ARU 01) in the 
present study were found to be biofilm producers at the ranges of temperatures, 
pHs and nutrient concentrations which were under study (Figure 4.1). The mean 
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absorbance corresponded to the amount of biofilm formed under each condition 
(experiment done in replicates and repeated three times). 
As pH increased strains JCM 3724 and ARU 01 in the biofilm assay, showed 
reduction in biofilm formation and the most amount of biofilm was formed at pH4 
(Figure 4.1a). Statistically, biofilm reduction in strains ARU 01 and JCM 3718 was 
not significant (p value=0.13 and 0.17 respectively). In the case of strain JCM 
3724, the p value was 0.003, which was statistically significant. However, although 
the pH of BHI in the biofilm assay after 48 hours incubation remained at 4 in case 
of the pH 4 medium, it decreased to 6 in case of the pH 7 medium and decreased 
to 8 in case of the pH 10 medium.  
Strain JCM 3718 was affected by low (26 oC) and high (42 oC) temperatures and 
formed less biofilm than at 37 oC (Figure 4.1b).  All other strains and the S. aureus 
control produced more biofilm at 26 oC than 37 oC and the least at 42 oC (Figure 
4.1b). Statistical analysis showed no significant difference in the amount of biofilm 
produced at each temperature for all three strains (JCM 3718, JCM 3724 and ARU 
01), with absorbances of 0.02, 1.63 and 0.01 respectively (p value = 0.47, 0.24 
and 0.08 respectively).  
For the nutrient concentration biofilm assay, decreased biofilm formation in strains 
ARU 01 and JCM 3718 was observed as the nutrient concentration was reduced; 
the largest amount of biofilm was formed at full BHI concentration (Figure 4.1c). 
More biofilm was produced with strain JCM 3724 at half BHI concentration, 
followed by quarter BHI concentration and then full BHI concentration (Figure 
4.1c). There were no statistical significance in the differences in the amount of 
biofilm produced at decreasing nutrient concentration for strains JCM 3718, JCM 
3724 and ARU 01 (p value = 0.86, 0.65 and 0.29 respectively). 
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Figure 4.1 Quantification of biofilm formed by the 3 F. necrophorum isolates  
(ARU 01, JCM 3718 and JCM 3724) under different conditions: 
pH, temperature and nutrient concentration, to study the amount of biofilm formed under 
different conditions and examine the optimum conditions for biofilm formation by F. 
necrophorum. (a) Mean biofilm formed at pH 4,7 and 10, (b) mean biofilm formed at 
26ºC,37ºC and 42ºC and (c) mean biofilm formed under different nutrient concentrations 
(full, half and quarter). Data represent n=48. {Error bars represent standard error.} 
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4.3.3 BacLight viability 
BacLight viability assay was initially carried out on mixed cultures of known ratios 
of live and dead cells; results showed that viable to dead cells ratios were as 
expected (results not shown).  ARU 01 cells killed by treatment with 70 % isopropyl 
alcohol (used for preparing dead bacteria as a control) showed mostly dead cells 
(see Figure 4.2b). 
 The assay was applied to biofilms formed to determine the ratio of Live/Dead cells 
within the biofilms. A high proportion (greater than 70 %) of viable cells were 
shown to be present in the reference strain JCM 3718 and ARU 01 Lemierre’s 
strain, whereas JCM 3724 showed equal numbers of Live/Dead cells.  S. aureus 
showed higher proportion of live cells (ratio of Live/Dead of approximately 95:5 
%).  
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Figure 4.2 Representative images of BacLight viability staining with 
mixture of SYTO9 and PI 
(a) Live cells of S. aureus stained green, (b) Dead cells of ARU (treated with 70% 
isopropyl alcohol) which are stained red, (c) JCM 3724 cells yellowish-orange 
staining (showing cells that have taken up both dyes) and (d) JCM 3718 showing 
mixed fluorescence micrograph of both live (green) and dead (red) stained cells.  
 
 
 
 
 
4.3.4 Single and Dual-species biofilm formation 
After growing of F. necrophorum samples anaerobically for 48 hours, biofilm 
formation in 96-well microtitre plates were quantified as described. The 
absorbance of single and dual-species biofilms was measured using the microtitre 
plate reader at OD600 (Figure 4.3).  
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Figure 4.3 Comparison of biofilm formed by F. necrophorum strains (ARU 
01, JCM 3718 and JCM 3724) as single or dual-species at absorbance of 600 
nm.  
The graph represents the absorbance values of biofilm formed by the strains. The     
single species values represent the results for 50 ul.  Data represent n=24. {Error bars 
represent standard error.} 
 
The absorbance values correspond to the amount of biofilm formed by each 
bacterial strain. The quantification of biofilm formation using the crystal violet 
staining method does not identify individual strain/species in a dual-species 
biofilm.  In the single species biofilm assay, JCM 3718 was observed to form the 
most biofilm, having a mean absorbance (OD600 of 0.85).  JCM 3724 and ARU 01 
produced less biofilm with mean absorbance of 0.67 and 0.35 respectively at 
OD600. E. coli single-species was observed to form the most biofilm (OD600 1.52), 
compared to S. aureus single-species biofilm (OD600 0.8).  For dual-species, ARU 
01 and E. coli formed the most biofilm giving a high absorbance of 1.28 at OD600, 
this was followed by JCM 3724 and E. coli (OD600 1.1) and the lowest dual-species 
biofilm was observed with JCM 3718 and E. coli (OD600 0.98).  Dual-species of F. 
necrophorum with S. aureus produced less biofilm with all the strains when 
compared to F. necrophorum strains with E. coli.  With the exception of ARU 01 
and E. coli, there was no evidence of enhanced biofilm formation in dual culture. 
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4.3.5 Antibiotic disc susceptibility testing of E. coli and S. aureus  
Antibiotic discs applied to the agar plates were examined after 24 hours incubation 
at 37 °C.  Zones of inhibition (ZOI) were measured to the nearest mm and the 
results were compared to a standard interpretation chart using BSAC guide 
(Andrews, 2001).  S. aureus was observed to be susceptible (S) to all the 
antibiotics tested, E. coli was seen to be susceptible to amikacin (AK) and 
ceftazidime (CAZ), but resistant (R) to ciprofloxacin (CIP), chloramphenicol (CHL) 
and gentamycin (GEN). 
 
4.3.6 Antibiotic disc susceptibility testing of F. necrophorum 
The disc diffusion test was interpreted using BSAC (2015) and EUCAST (2014) 
methods for antimicrobial susceptibility testing.  This was demonstrated by clear 
zones of inhibition (ZOI) on the agar plates, indicating that growth of both 
reference strains (JCM 3718 and 3724) and the clinical strain ARU 01 were 
inhibited by the antibiotics used (photos not included).  Imipenem (IMP) was seen 
to be the least efficient of the antibiotics used with a small zone of inhibition (this 
can be classified as resistant) and the other four antibiotics: CIP, PEN, MET, and 
tazobactam/piperacillin (TZP) were all equally effective on the strains of F. 
necrophorum tested, with similar size zones of inhibition.   It should be noted that, 
as yet, the disc diffusion test is not recommended for anaerobes. 
 
4.3.7 Minimum inhibition concentration (MIC) test using MTP 
Antibiotics were selected to test their efficacy to inhibit and or eradicate biofilm of 
F. necrophorum. The optical density of cultured cells treated with different 
concentrations (64 -512 µg/ml) of antibiotics were measured at 600 nm.  For the 
clinical strain ARU 01, penicillin and kanamycin were seen to be most effective at 
512 µg/ml, with the efficacy of inhibiting biofilms ranging from 72 % for penicillin 
and 77 % for kanamycin.  Metronidazole had a lower efficacy of 55 % with the 
clinical strain.  The antibiotics penicillin and kanamycin, in inhibiting reference 
strain JCM 3718 of F. necrophorum, were more effective than metronidazole, with 
percentage inhibition of 64 %, 60 % and 53 % respectively. Penicillin was more 
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effective for JCM 3724 at 55 % inhibition, with kanamycin and metronidazole 
having similar efficacies of 45 % and 44 % respectively.  Overall penicillin and 
kanamycin were seen to significantly inhibit the formation of biofilm.  For all the 
strains tested, metronidazole was observed be the least effective at inhibiting 
biofilm formation at all the concentrations of antibiotics used (see Figure 4.4).  
 
 
Figure 4.4a Strain ARU 01 
 
 
Figure 4.4b Strain JCM 3718 
(Continued below on page 69.) 
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Figure 4.4c Strain JCM 3724 
 
Figure 4.4  Antibiotic susceptibility testing of F. necrophorum strains: ARU 
01, JCM 3718 and JCM 3724 with three antibiotics (PEN-penicillin, KAN-
kanamycin and MET-metronidazole) at concentration of 512 – 64 µg/ml. Data 
represent n=24. {Error bars represent standard error.} 
 
 
Penicillin and kanamycin were shown to produce significant inhibition of biofilm 
formation on ARU 01 cells at all the four concentrations of antibiotics (Figure 4.4a). 
For JCM 3718, kanamycin and penicillin were seen to be better inhibitors when 
compared to metronidazole at the same concentrations (Figure 4.4b).  Penicillin 
was more effective in inhibiting biofilm formation of JCM 3724 at a concentration 
of 512 µg/ml than kanamycin and metronidazole (Figure 4.4c). 
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4.3.8 Single species biofilm with antibiotics 
 
  
Figure 4.5  Comparison of single-species biofilm with antibiotics.   
Biofilm assay with single species F. necrophorum strains (ARU 01, JCM 3718 and 
JCM 3724) and S. aureus used as a control. PEN- penicillin, MET- metronidazole and 
CIP- ciprofloxacin were used at concentration of 512 µg/ml, to compare the biocidal 
activity of the antibiotics on biofilm formation of the single-species bacteria used. 
Mean amount of biofilm formed was calculated (n=12). {Error bars represent standard 
error.} 
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4.3.9 Dual-species biofilm with antibiotics 
 
 
Figure 4.6   Comparison of dual-species biofilms of F. necrophorum strains 
with S. aureus with antibiotics.   
Dual-species biofilm of ARU 01, JCM 3718 and JCM 3724 with S. aureus in the 
presence of 512 µg/ml concentration of PEN, MET or CIP antibiotics, to study the 
effect of the antibiotics on biofilm formation. The data is representative of three 
independent experiments in 4 replicates each (n=12). {Error bars represent standard 
error.} 
 
All strains and isolates of F. necrophorum used for single and dual-species were 
observed to form biofilm to some extent.  Figure 4.5 shows the amount of biofilm 
formed in single and dual-species both in the presence and absence of antibiotics.  
Strain ARU 01 yielded the lowest amount of biofilm when grown alone as a single-
species compared to JCM 3718 and JCM 3724 strains.  The same strains in 
single-species biofilm with antibiotics resulted in less biofilm production for ARU 
01 and JCM 3724 suggesting the antibiotics had some inhibitory effect on these 
strains.  JCM 3718 did not show significant change in the amount of biofilm formed 
in single-species with or without antibiotics.  ARU 01 in dual-species combination 
with S. aureus resulted in good growth when compared to ARU 01 only.  The 
growth in all the dual-species biofilm were modest, but slight increases were 
observed in dual-species biofilm for JCM 3718 and JCM 3724 when compared to 
their single-species growth.  There was a slight decrease in ARU 01 biofilm in 
dual-species assay.  All three of the F. necrophorum strains grown with antibiotics 
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showed increased yield in biofilm formation.  Statistically, there were no significant 
difference between three strains (p = 0.56), however, a significant difference was 
observed in the different conditions tested: single-species with or without 
antibiotics, and dual-species with or without antibiotics (p = <0.0001). 
The biocidal activity of antibiotics, PEN, MET and CIP on single-species F. 
necrophorum strains was also compared with S. aureus for biofilm formation.  The 
clinical strain ARU 01 only grew in the presence of MET, but no growth was 
observed with PEN and very little growth in the presence of CIP.  Penicillin was 
the most effective antibiotic against all three strains of F. necrophorum tested, 
having high biocidal activity.  MET allowed growth in all the strains examined, thus 
showed the least biocidal activity.  S. aureus biofilm had reduced growth in the 
presence of CIP compared to PEN and MET.  The efficacy of the antibiotics to 
eradicate most of the strains in single-species biofilm was found to be statistically 
significant (p = 0.0082), and significant difference were observed between the 
different strains with antibiotics (p = 0.013) (Figure 4.5). 
The other part of this study examined the effect of antibiotics (PEN, MET and CIP) 
on dual-species biofilms (Figure 4.6).  The antibiotics PEN was seen to produce 
the least amount of biofilm, thus showing the highest efficacy in eradicating 
biofilms in the strains tested.  MET enabled the production of consistent biofilms 
in all strains tested in the dual-species assay, but CIP was only able to slightly 
inhibit JCM 3718 in a dual-species biofilm.  Overall, there was little difference in 
the efficacy of the antibiotics used in the dual-species biofilm, and no statistical 
significance on biofilm growth (p = 0.077) was shown.  There was also no 
statistical significance (p = 0.516) between the F. necrophorum strains in the 
presence of antibiotics. 
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4.3.10 16S rRNA gene amplification from the DNA extraction from 
planktonic cells and biofilms. 
 
  
 
 
 
 
 
 
 
 
 
Analysis of the DNA samples extracted from the planktonic cells and biofilm of the 
threes strains of F. necrophorum by PCR resulted in products of the expected 
sizes of 485 bp.  All observed bands had the same intensity for both planktonic 
cells and biofilm amplified DNA.  The positive controls also had bands of the 
expected sizes, in addition to faint multiple bands.  No bands were observed in 
the negative controls.  After sequencing the purified PCR products, the resulting 
sequence data were compared to those in the GenBank database using BLAST 
search, and this revealed all the strains as F. necrophorum (see Appendix II for 
sequencing data and BLAST results).  The DNA analysis was only carried out on 
single-species biofilms and not for the dual-species due to time constraints. 
Figure 4.7 Gel electrophoresis of PCR amplicons of DNA extracted 
from planktonic cells and biofilms of F. necrophorum using 16S rRNA 
primers. 
DNA were extracted from the biofilm assay samples (F. necrophorum strains: 
ARU 01, JCM 3718 and JCM 3724) 48 hours after anaerobic incubation at 
37°C.  Samples were amplified with 16S rRNA primers and the products 
resolved on 1 % agarose gel using a standard DNA marker.  Lane M – 100 bp 
DNA marker; Lane 1 –ARU 01 planktonic cells (PC); Lane 2 – JCM 3718 PC; 
Lane 3 – JCM 3724 PC; Lane 4 – ARU 01 positive control; Lane 5 – negative 
control; Lane 6 – ARU 01 biofilm; Lane 7 – JCM 3718 biofilm; Lane 8 – JCM 
3724 biofilm; Lane 9 – ARU 01 positive control; Lane 10 – negative control; 
Lane 11 – empty. 
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Primers could be designed specifically for each of the microorganism species, 
though a qPCR method would need to be developed for quantitation.  
 
 Discussion 
Infections caused by F. necrophorum are chronic and recurrent in the upper 
respiratory tract in humans are not fatal, but account for significant costs in the 
healthcare system due to their common presentation at general practitioner’s 
(GP’s) surgeries (Nord, 1995).  Decades of studies by scientists on bacteria in 
liquid suspension have provided many insights into the physiology and genetics 
of these microorganisms.  They are now known to exist naturally as sessile 
aggregates and not as planktonic cells as was original thought.  Biofilms are 
abundant in healthcare, industry and other settings and these have led to 
increased interest and research over the last few decades.  EPS of biofilms are 
thought to result in antibiotic resistance and persistent upper respiratory tract 
infections.  The cost of treating biofilm related infections are reported to be around 
$7 billion per year in the United States alone, with limited success (Licking, 1999). 
According to the National Institutes of Health, 80 % of human infections are due 
to biofilms, yet antibiotics have all been designed for planktonic cells (Schachter, 
2003b). Collective biofilms provide their inhabitants with resistance to 
antimicrobials and host defence mechanisms through quorum sensing and 
horizontal gene transfer and this is one of the rationales behind this study.  The 
lack of studies on F. necrophorum and its resurgence also justifies the need for 
further research on this microorganism. 
Due to circumstances outside our control, only preliminary work was carried out 
in an anaerobic cabinet.  Subsequently, microtitre plate-based assays, overlaid 
with mineral oil were used. All results presented here were from these 
experiments. 
The mineral oil overlay used in the microplate-based assays was shown to provide 
a suitable environment, achieving the anaerobic condition needed for the growth 
of F. necrophorum an obligate anaerobic organism.  The oil reduced growth of the 
facultative anaerobe S. aureus significantly, this reduction in growth indicates a 
change in respiratory conditions, as anaerobic respiration yields less ATP than 
aerobic respiration, thus less energy is available for cellular proliferation.  The 
theory for biofilm co-culture was that mineral oil would result the production of an 
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environment with greatly reduced oxygen, which would be reduced further by the 
presence of S. aureus.  It was important that F. necrophorum did not completely 
dominate the anaerobic culture.  Readings were taken after 48 hours incubation, 
at a point where the organisms were still in log phase.  Recording absorbance of 
samples in the microtitre plates at regular time intervals, and comparing bacterial 
growth under mineral oil and in an anaerobic jar would have improved analysis 
and allow clarification of which method was more effective; however, it was difficult 
to use the microtitre plates within the anaerobic jars and handling of the plates for 
repetitive absorbance readings could have affected the biofilms or, if the mineral 
oil layer was displaced, could have compromised the anaerobic culture.  An 
adaptation of the crystal violet method by Merritt et al., 2005 used for quantification 
of biofilm formed in this study could be used to assess growth over time.  Other 
studies have been able to show that the mean absorbance (i.e. biofilm formation) 
increases with extension of incubation times (Adetunji and Isola, 2011).   
The BacLight viability assay used for F. necrophorum proved to be an effective 
method for the detection of viable cells from the biofilm produced.  The procedure 
allowed for qualitative assessment of Live/Dead cells after biofilm formation and 
gave an indication of the survival of bacteria grown under different conditions. 
However, the results rendered interpretation of the data obtained from the 
absorbance assays difficult.  For example, although JCM 3724 appears to grow 
well at 26 °C many of those cells were shown to be dead.  There are three potential 
explanations;1- cells had grown well, reached a maximum and then died in situ; 
2-during the harvesting of the cells for the BacLight assay they were exposed to 
oxygen in the environment and died; 3-the biofilms were less tolerant to exposure 
to oxygen and died during processing.  As all experimental wells for one strain 
were seeded with the same original culture, and different results were obtained 
for the varied conditions, option 1 is unlikely.  It would be prudent to investigate 
this problem experimentally, exposing the cells from the biofilms and from 
standard culture to air for varying times prior to processing.  A further option 
(option 4) is that they did not grow at all but died immediately and stuck to the 
surface of the well.  However, dead cells do not adhere, and this is therefore an 
unlikely explanation.  It is noteworthy that S. aureus that is tolerant to air showed 
95 % viability during the experiments. 
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It was not possible to identify specific cells in the dual cultures in the BacLight 
assay, as there were no Gram stained references from some of the earlier co-
cultured biofilms.  Limitations also include an assumption that the viable cells in 
biofilm co-culture included both F. necrophorum strains and S. aureus, based on 
the fact that both organisms grew separately under mineral oil conditions.  It is 
possible that one species predominated; this could be checked using a qPCR 
assay with species-specific primers and standard curves. 
 
Under “conventional” in vitro conditions of incubation at pH 7, 37 °C and full 
nutrient concentration, all the strains of F. necrophorum formed biofilm.  
Conditions encountered by microorganisms in the human host are clearly different 
from those in vitro (Di Bonaventura et al., 2007).  It is widely known that 
environmental factors such as pH, temperature and nutrient availability all 
influence biofilm formation (Hadju et al., 2010), thus the experiments undertaken 
in this study allowed the quantification of biofilm formed by F. necrophorum strains 
(ARU 01, JCM 3718 and JCM 3724) on abiotic surfaces under different pHs, 
temperatures and nutrient concentrations.  It was believed that this was the first 
study investigating biofilm formation by F. necrophorum. 
Marked differences were observed in inhibition in biofilm formation by the three F. 
necrophorum strains studied at growth media pH 10.  Nostro et al., (2012), 
observed similar association between increased pH and biofilm formation, they 
demonstrated that Staphylococcal biofilm formation was obstructed at alkaline pH. 
The effect of inhibition by alkaline pH on the ability of F. necrophorum to form 
biofilm by bacterial attachment could be related to the effect of pH on attachment 
due to surface charge properties (Nostro et al., 2012).  There is an interest to study 
the effect of alkaline conditions together with antimicrobials in order to find 
effective antimicrobial therapy to eradicate bacteria colonisation and survival in 
biofilm which would lead to decrease in biofilm-related hazards.  On the other 
hand, increase in pH has been shown to result in increase in biofilm production in 
Pseudomonas aeruginosa, Klebsiella pneumoniae and Vibrio cholera (Hoštacká 
et al., 2010).  Increased biofilm production in P. aeruginosa at a higher pH of 8 is 
explained by the higher production of alginate, similar association has also been 
demonstrated in S. maltophilia (Harjai et al., 2005; Di Bonaventura et al., 2007; 
Hoštacká et al., 2010). 
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This study showed all three strains of F. necrophorum produced the greatest 
amount of biofilm at acidic pH (pH 4), suggesting that the formation of biofilm could 
be due to the response to stress signals which results in the production of 
extracellular matrix allowing survival at low pH.  Another interesting finding in this 
study was after 48 hours incubation of the biofilm under different pH conditions, 
the pH of the growth medium decreased from pH 10 to 8, and in the growth 
medium with pH 4, it decreased to pH 2.  The explanation for these findings may 
be due to the production of butyric acid by F. necrophorum as the main end 
product of its metabolism (Carlier et al., 1997).  It would be interesting to assess 
butyric acid production, using NMR/MS for biofilm and planktonic cells.  
One of the basic requirements for bacterial growth is temperature (Hadju et al., 
2010).  It was observed in this study that the relationship between incubation 
temperature and biofilm formation in F. necrophorum strains used did not show 
consistent behaviour.  At 37 °C incubation, ARU 01 and JCM 3718 strains formed 
the most biofilm, with reduction in biofilm observed 26 °C and 42 °C, indicating 
that these two strains are unable to form biofilm to help them survive at extreme 
temperatures.  Strain JCM 3724 on the other hand, formed most biofilm at the 
lower temperature of 26 °C and also a significant amount of biofilm at the higher 
incubation temperature of 42 °C.  This is an indication that strain JCM 3724 might 
be able to survive in extreme temperatures by forming biofilms.  
It can be seen that biofilm formation on abiotic surfaces was favoured by 
environment that is limited nutritionally as observed for F. necrophorum strain JCM 
3724.  This indicates that sessile growth during biofilm formation may be a survival 
strategy.  This has also been observed by Loo et al., 2000, where biofilm formation 
by Streptococcus gordonii was increased in low concentration nutrient medium 
but not in a rich nutrient medium.  This increase in biofilm formation in low nutrient 
medium could be associated with increase in the production of EPS by the 
organism.  The process usually demands high energy, therefore more nutrients 
would be required for increased EPS production (Allan et al., 2002).  In this study, 
results for strain ARU 01, was shown to form the most amount of biofilm at pH 7, 
26 °C and full nutrient concentration.  Strain JCM 3718 formed the most biofilm at 
pH 4, 37 °C and half nutrient concentration.  The observed results could be due 
to stress response where low pH enhances biofilm formation of strain JCM 3718. 
Most biofilm production for strain JCM 3724 was observed at pH 4, 26 °C and half 
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nutrient concentration.  The experiments in this study showed that the quantity of 
biofilm formed is dependent on all three conditions tested (pH, temperature, and 
nutrient concentration).  Change in any of these factors can dramatically affect 
biofilm formation, therefore the results shown in this study can reveal that F. 
necrophorum biofilm behaviour in vivo is dependent on the environmental 
conditions and most probably host immune responses at the site of infection.  In 
the production of biofilm in Pseudomonas, Klebsiella and Vibrio, there was a 
positive relationship observed between pH of incubation media and biofilm 
formation (Hoštacká et al., 2010). 
Two major regulatory genes, rpoS and algT found in P. aeruginosa and E. coli are 
thought to be responsible for the initiation of stress response during biofilm 
formation (Cochran et al., 2000).  These regulatory genes can be upregulated and 
thus moderate physiological changes that protect the biofilm structure from 
environmental stresses such as heat shock, cold shock, oxidative stress and other 
chemical agents.  P. aeruginosa has the ability to form biofilm under extreme 
environmental conditions due to the production of the EPS known as alginate 
(Stapper et al., 2004; Cotton et al., 2009).  Alginate in P. aeruginosa has been 
shown to provide specific protection to bacterial biofilms from antibiotics and 
immune responses, thus it is important to target this polymer in medical research 
(Cotton et al., 2009). 
The genetic background of the organism seems to play a more important role than 
the natural habitat with the environmental stress factors, which are less important 
in the role of biofilm production.  In the clinical setting, alkaline solutions or 
cleaners could be promising in preventing bacterial colonisation, by treating 
surfaces such as catheters or indwelling medical devices, reducing the risk of 
biofilm related infections.  
 
The bacteriostatic method for assessing antibiotic resistance for F. necrophorum 
in this study, demonstrated clear zones of inhibition showing susceptibility of F. 
necrophorum to PEN (penicillin), MET (metronidazole), CIP (ciprofloxacin) and 
TZP (tazobactam/piperacillin).  The study continued to investigate the ability of F. 
necrophorum strains to form biofilm in single and or dual-species using the MTP 
assay set up under “normal” in vitro settings for 48 hours under anaerobic 
conditions.  The results showed that all the strains (ARU 01, JCM 3718 and JCM 
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3724) were able to produce biofilms when grown as single-species.  ARU 01 was 
able to produce the most biofilm when grown as a single species but did not 
produce much biofilm when grown in combination with S. aureus.  When 
comparing the individual species forming biofilms with those of dual-species, we 
could estimate the amount of expected biofilm formed in co-culture, such as in the 
case of S. aureus, which produced low biofilm when compared to E. coli in single-
species biofilm.  Among the three F. necrophorum strains studied, ARU 01 
produced the lowest biofilm mass, so would be expected to be a poor biofilm 
producer in co-culture. Co-culture of ARU 01 with S. aureus produced a low mean 
absorbance value of 0.66 at OD600 (Figure 5.6) when compared with ARU 01 and 
E. coli co-culture with absorbance value of 1.12 (at OD600).  The expectation in 
this investigation was that dual-species biofilm would thrive due to the presence 
of S. aureus, which would consume the oxygen allowing for the survival of F. 
necrophorum, a fastidious anaerobe.  Jefferson, (2004) supports this hypothesis, 
by discussing oral colonisation by aerobes creating an environment suitable for 
anaerobic bacteria.  Hibbling et al., (2010) confirmed that biofilms can select the 
best variants to colonise the niche created by the biofilm. 
 
In nature, monospecies biofilms are rarely found (Burmølle et al., 2014), the 
experiments carried out in this study allowed for the quantification of dual-species 
biofilm of F. necrophorum grown with S. aureus, thus allowing the determination 
of the effect of antibiotic resistance with biofilm formed in dual-species biofilms. 
Polymicrobial cultures are able to create mutually beneficial communities within a 
biofilm.  S. aureus is a self-limited biofilm producer, with self-produced D-amino 
acids, which mediate the release of protein components of the matrix, preventing 
the formation of fully formed biofilm by S. aureus.  Nutrient depletion and waste 
product accumulation, which leads to subsequent disassembly of biofilm, may be 
some of the reasons for reduced biofilm formation by ARU 01 and S. aureus co-
culture (Hochbaum et al., 2011).  The biofilm assays were performed several times 
for individual species and co- cultures, but the data obtained were inconsistent. 
The wash stages for the crystal violet staining may have contributed to the 
inconsistency in the data obtained.  F. necrophorum is thought to die when 
exposed to air for a short period.  The handling of the culture during preparation 
of the biofilm assay can significantly reduce the viability of the organism.  Mineral 
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oil has been demonstrated in various studies to provide a relatively anaerobic 
environment (Ahn and Burne, 2007; Ahn et al., 2009; Liu and Burne, 2011) and 
was used in this study.  As well as mineral oil, anaerobic conditions can be 
improved by incubation of the microtitre plates in an anaerobic jar, but this can 
lead to F. necrophorum thriving and dominating both S. aureus and E. coli in the 
co-culture, generating results that are not representative.  It has been reported 
that E. coli, when grown on its own does not produce stable biofilm, but co-culture 
with P. aeruginosa facilitated biofilm production (Burmølle et al., 2014).  Their 
studies also demonstrated how bacteria can alter the physiochemical 
surroundings, thus changing the pH and oxygen concentration (Burmølle et al., 
2014). 
 
Biofilm had increased resistance to wide range of antibiotics compared to 
planktonic cells. The challenges of antibiotics resistance and difficulty of 
eradicating biofilms has prompted novel approaches to preventing or delaying 
biofilm growth.  The objectives of these studies included investigating the effect of 
different antibiotics on F. necrophorum biofilms in anaerobic condition.  Biofilm 
assays were set up in the presence of antibiotics including, penicillin (PEN), 
metronidazole (MET), kanamycin (KAN) and ciprofloxacin (CIP), each with 
different modes of action against bacteria.  The higher concentration of PEN and 
KAN at 512 µg/ml was observed to be the most effective for ARU 01 with antibiotic 
efficacy of 70 % and 60 % respectively.  PEN and KAN also had significant effect 
on inhibition of biofilm growth than MET for strain JCM 3718, with 65 % and 60 % 
efficacy of antibiotic respectively.  F. necrophorum is known to have high 
susceptibility to beta-lactams which include penicillin (Chukwu et al., 2013). 
Penicillin is known to target cell walls of Gram-positive bacteria and its mechanism 
of activity involves targeting the cross-linker polymer, peptidoglycan, which 
maintains integrity and shape of bacteria.  The binding of penicillin to penicillin 
binding protein irreversibly, results in the disruption of peptidoglycan synthesis, 
which subsequently decreases the enzyme activity, interrupting cell wall 
development and resulting in cell death (Scheffers and Pinho, 2005; Lange et al., 
2007). Penicillin, although widely used to treat infections caused by F. 
necrophorum, though resistance has been noted; a study reported 2 % of 100 F. 
necrophorum isolates were resistant to penicillin (Brazier et al., 2002).  
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Metronidazole was shown to be the least effective in inhibiting F. necrophorum 
biofilm formation. All single-species produced biofilms in the presence of 
metronidazole, with JCM 3724 shown to produce the most biofilms.  The result 
observed is conflicting, since metronidazole is the common antibiotic of choice for 
anaerobic infections (Brazier, 2006; Brazier et al., 2006; Lofmark et al., 2010).  
 
Examination of single-species biofilms showed that ARU 01 had reduced growth 
in the presence of antibiotics compared to no antibiotics.  Strains JCM 3718 and 
JCM 3724 in contrast had increased biofilm formation in the presence of 
antibiotics.  It was postulated by Vlamakis et al., (2008) that antibiotics may not be 
able to penetrate deep inside the biofilm, thus protecting its inhabitants.  They also 
stated that antibiotics diffusion are hindered by the slimy residue of the biofilms. 
In their study, they used mathematical models to predict that biofilm infections 
would not be cleared if the rate of antibiotic diffusion through biofilm was slower 
than the rate of antibiotic activation (Vlamakis et al., 2008).  This study confirms 
that with the exception of ARU 01, single-species biofilms do protect the bacteria, 
but planktonic cells are susceptible to a range of antibiotics.  Biofilm formation for 
dual-species in the presence of antibiotics was the most striking in this study. 
Biofilms resistant to antibiotics have not been fully elucidated, however, there are 
a number of factors that may be contributing to this resistance.  Several reasons 
for this increased antibiotic resistance in the biofilm communities include one 
suggested by Hall-Stoodley et al., (2004) that some cells within biofilms are in the 
stationary phase, creating areas of dormancy within the biofilm.  For antibiotics to 
have an effect on bacteria, there should be a display of some cellular activity (Hall-
Stoodley et al., 2004; Hall-Stoodley and Stoodley, 2009).  Kirby et al., (2012) 
support that biofilms unyielding to antibiotics are likely to be a result of metabolic 
state rather than environmental conditions.  The efficacy of antibiotic is dependent 
on active cell division and metabolism, but the activity of antibiotics may be 
influenced by low metabolic rate of bacteria forming biofilm (Cramton et al., 2001).  
Thus, there is the possibility that increase in biofilm formation from the dual-
species assays could be due to the antibiotics not being able to kill the bacteria, 
as the cells may be dormant.  The development of gradients within biofilm clusters 
are shown to create anoxic, acidic and nutrient-depleted areas, which can activate 
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dormancy states, where no growth or death are observed (Walters et al., 2003; 
Stoodley et al., 2008).  The idea of dormant cells lead to the hypothesis that 
persister cells occur within biofilm communities.  Persister cells are sub-population 
of bacteria produced during stationary growth phase that display tolerance to 
antimicrobial killing, and survival not shown by the other cells.  They have the 
ability to re-grow as planktonic cells and are responsible for repopulating and 
carrying on with biofilm infections through dispersal and colonisation of new niches 
(Lewis, 2001; Lewis, 2007); Keren et al., 2004; Keren et al., 2012; Zhang, 2014). 
Persister cells, which make up about 0.1-1 % of the biofilm communities are 
thought to be responsible for the tolerance to potent, high concentration antibiotic, 
which are unable to inhibit or eradicate biofilms (Lewis, 2001; Lewis, 2007).  The 
combination of species within multispecies biofilms are unaffected by the 
introduction of antibiotics.  Burmølle et al., (2014), hypothesised that resistant 
species might be providing synergism with their neighbours.  The mechanism 
underlying the formation of persister cells is still unknown, although it is known 
that the highest rate of persister cell formation is at the stationary phase of growth 
and is independent of quorum sensing (Lewis, 2007).  
 
Quorum sensing (QS), also known as bacterial communication, is a phenomenon 
where bacteria produce, release, detect and respond to extracellular chemical 
signal molecules known as autoinducers (AI) that increase in concentration as a 
function of cell density, when it reaches an optimum level.  The bacteria 
community undergoes phenotypic changes at this point (Davies et al., 1998;      
Miller & Bassler, 2001; Schachter, 2003b; Schachter, 2003; Parsek and 
Greenberg, 2005; Ng and Bassler, 2009).  Several bacteria species have evolved 
the ability to take advantage of this communication system.  Well studied systems 
include: N-acyl homoserine lactone (AHL), the first to be described for Vibrio 
fisheri, an aquatic bacterium (Moons et al., 2006), and the autoinducing peptide 
signalling system in Gram-positive species (Bassler, 2002; Bassler & Losick, 
2006).  A response regulator binds the signal once the “quorum” has been 
reached, and this modulates gene expression.  A loss in this signalling pathway 
will stop the formation of biofilm (Moons et al., 2006).  The third system is 
autoinducer-2 QS system, first described in Vibrio harveyi.  This system facilitates 
interspecies communication and was found to be produced by a large number of 
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Gram-negative and Gram-positive species, this signal stimulated the aggregation 
required for bioluminescence (DeKeersmaecker and Vanderleyden, 2003; 
Schachter, 2003; Bassler & Losick, 2006).  The expression of efflux systems has 
been implicated in quorum sensing regulation, and QS is known to control the 
expression of several virulence factors and differentiation of biofilm.  It was shown 
by Chan and Chua (2005) that QS controlled biofilm formation were dependent on 
BpeAB-OprB efflux pump function in Burkholderia pseudomallei.  P. aeruginosa 
presents several putative multidrug resistance (MDR) efflux pumps, which play an 
important role in antibiotic resistance of planktonic P. aeruginosa.  S. aureus has 
been reported to have six efflux pumps for mechanisms of resistance to 
antimicrobial agents, and in relation to biofilm, they found a polymicrobial-biofilm-
associated multidrug isolate of S. aureus, which may have the MDR gene cluster 
and the macrolides efflux pump msrA.  The expression of biofilm efflux pumps in 
E. coli may be the reason why their biofilms are more resistant to antibiotics than 
their planktonic cells (Soto, 2013).  QS and efflux pumps may have contributed to 
the increase observed in the biofilm of dual-species with antibiotics in this study. 
Indeed, the effect of QS molecules on the mono and dual species biofilms is an 
area worthy of future investigation. 
 
The EPS limits antibiotic diffusivity within the biofilm through chemical reaction 
with antimicrobial agents or by restricting their rate of transport.  Expression of 
resistance genes, low growth rates which reduce the rate of antibiotic uptake into 
the cells and the conditions presented in the surrounding environment of cells 
forming biofilm may collectively contribute to resistance (Cramton et al., 2001). 
The incubation step of the conventional MTP assay is undefined and subject to 
modification based on the growth requirement of the organism being investigated; 
slow- or fast-growing, aerobes or anaerobes.  Rigorous and careful washing steps 
are involved in the MTP assay where the 96-well plate is submerged in a bowl of 
water (Merritt et al., 2011).  The inconsistencies in the absorbance values of the 
crystal violet stained biofilm may be due to factors such as the washing steps as 
some biofilms may be washed off the unbound cells after incubation of the MTP 
plates (Merritt et al., 2011; Pye et al., 2013).  Therefore, bacterial isolates, which 
were classified either as weak, moderate or strong biofilm producers using the 
MTP assay may be inaccurate.  These variations suggest that the MTP assay may 
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be unreliable for accurate estimation and subsequent classification of bacterial 
isolates as biofilm producers. 
 
Some of the modifications made during this study to the MTP assay outlined in 
section 2.2.8.1 included fixation of the biofilm produced with 4 % formaldehyde 
before the initial washing step.  The rigorous washing step in a bowl of water was 
modified, by carefully aspirating the unbound, planktonic cells using a multi-
pipette, and the 96-wells were washed with 1X PBS buffer using a pipette.  The 
final modification to the assay was the solubilising agent used, 33 % acetic acid 
instead of the 95 % ethanol, 80 % ethanol/20 % acetone or 100 % dimethyl 
sulfoxide; the choice is dependent on the type of strains producing the biofilm 
(Merritt et al., 2011). 
 
The Live/Dead BacLight assay was used to measure the viability of biofilms 
formed by each of the F. necrophorum strain at each condition tested.  Low pH 
(4) and high pH (10) were shown to have increased viable cells in the biofilm.  The 
BacLight biofilm assay generated interesting results, under the different 
temperatures studied.  At low temperature of 26 °C there was a decrease in the 
amount of viable cells of the biofilm and an increase in the amount of viable cells 
at high temperature of 42 °C.  The interesting findings with decrease in nutrient 
concentration was that the viability of cells remained very high in the biofilm.  A 
possible explanation of these results might be that at extreme pH, high 
temperature and limiting nutrient, biofilm is more rigid where the EPS can protect 
the cells in the biofilm more efficiently.  
All the cultures were incubated anaerobically, but as manipulation was done 
outside an anaerobic cabinet, the observed results may be due to oxygen 
exposure during manipulation.  Studies by Cox et al., (1997), showed that 
manipulating anaerobic bacteria in air can compromise optimal results; their 
studies compared uses of anaerobic chamber versus anaerobic jars.  They were 
able to show that plates inoculated and incubated in anaerobic chambers yielded 
100 % viability.  Certain anaerobes such as F. necrophorum and C. perfringens 
passed the air inoculation-chamber incubation quality control test at 100 %, but F. 
nucleatum had a 19.2 % failure under these conditions.  The air-chamber 
procedure had lower percentage failures when compared to jar procedures, due 
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to shorter exposure in the air-chamber procedure.  Optimal growth was obtained 
under complete anaerobic conditions during all the manipulation and incubation 
steps (Cox et al., 1997). 
Problems encountered in this study included the inconsistency in the growth of 
the broth culture of the F. necrophorum strains and the biofilm assays, which were 
not carried out in an anaerobic chamber due to financial constraints, and loss of 
collaborators.  This could have resulted in these obligate anaerobes being unable 
to produce the level of biofilm that might have resulted under strict anaerobic 
conditions.  The production of biofilm formed increased towards the latter part of 
the studies, but this could be due to improved techniques and not as a direct result 
of the conditions being tested or the environment in which the study was 
performed.  In vitro biofilm studies do not resemble that of in vivo infections since 
biofilm in infections form before antibiotics are prescribed.  An experiment that 
would best represent the in vivo state would be to grow and mature the biofilms 
and then add the antibiotics to assess the resistance (Jefferson, 2004).  
Another issue that may have affected the results was the difficulty in growing F. 
necrophorum in BHI to the correct OD, and in trying to avoid introducing oxygen 
into the culture when taking samples for OD readings; the growth was hence 
sometimes estimated visually in the liquid culture.  As the organism sometimes 
did not grow to the required OD of 0.6-0.7, the dilutions used for the biofilm assays 
were 1:10 instead of 1:100.  It was not possible to remove the atmospheric oxygen 
from the BHI media before use and air bubbles may have been introduced into 
the broth media when mixing the cultures; growth of F. necrophorum in the broth 
media could have been hindered by the presence of oxygen.  All the issues 
mentioned could have contributed to the inconsistencies in results between the 
repeated experiments. 
Differences in starting material may be an intrinsic problem with F. necrophorum, 
as it is an obligate anaerobe, exposure time to air should be minimum.  The time 
taken in preparing the dilutions, aliquoting into the 96-well plates and overlaying 
with mineral oil varied between 10-30 minutes and sometimes longer and this 
could mean that some of the organisms might already be dead before incubation 
for growth of the assay.  Therefore, the results obtained may not be accurate.  This 
may explain the variation in results of F. necrophorum biofilm formed for each 
replicate when compared to S. aureus (positive control organism), which being a 
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facultative anaerobe formed firm and uniform biofilm.  Mohammed et al., (2013) 
studied biofilm formation of two anaerobes: F. nucleatum and Porphyromonas 
gingivalis using the MTP assay under anaerobic conditions.  They were able to 
show that F. nucleatum can grow in a non-strictly anaerobic environment using a 
flow cell biofilm model, but this was not the case for P. gingivalis.  It indicates that 
F. nucleatum might be protecting P. gingivalis from oxidative stress, thus biofilm 
formation is synergistically enhanced when these two organisms are grown 
together even in a partially oxygenated condition.  Others have also reported this 
in their studies (Mohammed et al., 2013). 
BacLight assay results were inconclusive; the percentage of Live/Dead cell ratios 
were estimated, as it was not possible to count individual cells.  It was observed 
that examination of the results immediately after staining was better with improved 
accuracy of interpretation when viewed under the microscope; photo-degradation 
occurred when the slides were stored for long periods of time.  Due to problems 
with the imaging software, most of the photomicrograph imaging was delayed and 
this may have affected the estimation of Live/Dead percentages.   
The biofilm study was successfully validated by sequencing the DNA extracted 
directly from planktonic and biofilms of all three strains; these were confirmed to 
be F. necrophorum.  Cell cultures were set up for biofilm formation using the 
microtitre plate method described in section 2.4.1. DNA was then extracted from 
planktonic cells and biofilm separately. This proved that the biofilms formed in this 
study were indeed produced by F. necrophorum isolates and not by other 
organisms, which might have contaminated the assay.  The strains were not 
identified to subspecies level.  
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Chapter 5  
 
5 Cell surface sugars and the Galactose-binding protein of F. 
necrophorum. 
 Introduction 
5.1.1 Glycan-lectin interactions 
Glycan-lectin binding plays a role in biofilm formation with for example, lectins on 
organisms binding to host glycans, lectins on the host binding bacterial glycans 
and lectin-glycan binding between organisms of the same or different species.  
The results of the investigation of the mechanisms of biofilm formation in F. 
necrophorum infection could lead to the development of biofilm inhibitors and 
potential therapeutic strategies based on glycan and biofilm formation (Lesman-
Movshovich et al., 2003; Ofek et al., 2003; Wu et al., 2007; Rachmaninov et al., 
2012).  The inhibition of glycan-lectin interactions and quorum sensing have been 
considered as alternative strategies to antibiotic treatment that can be useful in 
the treatment of chronic infections through the prevention and disruption of biofilm 
formation (Brackman et al., 2011).  An understanding of these interactions 
requires knowledge of the glycans and lectins present on the bacteria. 
Studies on the structures of Gram-negative anaerobes have focused on adhesins 
(lectins) that are involved in the interactions responsible for biofilm formation and 
for internalisation of bacteria into the host cells (Nobbs et al., 2009).  F. nucleatum 
is the most widely studied of the Fusobacterium species, due to its association 
with periodontitis.  In 1989, Mangan and co-workers showed that the attachment 
of F. nucleatum to human neutrophils was lectin-like and could be inhibited by N-
acetyl-D-galactosamine (GalNac), galactose (Gal), lactose (Gal β1,4Glc), but not 
mannose (Man), glucose (Glc) or N-acetyl-D-glucosamine (GlcNac) (Mangan et 
al., 1989).  Shaniztki et al., (1997) demonstrated that exogenous galactose 
prevented the action of four different monoclonal antibodies that inhibited 
coaggregation of F. nucleatum with P. gingivalis.  The study suggested that a 30 
kDa outer polypeptide of F. nucleatum helped in coaggregation with other Gram-
negative strains (Shaniztki et al., 1997).  Rosen and Sela (2006) reported that 
purified capsular polysaccharide (CPS) and lipopolysaccharide (LPS) of P. 
gingivalis could bind to F. nucleatum cells and inhibited its binding to P. gingivalis 
serotype K5.  Sugar binding studies showed that D-galactose was the sugar 
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involved in the interactions, and the authors concluded that galactose-binding 
determinants in F. nucleatum played a crucial role in biofilm (plaque) formation. 
More recent studies, (Coppenhagen-Glazer et al., 2015) demonstrated that 
the attachment of F. nucleatum to mammalian cells and the ability to 
coaggregate with the major periodontal pathogen Porphyromonas gingivalis 
and at least nine other oral bacterial species were also inhibited by D-
galactose.   
The current study utilised lectin-based detection of cell surface and intracellular 
sugars and analysis, and characterisation to elucidate the role of the Galactose-
binding protein.  
 
The aims of this study were to: 
1.  identify sugars on F. necrophorum cells using labelled lectins 
2.  investigate the Galactose binding lectin and determine its likely function. 
 
 Methods 
Lectin based assays, DNA extraction, primer design, PCR and sequencing were 
performed as described in the methods sections 2.3.3.3, 2.6.1, 2.6.2.4, 2.6.2.5 
and 2.6.5 (see chapter 2). 
5.2.1 Determination of specificity of the Galactose-binding protein 
To determine the likely glycan specificity of the Galactose-binding protein, three 
tests were carried out; 
a) Analysis of the agglutination of Human blood group A, B and O erythrocytes; 
these carry the glycans shown in Figure 5.1. 
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Figure 5.1 Glycan structures of the Human A, B and H antigens. 
(Gunnarsson et al., 1984). 
 
b) Analysis of the agglutination of sheep red blood cells that carry the terminal 
galactose containing glycans shown in Figure 5.2. 
 
Figure 5.2  Glycan structures of sheep; 
α 2,3 sialyllacto-N-biose 1(left), α 2,6 sialyllacto-N-biose 1 (centre) and α 2,6 
sialyllactosamine (right) (Gunnarsson et al., 1984). 
 
It is interesting to note that the Gal α1,3 Gal epitopes (both sialylated and 
unsialylated)  (Tan et al., 2010), that are commonly expressed on red cells of  
mammals other than humans and higher apes, have not been detected on sheep 
red cells; however, these epitopes are present on other ovine tissues (Macher & 
Galili, 2008). 
c) Bead based analysis using Sepharose and agarose beads carrying specific 
sugars. 
Methods are described in section 2.5.2.4 and 2.5.2.5. 
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5.2.2 Protein modelling 
The Uniprot Knowledgebase was used to obtain the FUS007_00675 D-Galactose-
binding protein sequence.  The target sequence was loaded into the SWISS-
MODEL (http://swissmodel.expasy.org) protein structure modelling server, and 
SwissDock (http://www.swissdock.ch/docking) was used to investigate ligand 
binding.  Models were visualised using DeepView Swiss pdb viewer 
(https://spdbv.vital-it.ch/). 
 
 
 Results 
5.3.1 Cell surface glycans; ELISA lectin binding assay 
In cell surface analyses using fluorescent labelled lectins, Con A (glucose and 
mannose specific) demonstrated very weak binding for the 3 reference strains 
JCM 3718, JCM 3724, ARU 01 and 4/11 of the clinical isolates (F21, F30, F39 
and F41); S. aureus and clinical isolate 40 demonstrated weak binding.  WGA (N-
acetylglucosamine/N- acetylneuraminic acid specific) bound very weakly to ARU 
01 and JCM 3718; PNA (Galβ1, 3GalNAc specific) bound weakly to ARU 01 and 
clinical strains F39 and F42 and weakly to JCM 3724and clinical isolate F62.  The 
SNA lectin (N-acetylglucosamine/N- acetylneuraminic acid specific) bound weakly 
to JCM 3718 and clinical sample F11 and weakly to clinical isolate F12. SBA (N-
acetylgalactosamine specific) bound very weakly to clinical isolates F21 and F52. 
Auto-fluorescence and patchy distribution of binding provided issues reading the 
fluorescence-based assay (Table 5.1).  Experiments using biotinylated lectins 
were very difficult to read and hence an ELLA assay was set up to detect sugars 
on the solubilise cell extracts of the bacteria. 
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Table 5.1  Results of lectin histochemistry using fluorescent-labelled lectins 
for F. necrophorum and S. aureus.  
 
 
Sample ID 
Con A WGA PNA SNA SBA Predicted sugars 
ARU 01 ± ± + − − Glu/mann, 
GlcNAc/NANA, 
Galβ1,3GalNAc 
JCM 3718 ± ± − ± − Glu/mann, 
GlcNAc/NANA, α2,6 
NANA /GlcNAc 
JCM 3724 ± − ± − − Glu/mann, 
Galβ1,3GalNAc 
         F1 − − − − −  
F11 − − − ± − α2,6 NANA /GlcNAc 
F21 ± − − + ± Glu/mann, α2,6 NANA 
/GlcNAc, GalNAc 
F24 − − − − −  
F30 ± − − − − Glu/mann, 
F39 ± − + − − Glu/mann, Gal 
F40 + − − − − Glu/mann, 
F41 ± − − − − Glu/mann, 
F42 − − + − − Galβ1,3GalNAc 
F52 − − − − ± GalNAc 
F62 − − ± − − Galβ1,3GalNAc 
S. aureus + ± − − − Glu/mann, GlcNAc/NANA 
 Key: +: Positive, ±: very weak, +: weakly positive and –: negative. Glu= glucose, Gal = 
galactose, mann = mannose, GlcNAc = N-acetylglucosamine, GalNAc = N-acetylgalactosamine, 
NANA= N-acetylneuraminic acid (sialic acid). 
 
5.3.2 Glycans present in whole cell extracts; ELLA assay 
To determine the glycans present in the solubilised fraction of the bacterial 
isolates, an adaptation of the ELISA procedure, ELLA, was used. This assay 
would detect a mixture of intracellular and cellular glycoconjugates. Assays were 
performed in duplicate using the reference strains, and 6 clinical isolates.  
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Table 5.2  ELLA lectin assay for F. necrophorum 
 
 
Sample 
ID 
Lectin  Predicted sugars 
ConA 
Abs 
WGA 
Abs 
PNA 
Abs 
SNA 
Abs 
SBA 
Abs 
ARU 01 3.4 0.01 3.4 1.8 0 Glu/mann, GlcNAc/NANA, 
Galβ1,3GalNAc, 2,6 NANA/GlcNAc 
JCM 
3718 
0.22 0 0 0.054 0 Glu/mann, 2,6 NANA/GlcNAc 
JCM 
3724 
0.28 0 0 0.44 0 Glu/mann, 2,6 NANA/GlcNAc 
F1 1.6 0.48 0.027 1.09 0 Glu/mann, GlcNAc/NANA, 
Galβ1,3GalNAc, 2,6 NANA/GlcNAc 
F11 0.03 0.016 0.15 0.21 0 Glu/mann, GlcNAc/NANA, 
Galβ1,3GalNAc, 2,6 NANA /GlcNAc 
F21 0.08 0.3 0.069 0.052 0 Glu/mann, GlcNAc/NANA, 
Galβ1,3GalNAc, 2,6 NANA /GlcNAc 
F30 1.1 0.024 0 0.83 0 Glu/mann, GlcNAc/NANA, 2,6 NANA 
/GlcNAc 
F42 0.59 0.04 0 0.65 0 Glu/mann, GlcNAc/NANA, 2,6 NANA 
/GlcNAc 
F52 0.62 0.016 0 0.61 0 Glu/mann, GlcNAc/NANA, 2,6 NANA 
/GlcNAc 
Solubilised proteins were probed with respective biotinylated lectins and absorbance was read  
at 405 nm. Key: Glu=glucose, gal=galactose, mann=mannose, GlcNAc=N-acetylglucosamine, 
GalNAc= N-acetylgalactosamine, NANA= N-acetylneuraminic acid (sialic acid). 
 
 
 
All reference and clinical isolates gave positive results with Con A suggesting that 
glucose and /or mannose was present: the highest values were obtained for ARU 
01 and clinical strains F1, F30, F42 and F52. WGA that detects N-
acetylglucosamine and/or sialic acid (α2,3, α2,6 and α2,8 linkages) bound less 
well and the highest results were seen with clinical isolates F1 and F21; neither of 
the two animal derived reference strains, JCM 3718 and JCM 3724, were 
detected.  PNA that preferentially binds to Galβ1, 3GalNAc detected ARU 01 and 
showed low levels of reactivity with F1, F11 and F21; all other isolates gave 
negative results.  SNA, that binds to α 2,6 sialic acid and to a much lesser extent 
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α2,3 sialic acid, was detected in all strains; the highest binding was seen with ARU 
01, JCM 3724 and clinical isolates F1, F11, F30, F42 and F52.  No binding was 
recorded for the lectin SBA that binds to α- or β-linked N-acetylgalactosamine, and 
to a lesser extent, galactose residues (Table 5.2). The results clearly 
demonstrated cell surface and intracellular glycans of F. necrophorum and 
suggest differences between different strains/isolates.  The potential presence of 
sialic acid (neuraminic acid) is important as it is implicated in pathogenicity of other 
bacterial species.  Hence, further studies were carried out to investigate the 
pathways of biosynthesis (see chapter 8). 
 
5.3.3 The galactose-binding protein gene; PCR based analysis 
The galactose-binding protein gene (FUSO07_00675) was amplified using the 
designed primers with DNA from the reference and clinical strains of F. 
necrophorum.  All the amplicons were analysed on 1 % agarose gel, the bands 
generated were of the expected size of 209 base pairs (Figure 5.3).  All other 
clinical samples produced amplicons with the galactose-binding primers (images 
not included).  
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Figure 5.3 Gel electrophoresis of amplicons of F. necrophorum clinical 
Lemierre’s strain ARU 01 and reference strains JCM 3718, JCM 3724 and 
clinical samples F1, F5, F11, F21, F24, F30, F39, F40, F41 & F42, amplified with 
F. necrophorum Gal-binding primers. 
No template controls were also included.  Lane 1 – DNA ladder, Lane 2 – ARU 01, Lane 
3 – JCM 3718, Lane 4 – JCM 3724, Lane 6 – F5, Lane 7 – F11, Lane 8 – F21, Lane 9 – 
F24, Lane 10 – F30, Lane 11 – F39, Lane 12 – F40, Lane 13 – F41, Lane 14 – 42 and 
Lane 15 – Negative (no template) control. 
200 bp 
 500 bp 
1000 bp 
3000 bp 
209 bp 
1       2       3      4      5       6      7      8      9     10    11    12   13    14    
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5.3.4 Rt qPCR analysis 
 
Table 5.3  qPCR results showing CT values and melting temperature 
analysis of F. necrophorum cDNA with the Gal binding primers. 
 
 
 
All isolates tested expressed mRNA encoding the Galactose binding protein as 
shown by the CT values and melting temperatures. Negative controls gave CT 
values of 30 or more. With the Gal1 primers, the highest expression was shown 
in ARU 01, F5, F11, F24, F30 and F41 the lowest expression was shown in F1, 
F21 and F42. For the Gal 2 primers similar trends were seen. 
  
5.3.5 DNA sequencing 
The chromatographs were checked for high quality reads and misreads using 
Chromas software.  All the sequences were retrieved and saved as ‘FASTA’ files 
and these were submitted to NCBI BLAST for further analysis.  Misread  
sequences were trimmed by removal of all misread bases prior to use.  The 
BLAST results identified the presence of the galactose-binding gene in the F. 
necrophorum DNA samples submitted.  The results showed that nucleotide 
sequences had 98 – 100% similarity to the galactose-binding gene of F. 
necrophorum in the NCBI database (See Appendix III for sequence data and 
BLAST query results).  The similarity between the F. necrophorum and other 
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Fusobacteria sp. was greater than 65%. Galactose/glucose binding proteins from 
other bacteria such as Aeromonas sp, Serratia sp, Yersinia sp, Tatumella sp, 
Citrobacter sp. and E. coli shared 60% or greater similarity to that from F. 
necrophorum. 
5.3.6 Haemagglutination assays 
No haemagglutination was detected between any of the F. necrophorum samples 
and red cells of Human blood groups A, B, O or AB, (see Appendix IV, Table I).  
This implies that the Galactose-binding protein did not recognise α1, 3 galactose 
linked to an α 1, 2 fucosylated β-galactose.  As there was no agglutination with 
blood group O cells, the protein did not bind to α 1, 2 fucosylated β-galactose 
either. By comparison, agglutination assays of F. necrophorum with 
neuraminidase treated sheep erythrocytes showed some positive reactions.  ARU 
01-mediated heamagglutination of the neuraminidase treated sheep erythrocytes 
was observed as grape-like clusters of cells.  Haemagglutination was also noted 
with JCM 3718 and JCM 3724; the results with JCM 3724 were weaker than those 
observed with JCM 3718.  As removal of the sialic acid residue at the N-terminus 
of α 2,3 or 2,6 sialyllacto-N-biose1 or 2,6 sialylated N-acetyllactosamine exposed 
β galactose linked β 1,3 or β 1,4 respectively to N-acetylglucosamine (or, in 
glycolipids, linked to glucose), these results suggested the Galactose-binding 
protein of F. necrophorum bound to unsubstituted β-galactose residues.  There 
was no evidence that the F. necrophorum cells self-agglutinated. 
 
The bacterial cells used for the haemagglutination assay were stained with 
BacLight Live/Dead staining ([Live/Dead®BacLightTM kit L7012].  Life 
technologies, NY, USA & Molecular Probes, USA), and the results (not shown) 
showed that the majority were viable.   
5.3.7 Bead based lectin assay 
Using beads with different sugars attached is one of the simplest ways of 
examining the attachment of bacteria to glycans; however, the concentration of 
sugars are significantly lower than that found on cells.  The results were not easy 
to interpret (see Appendix IV, Figure III and IV) as the beads were distorted and 
their size made it difficult to examine microscopically; it was difficult to determine 
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whether bacteria were specifically binding to the beads.  Results were interpreted 
by comparison of the test results with those of the unsubstituted Sepharose 
controls.  There was no compelling evidence that any specific binding had 
occurred.    
5.3.8 Protein modelling 
The sequence for FUSO07_00675 D-Galactose-binding protein of F. 
necrophorum was downloaded from the Uniprot Knowledgebase (Figure 5.4).  
The target sequence was then used to create a three-dimensional protein 
structure using the SWISS-MODEL server. 
 
 
MKKMGIVLGALVLAAGLVGCGEKKEAAAPAEAVRMGLTYKFDDNFIALFRQAFQAEADAVGD
QVALQMVDSQNDAAKQNEQLDVLLEKGIDTLAINLVDPAGVDVVLEKIKAKELPVVFYNRKPS
EEALASYDKAYYVGIDPNAQGVAQGKVEKAWQAPALDLNGDGVIFAMLKGEPGHPDAEART
VYSIKTLNEDGIKTEELHLDTAMWDTAQAKDKMDAWLSGPADKIEVVlCNDGMALGAIESMKA
FGKSLPVFGVDALPEAiTLIEKGEMAGTVLNDAKGQAKATQVAMNLGEGKEATEGTDIQMEN
KIVLVPSIGIDKENVAEYK 
Figure 5.4 Protein sequence of the Galactose-binding protein of F. 
necrophorum. 
 
 
 
Figure 5.5 shows the list of suggested template sequences generated by Swiss-
Model; all those with identity greater than 50 % were Galactose-binding proteins 
from a variety of bacteria.  Most (<75 %) homologues bound both galactose and 
glucose.  The structure selected (automatically) to generate the model was from 
Yersinia pestis.  The GMQE of 0.78 and QMean of 0.74 (Figure 5.6) rated the 
models as very good.
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Figure 5.5 Suggested templates for modelling the Galactose-binding protein (Swiss-Model) 
5kws.1 Crystal Structure of Galactose Binding Protein from Yersinia pestis in the Complex with beta D Glucose.  
3gbp.1 Structure of the periplasmic glucose/galactose receptor of Salmonella typhimurium. 
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Figure 5.6 Results of modelling the Galactose-binding protein of F. necrophorum 
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The pdb file of the Galactose-binding protein was loaded into SwissDock and the 
structure was interrogated with ligands of glucose, galactose, N-acetyllactosamine 
(Gal β1, 4 GlcNAc) and lacto-N-biose1 (Gal β1, 3Glc).  Based solely on the 
estimated ΔG (kcal/mol), the energy required to maintain the docked structure, the 
disaccharides N-acetyllactosamine and lacto-N-biose1 were bound more tightly -
∆G = -7.66 and -7.87 kcal/mol respectively, than glucose or galactose ∆G = -6.20 
and -6.55 kcal/mol respectively.  All of the sugars bound to 2 major sites on the 
protein, however, the galactose and glucose also bound weakly to other areas of 
the molecule (Figures 5.7, 5.8 and 5.9). 
 
 
  
 
Figure 5.7 N-acetyllactosamine (yellow) binding to the  
Galactose-binding protein.   
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Figure 5.8 Galactose binding (yellow) binding to the  
Galactose-binding protein. 
 
 
Figure 5.9 Overlay of galactose (white) and N-acetyllactosamine (yellow) 
predictive binding to the Galactose-binding protein.  
Two of the binding sites for galactose are co-incident with the binding sites for N-
acetyllactosamine.  The results for glucose and lacto-N-biose binding were similar to 
those for galactose and N-acetyllactosamine respectively. 
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 Discussion 
Cell surface glycans and bacterial lectins are important in interactions of bacterial 
cells and the formation of biofilms and in the binding of bacterial cells to host cells 
and tissues.  Hence, the identification of cell surface and intracellular glycans, and 
bacterial lectins is important for the future development of novel therapies.  
 
Preliminary work using fluorescent and biotinylated lectins to detect cell surface 
molecules gave results that were difficult to interpret; this was due to 
autofluoresence (fluorescence assays) and difficulties in discriminating the 
chromophores (biotin assays).  Therefore, bacterial cells were solubilised to free 
the intracellular content that was then bound to ELISA plates and probed with 
biotinylated lectins.  The results were semi-quantitative but represented 
interaction of lectins with glycans from the whole cells.  The results showed 
variations in the glycans present in different isolates, nevertheless, Glu/mann, 
GlcNAc/NANA, Galβ1, 3GalNAc, α2, 6 NANA /GlcNAc were detected in most 
isolates and there was no evidence of terminal GalNAc.  However, the “control” 
strains, JCM 3718 and JCM 3724 that were both isolated from animals, lacked 
GlcNAc/NANA and Galβ1, 3GalNAc and the clinical isolates F30, F42 and F52 
lacked Galβ1, 3GalNAc. F1 and F21 were the only 2 isolates to show strong 
expression of GlcNAc/NANA.  There were also significant differences in the 
amounts of glycans detected with the lectins used.   
 
The implications of these differences are difficult to interpret in the absence of 
clinical data.  To further understand the results and determine cell surface 
expression, biosensors, such as those marketed by Attana, Sweden,  could be 
utilised either by binding cells to inert supports, interrogating these with unlabelled 
lectins and detection using quartz balance technology or by immobilising lectins 
and evaluating bacterial binding (reviewed by Wang and Anzai, 2015).  Given the 
interplay between cell surface sugars carried by bacteria and the lectins present 
on bacterial and host cells, this is an area that requires further work.  Glycosylation 
is a complex process; a multidisciplinary approach, involving chemical, 
biochemical, molecular and genomic/proteomic technologies will be needed to 
unravel the mechanisms. 
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Compared to the difficulties encountered in the detection of surface sugars, the 
elucidation of the Galactose-binding protein of F. necrophorum was relatively 
straightforward.  The BioCyc genome database was used to identify the nucleotide 
sequence encoding the Galactose-binding protein of F. necrophorum.  Primers 
specific for the galactose- binding gene produced amplicons of the expected size 
with all the F. necrophorum strains (ARU 01, JCM 3718, JCM 3724 and the 
available clinical strains) studied.  DNA sequencing of the amplicons from the F. 
necrophorum strains and analysis using bioinformatics tools such as BLASTN 
enabled species-specific identification of the PCR amplicons.  The search results 
showed 99 – 100 % similarity with F. necrophorum BTFR-2 contig0006 and 98 % 
similarity to F. necrophorum BTFR-2 contig0032 whole genome shotgun 
sequence.  The encoded protein was well conserved in all Fusobacteria species 
(greater than 65 % similarity) and shared 60 % or greater similarity to Galactose-
binding proteins of Aeromonas sp, Serratia sp, Yersinia sp, Tatumella sp, 
Citrobacter sp. and E. coli. 
   
Shaniztki et al., (1997) demonstrated that the Galactose-binding protein of F. 
nucleatum was involved in mediating galactose-sensitive binding to galactose 
derivatives on bacterial and mammalian cells.  Given the recorded absence of 
both sialylated and unsialylated Gal α 1,3 Gal epitopes on sheep red blood cells, 
the results of the haemagglutination assays undertaken in the current study 
suggested that the Galactose-binding protein of F. necrophorum bound to the 
terminal unsubstituted β-galactose of cell surface glycans such as those described 
by Gunnarsson et al., (1984).  The lack of haemagglutination with Human blood 
group O cells or untreated sheep red blood cells was probably due to steric 
hindrance caused by the presence of fucose and sialic acid molecules respectively 
on the terminal β -galactose; once the sialic acid residues were removed with 
neuraminidase the bacterial cells were able to agglutinate the sheep red blood 
cells.  This suggested that the required epitope for binding had a terminal non-
reducing unsubsituted β-galactose residue.  The lack of “self-agglutination” 
suggested that the Galactose-binding protein did not bind to galactose residues 
carried by the organism itself. 
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The important role of Galactose-binding proteins in the interaction between 
bacteria and host cells has been demonstrated in a study of Vibrio cholera 
(Sasmal et al., 1999), an organism whose Galactose-binding protein had greater 
than 60 % similarity to that of F. necrophorum and whose structure was used as 
the template for protein modelling.  The Galactose binding protein of V. cholera 
selectively recognised host cell epitopes and was shown to facilitate intragenic 
coaggregation between V. cholera and P. aeruginosa resulting a chronic lung 
infections in patients who were immunocompromised (Ma et al., 2007).  Murray et 
al., (1988) demonstrated that the Galactose-binding proteins expressed on cell 
surfaces of F. nucleatum facilitated attachment of the pathogen to cell surfaces of 
the oral epithelial layer.  Weiss et al., (2000), reinforced these findings in their 
study and also demonstrated that the Galactose-binding protein resulted in 
coaggregation of F. nucleatum with Porphyromonas gingivitis, a pathogenic 
periodontal bacterium and Rosen et al., (2003) were able to show that the 
Galactose-binding protein of F. nucleatum played an indispensable role in 
formation of biofilm.  Yoneda et al., (2011) reported that F. nucleatum, a strict and 
invasive anaerobe contributed to polymicrobial anaerobic infections, which arose 
due to interaction of Galactose-binding proteins present on the oral surfaces 
allowing coaggregation with several anaerobes.  Hence, the discovery of a 
Galactose-binding protein in F. necrophorum suggests mechanisms for inter-
bacterial aggregation, production of biofilm and adhesion to host cells and opens 
an exciting area of future research.  
 
The inability to detect binding of the Galactose binding protein on F. necrophorum 
to glycans on agarose beads could have been due to 1) preferential binding to 
longer chain glycans, 2) the low density of glycans on the beads or 3) steric 
hindrance due to the size of the beads.  Using molecular modelling and ligand 
docking, there was an obvious binding preference of the Galactose-binding 
protein; the disaccharides used bound more tightly than did the monosaccharides 
supporting the first explanation.  Interestingly, both glucose and galactose were 
predicted to bind to the protein; this supports the reported activities of related 
Galactose-binding proteins, all of which had been identified as binding both 
galactose and glucose.  There were two common areas of predicted glycan 
binding for the 4 glycans investigated (galactose, glucose, N-acetyllactosamine 
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and lacto-N-biose 1); galactose and glucose showed potential binding to 4 other 
areas of the protein.  The disaccharides bound more strongly than did the 
monosaccharides but there was no difference in binding between N-
acetyllactosamine (Gal β1, 4 GlcNAc) and lacto-N-biose1 (Gal β1, 3 Glc).  This 
would indicate that neither the positional linkage (1, 3 versus 1, 4) nor the nature 
of the second sugar (GlcNAc versus Glc) was important for binding.  This in turn 
would suggest potential for binding to the β-galactosyl residues carried on both 
glycoproteins (GlcNAc) and glycolipids (Glc).  The SWISS-MODEL also revealed 
that the Galactose-binding protein contained a bound calcium ion; further studies 
should be undertaken to determine its role and importance.  
 
Novel therapeutic interventions have been investigated recently using glycan 
analogues to prevent the interactions of bacteria via Galactose binding proteins.  
Anti-adhesive therapeutics which use lactose [Gal β 1-4 Glc] and D-galactose 
derivatives were effective in early preclinical trials, as they interrupted the 
interaction between F. nucleatum Porphyromonas gingivalis in the oral 
microbiome (Kawsar et al., 2009).  However, sugar derivatives are inhibitory only 
in the micromolar range, are expensive and have the potential to be metabolised 
in vivo; this has prompted investigations into mimetics that could have clinical 
utility, though much of the work involves adhesins binding α1-4Gal rather than 
those binding to β-Gal, the principles are the same.  Ohlsson et al., (2005) 
investigated Gal α1-4Gal (galabiose) derivatives as inhibitors of two galactose 
binding proteins; PapG class II adhesin of uropathogenic E. coli and of the P (N) 
and P (O) adhesins of Streptococcus suis strains.  They determined that 
methoxyphenyl O-galabiosides were potent inhibitors of the PapG adhesion, 
whereas phenylurea derivatives and methoxymethylated galabiose inhibited the 
S. suis strains type P (N) adhesin with affinities of 30 and 50 nM, respectively.  
Bergmann et al., (2016) developed inhibitors with chloroacetylated dendrimer 
cores and digalactosylated dendritic arms to the Galactose specific lectin LecA 
that mediates the formation of antibiotic resistant biofilms by Pseudomonas 
aeruginosa.  In 2018, Huang, et al.,  developed LecA inhibitors based on bivalent 
galactosides supported on polyproline peptide scaffolds.  Haataja et al., (2018) 
designed chemically modified glycodendrimers that inhibited the adhesin SadP, a 
galactosyl-α1-4-Galactose binding protein, of Streptococcus suis at picomolar 
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concentrations.  They chemically modified ligands and constructed multivalent 
dendrimers; using a phenylurea-modified galabiose-containing trisaccharide in a 
tetravalent dendrimeric scaffold, these inhibited binding at a low picomolar levels.  
Although these derivatives showed promise as therapeutic agents, care would 
need to be taken when using them in humans.  There are a number of Galactose 
binding proteins in the human proteome, for example galactosyltransferases, 
galectin and C-type lectins, whose inhibition could be detrimental to the host and 
hence any agents delivered systemically would need to be bacteria specific; those 
delivered topically would provide less risk.  
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Chapter 6  
 
6 LPS and lipid A biosynthesis 
 
 Introduction 
Lipopolysaccharide (LPS) is the major component of the outer membrane of 
Gram-negative bacteria where it contributes to the structural integrity of the 
bacteria. LPS is a large molecule comprising of lipid A, a core oligosaccharide and 
the polysaccharide O-antigen.  LPS also increases the negative charge of the cell 
membrane and helps stabilise the overall membrane structure. 
Lipopolysaccharide (LPS) is important for the growth and survival of Gram-
negative bacteria and helps to anchor the outer membrane, protects from 
chemical attack and promotes cell adhesion to different surfaces (Emiola et al., 
2015; Christie, 2018; Cuny, 2009).  It is a potent endotoxin, which is able to trigger 
the life-threatening condition: septic shock.  The LPS layer forms the outer 
membrane that provides an effective barrier at the environmental interface, 
resisting antimicrobials and preventing harmful toxins and antibiotics, including 
those of clinical value from entering the cells.  This impermeability is due mainly 
to the asymmetrical outer membrane, with the LPS molecules surrounding the 
outer leaflet and glycerophospholipids in the inner leaflet. 
Kirchheiner (1940) first reported the presence of a toxic lipopolysaccharide (LPS) 
in extracts of F. necrophorum cells.  In 1972, Sonnenwirth et al. reported 
endotoxins isolated from Bacteroidaceae, including clinical isolates of F. 
necrophorum.  Garcia et al., (1975) prepared endotoxic lipopolysaccharide from 
F. necrophorum and reported that on acid hydrolysis, hexosamines (7.0%), 
neutral and reducing sugars (50.5%), heptose (6.4%), 2-keto-3-deoxyoctonate 
(0.8%), lipid A (21.0%), and phosphorus (1.7%) were detected.  The endotoxin 
produced both localised and generalised Shwartzman reactions and biphasic 
pyrogenic responses in animal models.  A mouse LD50 value of 584 µg/Kg was 
obtained for this endotoxin; a parallel test using Escherichia coli O111:B4 LPS 
(Difco) produced an LD50 of 555 µg/Kg.  The authors suggested that their results 
established that a classical and potent endotoxin was present in F. necrophorum 
providing support to their suggestion that cell wall-associated components 
contributed significantly to the pathogenicity of F. necrophorum.  
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Extracellular products such as lipopolysaccharide (LPS) endotoxins confer the 
pathogenicity of Fusobacteria.  The LPS is released after lysis and is recognized 
by LPS-binding protein (LBP) circulating in the blood.  This complex triggers the 
production of cytokines, which are responsible of inflammatory response, 
activation of complement pathways and the coagulation pathway. This 
mechanism is essential to overcome the infection, but severe systemic infections 
can induce excessive cytokine production harming the body.  Massive Gram- 
negative infection can advance to high fever, breathing difficulties, tissue 
destruction, hypotension, disseminated intravascular coagulation (DIC), 
multisystem organ failure (MSOF), shock and death.  
Though lipid A is a hydrophobic glycolipid with a conserved biosynthetic pathway, 
there are variations downstream of lipid A biosynthesis by way of enzyme 
modification and adaptation of lipid A species to particular functions, which 
increase bacterial fitness.   Resistance to certain types of antibiotics are provided 
by these modifying enzymes, and this may alter the permeability of the outer 
membrane (Powers and Trent, 2018).  These features highlight the importance of 
the study of LPS in the fields of bacteriology, immunology and drug discovery 
(Dong et al., 2014; Emiola et al., 2015; Christie, 2018).  The outer membrane of 
Gram-negative bacteria, the most important feature distinguishing them from 
Gram-positive bacteria, provided a significant challenge to the discovery of 
antibacterial drugs because of its ability to prevent access of small molecules to 
the periplasmic space (Tomaras et al., 2014).  
Their amphipathic nature and strong tendency to aggregate by hydrophobic 
bonding or through cross-linking via ionic species, hindered earlier attempts to 
determine lipid A and lipopolysaccharide structures. Improved extraction methods 
and cleavage of the lipid component from the rest of the molecule by hydrolysis 
has resolved the detailed structures.  Analyses have been made possible by 
modern mass spectrometric methods such as matrix-assisted laser 
desorption/ionisation (MALDI) and electrospray ionisation (Christie, 2018).  
LPS is a complex molecule of about 30 KDa known to consist of three regions: 
lipid A anchor, core oligosaccharide, and O-antigen (see Figure 6.1).  Lipid A, the 
endotoxin component includes six hydrophobic acyl chains located in the outer 
leaflet of the outer membrane of the bacteria, linked together by a glucosamine 
and phosphate head group (Emiola et al., 2015).  Lipid A is a unique and distinctive 
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phosphoglycolipid, with a highly conserved structure among species and 
considered essential for survival of Gram-negative bacteria.   
 
                      
                                        
 
 
 
                             
                       
 
 
 
The O-antigen that is bound to the core oligosaccharide is the most 
heterogeneous part of the LPS, consisting of many sugar unit repeats.  This is the 
outer part of the LPS and the first target of the host immune system and is 
important in serological classification of bacteria strains (Atlas, 1997).  The core 
part of the LPS is the hetero-oligosaccharide consisting of sugars, such as: 2-
Figure 6.1 Schematic of the basic structure of lipopolysaccharide.  
LPS consists of three regions: from the bottom, lipid A (chair structure 
indicates di-glucosamine head group, red circles indicate phosphate groups, 
squiggly lines indicate acyl chains), core sugars, and O-antigen, which 
consists of repeating units (denoted in brackets, with an “n”) of 
oligosaccharides (Maeshima and Fernandez, 2013). 
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keto-3-deoxyoctulosonate (KDO), L-glycerol-D-manno-heptose, D-galactose and 
D-glucose.  This connects the O-antigen repeats with lipid A (Henderson, 2001). 
The lipid A moiety is of interest because it is highly conserved and is important for 
cell viability, thus making its biosynthetic pathway attractive for the targeting of 
new antibiotics (Emiola et al., 2015).  Studies in E. coli have shown involvement 
of a number of enzymes and genes in the biosynthesis of lipid A, many of which 
are shared by Gram-negative bacteria (Wang et al., 2010). 
Research into the biochemical structure and synthesis of LPS began in the 1960s, 
and the general outline of LPS synthesis and its assembly was completed in the 
early 1970s.  Christian Raetz determined the biochemical pathway for lipid A 
synthesis; the enzymes in the pathway were discovered by groups led by Raetz, 
who identified the deacetylase enzyme, UDP-3-O(R-3-hydroxymyristol)-N-
acetylglucosamine deacetylase, which is now known as LpxC.  This is a cytosolic 
zinc-based enzyme that catalyses the first committed step in the synthesis of lipid 
A (Cuny, 2009; Zhang et al., 2017).  Although the whole biosynthetic pathway has 
been elucidated for E. coli, little research has been carried out on anaerobes such 
as F. necrophorum.  Since the initial reports, there has been some debate on the 
composition of the LPS in F. necrophorum.  Inoue et al., (1985) stated that the 
organism had been shown to contain lipopolysaccharide, comprising Kdo (3-
deoxy-D-manno-octulosonic acid), and heptose, as well as neutral and amino 
sugars including D-mannosamine.  This work was supported in 1988 when 
Okahashi and co-workers demonstrated the major sugars of the F. necrophorum 
LPS were glucose and heptose.  However, Garcia and co-workers (1999) 
suggested that LPS from F. necrophorum contained neither heptose nor Kdo.  
 
 
 
 
The aims of this study were to: 
1. identify the presence and expression of the genes of the lipid A pathway in 
different subspecies of F. necrophorum (subsp. necrophorum, and subsp. 
funduliforme).  
2. utilise bioinformatics to understand the lipid A pathway in F. necrophorum. 
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 Methods 
DNA extraction, PCR, RNA extraction, cDNA synthesis, qRT-PCR and 
sequencing were performed as described in methods sections 2.2.2.4, 2.2.2.6 and 
2.2.2.8. 
 
6.2.1 Bacterial strains 
The clinical strain of F. necrophorum, ARU 01, two reference strains JCM 3718 
and JCM 3724 and clinical strains (from UCLH, London, UK) were used in this 
study.  S. aureus was used as positive control.  All the microorganisms were grown 
as detailed in the general method section 2.3.2.1 and 2.3.3.2 (see chapter 2). 
 
6.2.2 Bioinformatics 
The nucleotide sequences of the enzymes implicated in the biosynthetic pathways 
of F. necrophorum were obtained from the BioCyc database 
(http://www.biocyc.org) or from Uniprot (www.uniprot.org).  Clustal Omega was 
used to identify highly conserved amino acids within and between strains.  
Primers for the genes (in the lipid A pathway) were designed using ‘Primer 3’ and 
the sequences were confirmed by BLAST (The Basic Local Alignment Search 
Tool).  The primers are shown in Table 2.6. 
All primers were synthesized by MWG - Eurofins Genomics, Ebersberg, Germany. 
 
6.2.3 PCR and Sequencing 
These were carried out as described in the method section 2.6.2.  
6.2.4 Sequence analysis 
The sequences obtained were compared with sequences in the NCBI 
(www.ncbi.nlm.nih.gov/Blast.cgi) GenBank database using BLAST.  CLUSTALW 
(www.ebi.ac.uk/Tools/msa/clustalw2/) was used to align the sequences from the 
different strains of F. necrophorum.  DNA to protein translation was performed 
using ExPASy translate tool (https://www.expasy.org/genomics) to confirm any 
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changes of the primary amino acids structure due to nucleotide sequence 
differences.  RaptorX server (http://raptorx.uchicago.edu/) was used to predict 3D 
structure of the enzyme of lipid A biosynthesis. 
 
 Results 
6.3.1 LPS and lipid IVA pathway of F. necrophorum 
The original work on the lipid IVA pathway was based on information on the lipid 
IVA pathway of E. coli (Fig. 6.2) and sequences available at BioCyc. There was 
no sequence information for the lpxH gene in F. necrophorum hence it was 
reported as absent.  Preliminary work focussed on the lpxA, lpxB, lpxC and lpxD 
genes. 
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Figure 6.2  Biosynthetic pathway of lipid A in E. coli.  
Each reaction is catalyzed by enzymes shown in red. The second reaction catalyzed 
by LpxC (deacetylation) is the committed step of lipid A biosynthesis representing an 
excellent target to develop new antibiotics. LpxH* is reported to be absent in lipid A 
pathway of Fusobacterium necrophorum. 
 
PCR was performed using gene-specific primers designed from sequences 
available at BioCyc. The DNA from F. necrophorum isolates used in this study 
generated PCR products of the expected size (base pairs) for target sequences 
of all four genes implicated in the lipid A pathway: lpxA: UDP-N-
acetylglucosamine-O-acyltransferase, lpxC: UDP-3-O-[hydroxymyristolyl]-N-
acetylglucosamine deacetylase; lpxD: UDP-3-O-[3-hydroxymyristoyl] 
glucosamine -N- acetyltransferase and lpxB: lipid-A-disaccharide synthetase 
(Figures 6.3 and 6.4).  
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Figure 6.3  Analysis of amplicons of F. necrophorum using lpxA and lpxC 
primer sets run on 1% agarose gel.   
DNA bands were observed in all Fusobacteria samples: ARU 01, JCM 3718, JCM 
3724, F5, F21, F24 and F30 indicating successful amplification of the target genes 
implicated in the lipid IVA pathway. DNA ladder (Lane 1), Positive Control (PC) Lane 
11) and Negative Controls (NC) lanes 10 and 20) are also shown on the gel image. 
 
 
 
 
Figure 6.4 Analysis of amplicons of F. necrophorum with the lpxD and lpxB 
primers.  
The sequences target for the lpxD and lpxB genes implicated in the lipid IV A pathway 
were amplified in all the following samples ARU 01, JCM 3718, JCM 3724, F5, F21, 
F24 and F30. DNA ladder (Lane 1), Positive Control (PC) and Negative Control (NC) 
are shown on the gel image. 
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The amplicons were sequenced and ClustalW 
(https://www.ebi.ac.uk/Tools/msa/clustalw2/) was used to compare the 
sequences generated, by different isolates, for each of the enzymes involved in 
the lipid A pathway. The multiple alignment shows greater similarity between JCM 
3724 (less virulent subspecies, funduliforme) and the clinical strain ARU 01, 
compared with JCM 3718 (more virulent subspecies, necrophorum), especially for 
lpxC. The portions shown in red (Figures 6.5, 6.6 and 6.7) show the overall identity 
among target sequences.  Mismatches at the beginning and end region of the 
target sequences may be due to errors during sequencing; in these regions the 
chromatogram showed ambiguity. Analysis of the impact of single base changes 
in lpxA, lpxB, lpxC and lpxD on the encoded sequences were carried out.  
 
 
Figure 6.5  Multiple Alignment of the target sequence of lpxA of lipid A 
pathway for all samples. 
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Figure 6.6 Multiple Alignment of the target sequence of lpxD of lipid A 
pathway for all samples. 
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Figure 6.7 Multiple Alignment of the target sequence of lpxB of lipid A 
pathway for all samples. 
 
It appeared from the analysis of the amplicons from the lpxC gene that there were 
deleted areas of the sequence in JCM 3718 compared to the other sequences 
generated (Figure 6.8).  Interestingly, 5 out of 7 of these deletions were in areas 
where there was nucleotide repetition; AAAGACCCGA, CTGGG, AAAGC, 
GAACAT and TTTA.  Translation of the amplicons showed that 9 amino acids 
were changed after which the sequence was restored (Figure 6.9).  However, on 
analysis of the LpxC these differences were not located in regions involved in 
catalytic activity and hence would probably not affect the enzyme activity (Figure 
6.10).  
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Figure 6.8  Multiple Alignment of the target sequence of lpxC of lipid A 
pathway for all samples. 
 
 
 
 
Figure 6.9  Impact of nucleotide deletions in lpxC on derived protein 
sequence. 
A pairwise alignment of the LpxC protein showed that the amplified area contained 
none of the enzyme active sites.  
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This issue was resolved at a later stage when whole genome sequencing was 
performed for all strains (see chapter 7); the sequence encoding 
SIRFEHSFLKSQMAEFV seen in all LpxC sequences was also present in JCM 
3718. The original discrepancy could have been due to issues in either the original 
PCR or DNA sequencing.  
 
 
Figure 6.10 The amino acids sequence alignment of E. coli and F.  
necrophorum produced by ClustalW of LpxC.  
The conserved sites shown in red concern catalytic residue and zinc-binding residues. 
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  LpxA 
ARU  F K K V Y R I I F R R G L P L K E A L A E A E E Q 
3718  L K K V Y R I I F R K G L P L K E A L A K A E E Q 
 
3724                           F K K V Y R I I F R R G L P L K E A L A E A E E Q  
 
F5                              F K K V Y R I I F R R G L P L K E A L A E A E E Q 
 
F21  L K K V Y R I I F R R G L P L K E A L A E A E E Q 
 
F24                       F K K V Y R I I F R R G L P L K E A L A E A E E Q 
 
F30                            F K K V Y R I I F R R G L P L K E A L A E A E E Q 
Figure 6.11 Protein sequence analysis of the amino acid for the  
enzyme LpxA. 
 
 
LpxD 
ARU G A V I G S D G F G F V K V Q G N N Met K I E Q I G S V V I E D F V E I G A N T 
T V 
3718 G A V I G S D G F G F V K V Q G N N Met K I E Q I G S V V I E D F V E I G A N T 
T E 
3724 G A V I G S D G F G F V K V Q G N N Met K I E Q I G S V V I E D F V E I G A N T 
T V 
F5    G A V I G S D G F G F V K V Q G N N Met K I E Q I G S V V I E D F V E I G A N T 
T V   
F21 G A V I G S D G F G F V K V Q G N N Met K I E Q I G S V V I E D F V E I G A N T 
T V    
F24 G A V I G S D G F G F V K V Q G N N Met K I E Q I G S V V I E D F V E I G A N T 
T V   
F30 G A V I G S D G F G F V K V Q G N N Met K I E Q I G S V V I E D F V E I G A N T 
T V 
 
Figure 6.12 Protein sequence analysis of the amino acid for the  
enzyme LpxD. 
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LpxB 
ARU S L E E E V F P E L I Q K D C N V V N I E N S L Q E I E N K P E L  
 
3718 S L E E E V F P E L I Q K D C N V V N I E N S L Q E I E N K P E L  
 
3724 S L E E E V F P E L I Q K D C N V V N I E N S L Q E I E N K P E L 
 
F5    Q L R E E V F P E L I Q K D C N V V N I E N S L Q E I E N K P E L  
 
F21 S L E E E V F P E L I Q K D C N V V N I E N S L Q E I E N K P E L  
 
F24 S L E E E V F P E L I Q K D C N V V N I E N S L Q E I E N K P E L  
 
F30 S L E E E V F P E L I Q K D C N V V N I E N S L Q E I E N K P E L  
 
 
Figure 6.13  Protein sequence analysis of the amino acid for the  
enzyme LpxB. 
 
 
The impact of the nucleotide substitutions in the amplicons from lpxA, lpxB and 
lpxD was determined by translating each DNA sequence.  The translation 
(http://web.expasy.org/translate/) of the amplified sequences detected a single 
amino acid change in the LpxA protein (Figure 6.11); 2 alternative sequences were 
seen: LKKVYR in JCM 3718, and clinical isolate F21 and FKKVYR in the other 
isolates (Figure 6.11).  There is no significant difference in the amino acids leucine 
and phenylalanine; both are non-polar and hydrophobic, hence there is unlikely to 
be any impact on protein function.  A pairwise alignment of the genes in E. coli 
and F. necrophorum (Figure 6.14) demonstrated that the active sites were found 
outside the amplified area. 
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Figure 6.14  The amino acids sequence alignment of E. coli and F. 
necrophorum produced by ClustalW of LpxA.  
The conserved sites shown in red are the catalytic and substrate binding residues. 
The amplified area is underlined. 
 
For LpxD, a single amino acid change was observed in strain JCM 3718; V (non-
polar; hydrophobic) to E (negatively charged; polar; hydrophobic) (Figure 6.12). 
Such a change could affect the protein structure, but an analysis of the active site 
and 3D structure would be required to determine the impact.  A single amino acid 
change S (no charge; polar; hydrophilic) to Q (no charge; polar; hydrophilic) was 
found in the amino acid sequences derived from the lpxB amplicon in clinical 
isolate F5.  The properties of these two amino acids are similar and hence this 
would be unlikely to impact protein function. 
 
To determine whether these genes were expressed, quantitative reverse 
transcriptase polymerase chain reaction (Q-RT-PCR) was performed.  Gene 
expression was seen for all four genes in the samples studied (Tables 6.2, 6.3, 
6.4, 6.5).  The amplicons for each gene had the same Tm confirming the specificity 
of sequences amplified.  The presence of a peak in the negative control was due 
to primer dimer formation.  In the analysis of the lpxC gene the similarity in Tm of 
all samples including JCM 3718 suggests that in the previous PCR and 
sequencing experiments, the apparent deletions were sequencing artefacts. 
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6.3.2 Identification of the lpxI gene in Fusobacterium necrophorum 
A bioinformatics analysis using BLASTN and BLASTP revealed no homology 
between the lpxH gene (or encoded protein) from a range of organisms (including 
Haemophilus influenzae, Escherichia coli, Pseudomonas aeruginosa and 
Enterobacter cloacae) with any genes / proteins in Fusobacteria species (data not 
shown).  However, an alternative gene must exist as these organisms produce 
the metabolic end-product, lipid A.  Based on the fact that many Gram-negative 
organisms, including all α-proteobacteria, lack LpxH even though they produce 
lipid A  Metzger & Raetz (2010), put forward an alternative pathway.  They 
identified a novel lpxI gene in Caulobacter crescentus, this was a conserved 
structural gene located between lpxA and lpxB; the site where the lpxH gene is 
found in other organisms.  LpxI had no homology with lpxH at either the DNA or 
protein sequence level but the authors synthesised a recombinant form of the 
protein that demonstrated the same biological/enzymatic function, converting 
UDP-2,3-bis[O-(3R)-3-hydroxymyristoyl]-α-D-glucosamine to 2,3-bis[(3R)-3-
hydroxymyristoyl]-α-D-glucosaminyl 1-phosphate.  This led to the conclusion that 
this lpxI gene was a functional replacement for the lpxH gene. 
Therefore, in this current study the operon containing lpx A, B and C in the F. 
necrophorum (ATCC 51357) genome was accessed using BioCyc and analysed 
for the possible presence of a lpxI homolog.  The encoded protein sequences of 
an unannotated gene (HMPREF1049_1173; G11D6-1165 [Fnec1095747Cyc]) 
that lay between the lpxA and B genes was analysed by multiple sequence 
alignment with the sequences identified as LpxI by Metzger et al., (2010).  Only 
two wild-type protein sequences for LpxI were available in the Uniprot database, 
one from Rhizobium galegae and one from Caulobacter crescentus (strain 
NA1000/ CB15N), these two protein sequences were used in a multiple sequence 
alignment with the candidate LpxI protein (HMPREF1049_1173) from F. 
necrophorum.  Although the overall similarity between these three proteins was 
low (28-42 %), it is clear from Figure 6.15 that all the key amino acids identified in 
LpxI by Metzger et al., (2010) as important in the functioning of the enzyme (where 
they were believed to play a role in substrate binding, catalysis and dimerization) 
were also present in the F. necrophorum candidate protein. 
 
  124 
 
Figure 6.15 Multiple sequence alignment of the LpxI proteins of F. 
necrophorum, Caulobacter crescentus and Rhizobium galegae. 
The residues highlighted by coloured boxes are absolutely conserved polar residues 
within the LpxI sequence. Those residues thought to be involved in substrate binding 
and/or catalysis are coloured in red and those thought to be involved in dimerization 
are shown in green. 
 
 
In a multiple sequence alignment of candidate LpxI homologues from all available 
Fusobacteria species, the residues highlighted in Figure 6.16 were also found to 
be conserved; the sequence identity between the homologues varied between 53 
and 97 % (results not shown).  
The 3D structure of the candidate LpxI protein was predicted using Swiss-Model 
(https://swissmodel.expasy.org/) using 4ggm (www.pdb.org), the known LpxI 
protein from C. crescentus, whose sequence identity with the Fusobacterium 
species was 28.4 %, as template.  This template sequence also contained a bound 
ligand LPX (also termed LP5), derived from E. coli during preparation of the 
recombinant protein; LP5 is a lipid A precursor.  The resultant model generated 
was rated as poor based on a GMQE score of 0.68 and a QMEAN4 of - 6.63 
(https://swissmodel.expasy.org/docs/help).  Thus, to achieve a better model 
Raptor X, which utilises a different algorithm was used (Källberg et al., 2012).  The 
models generated were subjected to structural alignment using the Dali server 
(Holm and Rosenstrom, 2010).  The results had very high structural homology and 
the key conserved amino acids (see Figure 6.16) all lay in areas where there was 
no conflict in the predicted structures. 
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Figure 6.16 Structural alignment of models of LpxI from F. necrophorum 
generated using Swiss-Model (green) and RaptorX (red) using the Dali 
server. 
 
The “Select neighbours” function of Dali was used to find any potential structural 
homologues of the F. necrophorum candidate LpxI protein in the PDB; retrieved 
structures with the highest Z-scores (Holm and Rosenström, 2010).  ‘Significant 
similarities’ have a Z-score above 2; they usually correspond to similar folds. 
‘Strong matches’ have sequence identity above 20% or a Z-score above a cut-off 
that is empirically set to n/10 − 4, where n is the number of residues in the query 
structure; in this case the value would be 23.  Each neighbour has links to a 
pairwise structural alignment with the query structure, to pre-computed structural 
neighbours in the Dali Database, and to the PDB format coordinate file where the 
neighbour is superimposed onto the query structure.  The three top “hits” from this 
analysis that were “Strong matches” with Z-scores of 39.8 (rmsd 0.6), 26.0 (rmsd 
5.7) and 25.7 (rmsd 5.6)  (Table 6.1) were 4ggm, 4j6e and 4ggi (now re-submitted 
as 4j6e) respectively: all three structures correspond to LpxI, UDP-2,3-
diacylglucosamine pyrophosphatase, from Caulobacter vibrioides (previously 
known as Caulobacter crescentus str. CB15) whose structure was first reported 
  126 
by Metzler et al., (2012).  The results show that a higher Z score and much lower 
RMSD was obtained when comparing the Fusobacterium structure to 4ggm than 
to the 4j6e structure (Table 6.1). 
 
Table 6.1 Output of the “Select neighbours” function of the Dali server 
 
 
 
The related models are sorted by Z-score.  4j6e and 4ggi are now recognised to 
represent the same protein; now named 4j6e.   
 
Visualisation of the 4ggm and 4j6e structures showed that these molecules, 
though differing only by 1 key catalytic amino acid (D225), differ very significantly 
in their crystal structure presumably as a consequence of a conformational change 
when the ligands bound; 4ggm is reported to have spontaneously co-crystalised 
with lipid X (LP5) a lipid A precursor whereas 4j6e is the structure of LPXI D225A 
mutant with the bound nucleotide sugar substrate, UDP-2,3-diacylglucosamine. 
Metzger et al., (2012) described that “The domains of the CcLpxI-D225A (4j6e) -
substrate complex swing open on forming the CcLpxI-product complex”, however, 
the authors also acknowledged that they could not exclude the fact that the 
conformational changes were artefacts of crystal packing. 
A structural alignment of the three structures: 4ggm, 4je6 and the candidate LpxI 
from F. necrophorum is shown in Figure 6.17.  4ggmX is shown in red (with the 
ligand LP5 bound) and 4j6e is shown in grey (with UDP-2,3, -diacylglucosamine 
bound at the potential interface of the dimeric active structure) and the putative 
LpxI protein from Fusobacterium is shown in green.  It is clear that there is a high 
degree of structural homology between the Fusobacterium LpxI candidate protein 
and 4ggm (LpxI from C. crescentus) particularly surrounding the substrate-binding 
sites. 
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Figure 6.18: Structural alignment of the F. necrophorum LpxI with models of 
the LpxI from Caulobacter crescentus str. CB15 (previously Caulobacter 
vibrioides).  
4ggm (Caulobacter crescentus) is shown in red with the bound ligand, LP5, shown as red spheres; 
4j6e (Caulobacter crescentus) is shown in grey with UDP-2, 3, -diacylglucosamine shown as grey 
spheres at the potential interface of the dimeric active structure.  The candidate LpxI protein from 
Fusobacteria is shown in green.  All proteins are shown as monomers.  
 
Table 6.2 (A and B) illustrates the amino acid residues of C. crescentus predicted 
by Poseview and Raptor X to be important in ligand binding.  The Poseview 
prediction (http://www.rcsb.org/structure/4GGM) showed the acyl chains of lipid 5 
(part of the substrate for LpxI) interacting with F71, V75, V111 on one side of the 
binding site, and I51, P78, L107, L108 on the other side.  Raptor X predicted 
additional amino acids binding the acyl groups but, in both cases, these interacting 
amino acids were hydrophobic and aliphatic.   
All amino acids predicted by Poseview to be involved in binding of LP5 in C. 
crescentus were also predicted by RaptorX.  Of these 9 amino acids, 7 had been 
reported in the Metzger et al., (2012) paper as being highly conserved.  Six of 
these 9 amino acids were also predicted by RaptorX to be involved in LP5 binding 
in F. necrophorum; at V111, F. necrophorum has M110, a change from polar 
neutral to hydrophobic aliphatic; at F54 there is a change to L55, both are 
hydrophobic aliphatic amino acids.  RaptorX predicted binding at D104 for C. 
crescentus; in F. necrophorum where there is a change to N103, no binding was 
predicted.  Both amino acids are polar and hydrophilic; D is negatively charged 
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whereas N has no charge.  Of the19 amino acids identified by Raptor for C. 
crescentus, 10 were completely conserved in F. necrophorum, 6 were partially 
conserved and 3 resulted in changes in properties.  
In the case of UDG binding, of the 12 amino acids identified by Poseview, 2 (P78 
and D88) were not identified by RaptorX.  For F. necrophorum, of the 10 identified 
by both programs, 8 were also completely conserved between the two bacteria; 
the other 2 were strongly conserved.  A comparison of the binding of UDG as 
predicted by Raptor X showed of 35 amino acids involved 20 were completely 
conserved, of the remaining 15, 9 were strongly conserved, 4 were not conserved 
and one (D104) was identified in C. crescentus whilst another (F50) was only 
identified in F. necrophorum.  
The results obtained from both programs strongly supported the hypothesis that 
the candidate protein in F. necrophorum was indeed LpxI. 
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Table 6.2 Amino acids implicated by Raptor X in substrate binding 
 
A-Binding of LP5 
Raptor X prediction of amino 
acids involved in binding 
 Poseview 
prediction  
Amino acid characteristics 
Fusobacterium  Caulobacter 
crescentus 
Caulobacter 
crescentus 
F50 -  Hydrophobic no charge 
H51* G50   Basic charged to Hydrophobic no 
charge 
I52*** I51 I51 Hydrophobic aliphatic 
G53*** G52   Hydrophobic no charge 
H54* E53   Basic charged to acidic charged 
L55** F54 F54 Hydrophobic aliphatic 
I58*** I57  I57 Hydrophobic aliphatic 
L72** F71  F71 Hydrophobic aliphatic 
L73** A72  Hydrophobic aliphatic 
G74*** G73   Hydrophobic no charge 
V76*** V75  V75 Hydrophobic aliphatic 
E77* S76   Charged acidic to polar neutral 
K78** R77   Basic charged  
L85*** L83   Hydrophobic aliphatic 
L98*** L96   Hydrophobic aliphatic 
-(N103) D104  D104 Hydrophilic polar negative to 
uncharged 
L106*** L107  L107 Hydrophobic aliphatic 
L107** L108  L108 Hydrophobic aliphatic 
M110** V111  V111 Polar neutral to hydrophobic 
aliphatic 
F114*** F115   Hydrophobic  
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B-Binding of UDG 
Raptor X prediction of 
amino acids involved in 
binding 
Poseview 
prediction  
Amino acid characteristics 
Fusobacterium Caulobacter 
crescentus 
Caulobacter 
crescentus 
F50 -(V49)  Hydrophobic no charge 
H51* G50  Basic charged to Hydrophobic no charge 
I52*** I51 I51 Hydrophobic aliphatic 
G53*** G52   Hydrophobic no charge 
H54* E53   Basic charged to acidic charged 
L55** F54  Hydrophobic aliphatic 
I58*** I57   Hydrophobic aliphatic 
L72** F71  F71 Hydrophobic aliphatic 
L73** A72  Hydrophobic aliphatic 
G74*** G73   Hydrophobic no charge 
V76*** V75  V75 Hydrophobic aliphatic 
E77* S76   Charged acidic to polar neutral 
K78** R77   Basic charged  
-(S79) -(P78) P78 Non-polar; Hydrophobic to polar 
hydrophilic 
L85*** L83   Hydrophobic aliphatic 
-(D87) -(D88) D88 Negatively charged, polar, hydrophilic 
L98*** L96   Hydrophobic aliphatic 
-(N103) D104   Hydrophilic negative 
L106*** L107  L107 Hydrophobic aliphatic 
L107** L108  L108 Hydrophobic aliphatic 
M110** V111  V111 Polar neutral to hydrophobic aliphatic 
F114*** F115   Hydrophobic  
Q168*** Q169 #  Polar neutral  
T186*** T187  T187 Polar neutral 
D187*** D188#  Charged acidic 
K205*** K214 #  K214 Basic charged 
D216*** D225 #  Charged acidic 
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I217** L226   Hydrophobic aliphatic 
P218*** P227  Hydrophobic no charge 
T219*** T228  T228 Polar neutral 
V220** I229  Hydrophobic aliphatic 
G221*** G230  Hydrophobic no charge 
V222*** V231  Hydrophobic aliphatic 
E223* A232  Charged acidic to hydrophobic aliphatic 
T224*** T233  T233 Polar neutral 
L246** V255  Hydrophobic aliphatic 
Key red= conserved in Metzger et al., (2012), *** conserved, ** similar properties, * dissimilar 
properties; - indicates no amino acid highlighted at this position by RaptorX. # active site amino 
acids.  Poseview was developed by Center for Bioinformatics Hamburg. LP5 =R -
(2R,3S,4R,5R,6R)-3-Hydroxy-2-(hydroxymethyl)-5- (R)-3-hydroxytetradecanamido)-6-
(phosphonooxy) tetrahydro-2H-pyran-4-YL) 3-hydroxytetradecanoate.   UDG= 
(2R,3R,4R,5S,6R)-2-{[(S)-{[(S)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-
dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy }(hydroxy)phosphoryl]oxy}-5-
hydroxy-6-(hydroxymethyl)-3-{[(3R)-3-hydroxytetra decanoyl]amino}tetrahydro-2H-pyran-4-yl 
(3R)-3-hydroxytetradecanoate.  
 
The table shows a comparison of the amino acids predicted to be involved in 
binding LPS and UDG substrates, and the impact of changes/differences. 
Although experimental biochemical work was not performed, due to issues of 
availability of substrates and equipment required, the work presented and the 
published research showing that Fusobacteria do produce lipid A strongly support 
the hypothesis that LpxI acts as a replacement of LpxH in this organism. 
 
 
 Discussion 
This study was undertaken to elucidate the lipid A pathway in the two subspecies 
of F. necrophorum.  The presence of lpxA, B, C and D amplicons implies that all 
isolates tested had the genes encoding the first four enzymes of the lipid A 
pathway.  In the multiple alignment of the target sequences, greater similarity was 
seen between JCM 3724 (subsp. funduliforme) and the clinical strains than 
between JCM 3718 (subsp. necrophorum) and the clinical strains.  This supports 
the fact that the subsp. funduliforme is involved in human infection rather than 
subsp. necrophorum, which is more common as pathogen in animals (Riordan, 
2007). 
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The pathogenic mechanism of F. necrophorum is complex and not well defined; it 
is unclear why F. necrophorum subsp. necrophorum is more virulent than the 
subsp. funduliforme.  Among the several toxins expressed by these organisms, 
leukotoxin, endotoxin and lipid A are considered as major virulence factors. 
Recent studies have identified additional enzymes responsible for the modification 
of lipid A, which are closely related to the virulence.  Two of these enzymes LpxE 
and LpxF are implicated in removing, or modification, of phosphate; in position ‘1’ 
and ‘4’ of lipid A, respectively; there is scope for further study.   
Some differences and similarities were noted from the comparative studies 
between F. necrophorum D12 and E. coli K12.  There were differences in the 
number of enzymes involved in the lipid A pathway between these two 
microorganisms.  Studies on the evolution of the lipid A in bacteria revealed that 
the number of enzymes in Gram-negative organisms are different, but all the 
organisms shared the first four enzymes in the pathway.  Opiyo et al.,  (2010) 
observed that more enzymes could be generated by duplicated genes which 
allowed functional specialisation and pathway optimisation, giving greater 
adaptability as in the highly adapted E. coli with vertebrate enteric habitats.  Their 
studies showed that gene duplication as well as the partial or complete loss of 
genes encoding the enzymes has happened independently several times during 
the bacterial evolution.  Each group of bacteria has taken advantage of such 
evolutionary events to optimise the pathway and adapt to their specialised life style 
(Opiyo et al., 2010).  
The first four genes of the lipid IVA pathway were investigated in F. necrophorum; 
all four genes, lpxA, lpxB, lpxC and lpxD had been annotated and sequences were 
available in the BioCyc database.  PCR and sequencing of the amplicons 
demonstrated single base pair changes that either did not change the properties 
of the encoded amino acid or did not affect the active site of the enzymes.  Q-RT-
PCR suggested that all enzymes were well-expressed in the strains/isolates 
examined.  Alignment of the amino acid sequences (for the LpxA and LpxC 
enzymes of the lipid A pathway) of F. necrophorum D12 and E. coli K12 (for the 
LpxA and LpxC enzymes of the lipid A pathway) showed 57 % and 40 % identity 
respectively.  The sites involved in the binding and catalytic activity in both 
enzymes were highly conserved.  The enzymes, especially LpxC, are of interest 
in helping to develop new antibiotics by targeting the conserved domains to treat 
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Gram-negative bacterial infections.  LpxC is a metalloenzyme that requires bound 
zinc for activity; thus, it is an essential gene.  Mutations in this gene compromise 
cell division, reduce expression of LPS increasing the permeability to antibacterial 
agents.  LpxC does not have sequence homology to other deacetylases or 
eukaryotic proteins; therefore, it is a target for the design of new antibiotics specific 
for Gram-negative bacteria.  The advantage of using LpxC as a target for novel 
antibiotics is that it allows specific inhibition, reducing undesirable effects and the 
high conservation of the protein in bacteria allows a wide spectrum of action.  
Recent studies identified LpxC inhibitors containing hydroxamate group as 
targeting the catalytic zinc ion (Barb and Zhou, 2008).  CHIR-090 is particularly 
interesting among the LpxC inhibitors; this is an antibiotic, which controls the 
growth of E. coli and P. aeruginosa with an efficacy comparable to that of 
ciprofloxacin.  The success of this antibiotic suggests that potent LpxC-targeting 
antibiotics may be developed which can control a broad range of Gram-negative 
bacteria (Barb and Zhou, 2008). 
 
In the lipid IVA pathway, lpxH that belongs to the metallophosphoesterase 
superfamily, and in E. coli and many other bacteria, it catalyses the hydrolysis of 
pyrophosphate bond of UDP-2, 3-diacylglucosamine, was absent from all 
Fusobacteria sp.  The current study demonstrated that the lpxI gene that catalyses 
UDP-2, 3-diacylglucosamine hydrolysis by a different mechanism that had been 
fully characterised in Caulobacteria (Metzger et al., 2012), was utilised instead of 
lpxH not only by F. necrophorum, but also by all other Fusobacteria sp.  These 
findings may enable research into specific inhibitors that could be used in the 
future as therapeutic agents. 
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Chapter 7  
 
7 Genome Analysis of F. necrophorum reference strains and clinical 
isolates using NGS  
 
 Introduction 
To date, much of the focus of genomic studies of Fusobacteria sp. has centred on 
F. nucleatum.  DNA sequence analysis of F. nucleatum subspecies nucleatum 
(ATCC 25586) and vincentii (ATCC 49256) shows clear differences in genetic 
content between the strains.  Some of the open reading frames (ORFs) from these 
strains were not present in the other strains of F. nucleatum (polymorphum, 
fusiforme, and animalis) and there was evidence of rearrangements in the ORFs 
present in both strains.  There was phenotypic heterogeneity among the F. 
nucleatum strains giving rise to the idea that it is a “species complex” (Karpathy 
et al., 2007).  From the taxonomic studies, researchers confirmed that subspecies 
polymorphum ATCC 10953 represents a separate phylogenetic branch that 
included significant human pathogens compared to the other previously 
sequenced strains of F. nucleatum.  Phenotypic studies of polymorphum ATCC 
10953 have characterised some of its functions, such as its uptake and 
metabolism of amino acids, simple sugars and peptides and how it interacts with 
epithelial, host immune cells and connective tissues and its modulation of host 
immune cells to induce apoptosis and enhance survival of strict anaerobes in both 
planktonic and biofilm multispecies cultures.  They also characterised how it acts 
synergistically with other oral pathogens, enhancing virulence in animal model 
systems.  The taxonomic status, phenotypic analysis and genetic transformability 
of F. nucleatum subsp. polymorphum (FNP) ATCC 10953 indicated that genomic 
analysis would be of benefit for future studies of this species.  Further studies and 
analysis of the FNP genome, led to the observation that 25 % of the genes 
identified were not represented in genomes of the previously sequenced 
Fusobacteria, which suggested that evolution of this strain was due to contribution 
of horizontal gene transfer (HGT) (Karpathy et al., 2007). 
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Availability of the complete genome sequence from F. necrophorum should give 
some insight into the relatedness of the mechanisms resulting in disease 
progression to Lemierre’s syndrome. 
 
The aims of this study were to: 
1. understand the genetic, metabolic and pathogenic features by analyzing 
the genomes sequences of F. necrophorum reference strains and clinical 
isolates. 
2. determine the impact of nucleotide substitutions on amino acid sequence. 
 
  
 Methods 
7.2.1 Retrieval of whole genome sequences from public databases and 
microbesNG.  
Whole genome sequence data for 20 Fusobacterium necrophorum isolates were 
generated by microbesNG (Table 7.1) and whole-genome nucleotide sequences 
for 31 Fusobacterium necrophorum isolates and 32 representative isolates of 
related species were downloaded from NCBI and NCTC 3000 on 18 June 2018 
(Table 7.1). 
(https://www.phe-culturecollections.org.uk/products/bacteria/nctc-3000-strains-d-
f.aspx)  
 
7.2.2 Preliminary phylogenetic analyses.   
Prokka 1.13 (Seemann, 2014) software was used to predict genes encoded within 
the genomes listed in Table 7.1.  All protein sequences were analysed with 
PhyloPhlAn 0.99, to determine the placement of the whole-genome within the 
Fusobacterium genus (Segata et al., 2013).  The resulting multiple-sequence 
alignment was imported into R and phangorn v.2.3.1 (Schliep, 2011) was used to 
construct a neighbour-joining tree.  FigTree v1.4.2 
(http://tree.bio.ed.ac.uk/software/figtree/) was used to visualize the phylogenetic 
tree and it was annotated using Adobe Illustrator. 
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7.2.3 16S rRNA gene sequence analysis of strain F88.   
Using RNAmmer 1.2 (Lagesen et al., 2007) the 16S rRNA gene sequence of strain 
F88 was predicted, with a partial (1229 nt) sequence recovered that was extended 
to 1514 nt by comparison with other Fusobacterium spp.  Accession numbers for 
16S rRNA gene sequences of type strains of the genus Fusobacterium were 
obtained from the List of Prokaryotic Names With Standing In Nomenclature 
(http://www.bacterio.net/fusobacterium.html) and De Witte et al., (2017).  The 
sequences were imported into Geneious 8.1.4.  A multiple-sequence alignment 
was created using CLUSTAL W, and this used to create a neighbour-joining tree 
(Jukes Cantor); bootstrap values were generated from 1000 replicates. 
 
7.2.4 Quality control checks on genome sequence data.  
For all Fusobacterium necrophorum genomes listed in Table 7.1, the size of 
genome, number of CDS and number of scaffolds were examined.  Potential 
contaminants within genomes were identified by running any questionable 
Fusobacterium necrophorum assemblies against the nt (NCBI non-redundant 
nucleotide) database (created 3 March 2018) of Centrifuge 1.0.3 (Kim et al., 
2016). 
 
7.2.5 Determination of average nucleotide identity (ANI).  
This was determined between pairs of genomes using OrhtoANI implemented in 
OAT 0.93 (≤10 sequences to compare) or OAT_cmd 1.30 (Lee et al., 2016); 
outputs were imported into R to generate a heatmap (heatmap.2 function in 
package gplots). 
 
7.2.6 Comparative and pangenome analyses of Fusobacterium 
necrophorum strains. 
The 49 whole-genome sequences identified as Fusobacterium necrophorum were 
subject to further analyses.  ANI was determined for the 49 genome sequences 
and other Fusobacterium species using OAT_cmd 1.3.0.  A pangenome analysis 
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was carried out on the 49 Fusobacterium necrophorum strains using Roary (Page 
et al., 2015).  
 
Using Roary, coding sequences (CDSs) were extracted from the input files and 
translated to protein sequences, filtered to remove partial sequences and 
iteratively pre-clustered using CD-HIT (Fu et al., 2012).  This resulted in a 
substantially smaller dataset of protein sequences, which were then clustered with 
TRIBE-MCL (Enright et al., 2002).  Finally, results from CD-HIT and TRIBE-MCL 
were merged together and used to make a core gene alignment with MAFFT 
(Katoh et al., 2002); the output was a core cluster alignment file.  A maximum-
likelihood tree (GTR model) was created using FastTree with the core alignment 
file.  The phylogenetic tree was visualised using FigTree v1.4.2, phandango 
(Hadfield et al., 2017) was used to visualise pangenome data.  Single nucleotide 
polymorphism (SNP) sites in the core cluster alignment file generated by Roary 
were identified using SNP-sites (Page et al., 2016).  Principal component analysis 
(PCA) of the presence/absence of accessory genes within Fusobacterium 
necrophorum subsp. funduliforme genomes was performed using the R package 
FactoMineR (Lê et al., 2008).  Representative sequences of the 6819 genes 
detected in the Roary analysis were submitted to eggNOG-mapper v4.5.1 
(http://eggnogdb.embl.de/#/app/home); (Huerta-Cepas et al., 2016) to obtain 
additional functional information.  ProgressiveMauve (Darling et al., 2010) was 
used to visualize genome arrangements, using the .gbk files produced by Prokka.  
 
7.2.7 Impact of nucleotide changes on amino acid sequence. 
A large number of single nucleotide polymorphisms were noted in the genomic 
studies and research was undertaken to determine their impact on the encoded 
amino acids in a small number of proteins.  The protein sequences were 
downloaded from the annotated sequence data supplied by microbesNG.  Clustal 
Omega was used to align the encoded protein sequences.  
 
LpxI encodes an enzyme in the lipid A pathway (see chapter 6) and Galactose 
binding periplasmic protein enables binding of the organism to cell surface 
unsubstituted β-galactose residues (see chapter 5).  Pyruvate synthase (nifJ_1) 
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is a member of the pyruvate ferredoxin flavodoxin oxidoreductase family involved 
in the electron transport chain.  DNA polymerase III Tau (dnaX_1) is a 
nucleotidyltransferase (https://www.uniprot.org/uniparc/?query=A0A2X3M9F5).  
Leukotoxin (lktA) (from amino acid 121-419) is a potent virulence factor toxic to 
human white blood cells (https://www.uniprot.org/uniprot/Q2NLH6).  Threonine--
tRNA ligase 2 (thrS) catalyzes the attachment of threonine to tRNA (Thr) 
(https://www.uniprot.org/uniprot/A0A017H6B3).  The Elongation factor Tu (tuf) 
protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of 
ribosomes during protein biosynthesis (https://www.uniprot.org/uniprot/J5VR20).  
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Table 7.1 Information for NCBI, NCTC and microbesNG genome assemblies used in preliminary phylogenetic  
analyses 
Summary statistics (i.e. size, scaffolds, CDS) were generated using Prokka 1.13. GC % information as supplied by NCBI, NCTC and 
microbesNG. 
 
Strain Identified in this study as: WGS Size(Mb) GC% Scaffolds CDS Source Genome reference 
F59 Fusobacterium necrophorum subsp. funduliforme  2.08 35.1 70 1979 Human, recurrent and persistent 
sort throat (HRPSR) 
This study 
F62 Fusobacterium necrophorum subsp. funduliforme  2.22 34.5 45 2110 HRPSR This study 
F70 Fusobacterium necrophorum subsp. funduliforme  2.14 35.1 114 2001 HRPSR This study 
F80 Contaminated*  4.02 37.6 316 3758 HRPSR This study 
F86 Fusobacterium necrophorum subsp. funduliforme  2.19 35.0 67 2149 HRPSR This study 
F87 Fusobacterium necrophorum subsp. funduliforme  2.35 35.0 73 2321 HRPSR This study 
F88 Fusobacterium nucleatum/Fusobacterium simiae†  2.49 27.1 140 2248 HRPSR This study 
F1 Fusobacterium necrophorum subsp. funduliforme  2.16 35.0 66 2044 HRPSR This study 
F5 Fusobacterium necrophorum subsp. funduliforme  2.14 35.1 69 2043 HRPSR This study 
F11 Fusobacterium necrophorum subsp. funduliforme  2.06 35.1 48 1929 HRPSR This study 
F21 Fusobacterium necrophorum subsp. funduliforme  2.26 34.9 36 2211 HRPSR This study 
F24 Fusobacterium necrophorum subsp. funduliforme  2.24 35.0 66 2162 HRPSR This study 
F30 Fusobacterium necrophorum subsp. funduliforme  2.16 35.0 60 2070 HRPSR This study 
F39 Fusobacterium necrophorum subsp. funduliforme  2.21 34.9 78 2080 HRPSR This study 
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Strain Identified in this study as: WGS Size(Mb) GC% Scaffolds CDS Source Genome reference 
F40 Fusobacterium necrophorum subsp. funduliforme  2.16 35.0 71 2039 HRPSR This study 
F42 Fusobacterium necrophorum subsp. funduliforme  2.21 35.0 74 2159 HRPSR This study 
F52 Fusobacterium necrophorum subsp. funduliforme  2.48 34.9 61 2075 HRPSR This study 
Aru 01 Fusobacterium necrophorum subsp. funduliforme  2.15 35.1 54 2068 Patient with Lemierre's disease, 
Cardiff 
This study 
JCM 3718T Fusobacterium necrophorum subsp. necrophorum  2.60 34.0 189 2268 Bovine liver abscess This study 
JCM 3724T Fusobacterium necrophorum subsp. funduliforme  2.13 34.9 42 2025 Bovine liver abscess This study 
HUN048 Fusobacterium necrophorum subsp. funduliforme‡ GCA_000622045.1 2.03 35.1 17 1872 Cow rumen, NZ Seshadri et al. (2018) 
BL Fusobacterium necrophorum subsp. necrophorum‡ GCA_000691645.1 2.46 34.1 235 2164 Bovine liver – 
DJ-1 Fusobacterium necrophorum subsp. necrophorum‡ GCA_000691665.1 2.46 34.0 370 2176 Deer tongue, jaw – 
BFTR-1 Fusobacterium necrophorum subsp. necrophorum‡ GCA_000691685.1 2.53 33.9 304 2234 Bovine foot rot – 
DAB Fusobacterium necrophorum subsp. necrophorum‡ GCA_000691705.1 2.52 34.0 254 2225 Deer jaw abscess – 
BFTR-2 Fusobacterium necrophorum subsp. necrophorum‡ GCA_000691725.1 2.61 33.8 389 2380 Bovine foot rot – 
DJ-2 Fusobacterium necrophorum subsp. necrophorum‡ GCA_000691745.1 2.52 34.0 226 2235 Deer jaw – 
LS_1260 Fusobacterium necrophorum subsp. funduliforme GCA_001596475.1 2.24 35.1 62 2207 Human blood, Denmark – 
LS_1264 Fusobacterium necrophorum subsp. funduliforme GCA_001596485.1 2.33 34.4 117 2249 Human blood, Denmark – 
LS_1197 Fusobacterium necrophorum subsp. funduliforme GCA_001596495.1 1.98 35.2 38 1811 Human blood, Denmark – 
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Strain Identified in this study as: WGS Size(Mb) GC% Scaffolds CDS Source Genome reference 
LS_1195 Fusobacterium necrophorum subsp. funduliforme GCA_001597305.1 2.23 35.3 36 2135 Human blood, Denmark – 
LS_1266 Fusobacterium necrophorum subsp. funduliforme GCA_001597315.1 2.10 35.1 83 2013 Human blood, Denmark – 
LS_1280 Fusobacterium necrophorum subsp. funduliforme GCA_001597325.1 2.10 35.1 56 1978 Human blood, Denmark – 
LS_1272 Fusobacterium necrophorum subsp. funduliforme GCA_001597335.1 2.14 35.2 32 1984 Human blood, Denmark – 
LS_1291 Fusobacterium necrophorum subsp. funduliforme GCA_001597385.1 2.10 35.1 37 1988 Human blood, Denmark – 
F1248 Fusobacterium necrophorum subsp. funduliforme GCA_001597395.1 2.24 34.8 49 2208 Human throat swab, Denmark – 
F1285 Fusobacterium necrophorum subsp. funduliforme GCA_001597405.1 2.34 35.0 70 2306 Human throat swab, Denmark – 
F1250 Fusobacterium necrophorum subsp. funduliforme GCA_001597445.1 2.42 34.9 46 2452 Human throat swab, Denmark – 
F1267 Fusobacterium necrophorum subsp. funduliforme GCA_001597465.1 2.29 35.1 71 2204 Human throat swab, Denmark – 
F1309 Fusobacterium necrophorum subsp. funduliforme GCA_001597475.1 2.14 35.2 51 2051 Human throat swab, Denmark – 
F1314 Fusobacterium necrophorum subsp. funduliforme GCA_001597485.1 2.08 35.1 105 1937 Human throat swab, Denmark – 
F1353 Fusobacterium necrophorum subsp. funduliforme GCA_001597525.1 2.11 35.1 45 2013 Human throat swab, Denmark – 
F1330 Fusobacterium necrophorum subsp. funduliforme GCA_001597545.1 2.11 35.2 72 1979 Human throat swab, Denmark – 
F1365 Fusobacterium necrophorum subsp. funduliforme GCA_001597565.1 2.17 35.1 47 2102 Human throat swab, Denmark – 
F1351 Fusobacterium necrophorum subsp. funduliforme GCA_001597575.1 2.20 35.0 56 2184 Human throat swab, Denmark – 
P1_CP Fusobacterium necrophorum subsp. funduliforme GCA_002761995.1 2.10 35.2 34 1977 Human colorectal primary tumour, 
Spain 
– 
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Strain Identified in this study as: WGS Size(Mb) GC% Scaffolds CDS Source Genome reference 
P1_LM Fusobacterium necrophorum subsp. funduliforme GCA_002762025.1 2.09 35.2 35 1976 Human liver metastasis, Spain – 
D12 Fusobacterium necrophorum subsp. funduliforme‡ GCA_000158295.2 1.96 35.2 17 1919 Human gastrointestinal tract, 
ulcerative colitis 
Human microbiome project 
B35 Fusobacterium necrophorum subsp. funduliforme GCA_000814775.1 2.05 35.0 42 2320 Bovine liver abscess Calcutt et al. (2014) 
1_1_36S Fusobacterium necrophorum subsp. funduliforme GCA_003019715.1 2.28 34.7 1 2119 Human terminal ileum Sanders et al. (2018) 
Fnf 1007 Fusobacterium necrophorum subsp. funduliforme GCA_000292975.1 2.17 35.1 87 2090 Unknown Human microbiome project 
CMW8396 Fusobacterium equinum GCA_001546395.1 1.80 32.5 77 1748 Human vagina Human microbiome project 
ATCC 25563T Fusobacterium gonidiaformans GCA_003019695.1 1.68 32.7 1 1610 Human tonsil Sanders et al. (2018) 
ChDC F128 Fusobacterium hwasookii' GCA_000292935.1 2.36 27.0 30 2210 Human upper jaw tissue with 
sinusitis, South Korea 
Park et al. (2012a) 
Marseille-P2749 Fusobacterium massiliense' GCA_900095705.1 1.81 27.3 6 1649 Human duodenum sample Mailhe et al. (2016) 
ATCC 9817 Fusobacterium mortiferum GCA_003019315.1 2.72 29.3 1 2631 Human peri-renal abscess Sanders et al. (2018) 
ATCC 25832T Fusobacterium naviforme GCA_003014445.1 2.40 52.8 23 2184 Human, exudate from head lesion – 
NCTC 10723T Fusobacterium necrogenes ERS956170 2.02 29.2 5 1802 Duck caecum NCTC 3000 
ATCC 51190T Fusobacterium nucleatum subsp. fusiforme GCA_000279975.1 1.84 27.2 198 1718 Human sinusitis in upper jaw Park et al. (2012b) 
ATCC 25586T Fusobacterium nucleatum subsp. nucleatum GCA_000007325.1 2.17 27.2 1 2016 Human cervico-facial lesion Kapatral et al. (2002) 
NCTC 10562T Fusobacterium nucleatum subsp. polymorphum NZ_LN831027 (chr.), 
NZ_LN831028 (plasmid) 
2.46 27.0 2 2330 Human inflamed gingiva NCTC 3000 
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Strain Identified in this study as: WGS Size(Mb) GC% Scaffolds CDS Source Genome reference 
ATCC 49256T Fusobacterium nucleatum subsp. vincentii GCA_000182945.1 2.12 27.3 302 2240 Human periodontal pocket Kapatral et al. (2003) 
ATCC 29250T Fusobacterium perfoetens GCA_000622245.1 2.10 26.0 25 1934 Piglet faeces – 
ATCC 33693T Fusobacterium periodonticum GCA_000160475.1 2.62 27.7 53 2454 Human periodontitis – 
ATCC 25533T Fusobacterium russii GCA_000381725.1 1.94 28.7 41 1714 Infection in a cat – 
clos_1_1 Fusobacterium sp. GCA_900015295.1 2.04 28.9 8 1852 Soil – 
CAG:649 Fusobacterium sp. GCA_000433695.1 2.16 26.7 172 2121 Human gut metagenome – 
CAG:815 Fusobacterium sp. GCA_000437775.1 1.84 32.2 32 1825 Human gut metagenome – 
CAG:439 Fusobacterium sp. GCA_000438175.1 2.19 34.7 90 2333 Human gut metagenome – 
CM1 Fusobacterium sp. GCA_000524215.1 2.44 26.7 155 2288 Unknown Human microbiome project 
CM21 Fusobacterium sp. GCA_000517705.1 2.36 27.7 471 2058 Unknown Human microbiome project 
CM22 Fusobacterium sp. GCA_000524395.1 2.44 26.7 87 2362 Unknown Human microbiome project 
HMSC064B11 Fusobacterium sp. GCA_001815715.1 2.40 26.8 119 2258 Human blood, central line – 
HMSC064B12 Fusobacterium sp. GCA_001810995.1 2.12 26.9 56 1950 Human breast wound – 
HMSC065F01 Fusobacterium sp. GCA_001813745.1 2.13 26.8 56 1939 Human gastric wound – 
HMSC073F01 Fusobacterium sp. GCA_001810475.1 3.50 29.3 221 3132 Human abdominal fluid – 
OBRC1 Fusobacterium sp. GCA_000524235.1 2.50 26.8 87 2428 Unknown Human microbiome project 
W7671 Fusobacterium sp. oral taxon 203 GCA_002243405.1 2.13 27.5 1 1973 Human, curette – 
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Strain Identified in this study as: WGS Size(Mb) GC% Scaffolds CDS Source Genome reference 
F0437 Fusobacterium sp. oral taxon 370 GCA_000235465.1 2.09 27.6 133 2141 Unknown Human microbiome project 
ATCC 49185T Fusobacterium ulcerans GCA_003019675.1 3.54 30.5 1 3230 Human skin ulcer, Gambia Sanders et al. (2018) 
ATCC 27725 Fusobacterium varium GCA_003019655.1 3.35 29.3 2 3053 Unknown Sanders et al. (2018) 
ATCC 700028T Cetobacterium ceti GCA_900167275.1 2.58 28.3 61 2500 Sea mammal – 
DSM 19335T Psychrilyobacter atlanticus GCA_000426625.1 3.54 31.9 3 3302 Marine sediment – 
 
*Contaminated sequence; see text and Figure 7.1 and Figure 7.2 for explanation. 
†Misclassified, should be Fusobacterium nucleatum/Fusobacterium simiae.  See text and Figure 7.1 and Figure 7.3 for explanation. 
‡Deposited in NCBI as Fusobacterium necrophorum. 
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 RESULTS 
7.3.1 Preliminary sequence analyses 
The 20 genome sequences generated in this study and other, publicly available 
Fusobacterium necrophorum strains within the family Fusobacteriaceae, a total of 
83 whole genome sequences, were included in a preliminary phylogenetic 
analysis (Figure 7.1).  Original whole genome nucleotide assemblies were used 
(from NCBI, NCTC or microbesNG) as raw reads were not available for the 
majority of publicly available genomes, preventing assembly of all sequence data 
using the same assembler.  However, proteins in all genomes were predicted 
using Prokka 1.13; this analysis predicted 2119 genes for the complete genome 
sequence of Fusobacterium necrophorum subsp. funduliforme 1_1_36S, whereas 
Sanders et al., (2018) predicted 2125 using a combination of Prodigal, RAST, 
Barrnap and CRISPRone. 
 
Of the 20 whole genome sequences generated by microbesNG for this study, F80 
and F88 were problematical (Figure 7.1).  The microbesNG-generated genome of 
F80 was much larger than those of other Fusobacterium necrophorum isolates 
and encoded far more proteins (Table 7.1); microbesNG had also reported the 
genome sequence might represent a mixed culture as numerous sequence reads 
mapped to Streptococcus spp.  Together, these results suggested F80 either 
represented a novel species or its genome was contaminated.  Searching the 
assembled contigs against the non-redundant NCBI nucleotide database via 
Centrifuge 1.0.3 (Kim et al., 2016) revealed the genome of F80 was contaminated 
with a large number of Streptococcus-associated reads (Figure 7.2).  Given that 
the genome of F80 was contaminated, it was removed from the dataset. 
 
Strain F88 fell within a clade containing proteome data from Fusobacterium 
hwasookii, the four subspecies of Fusobacterium nucleatum, Fusobacterium 
periodonticum, ‘Fusobacterium massiliense’ and Fusobacterium russii; no issues 
with the genome of F88 had been reported by microbesNG.  An ANI analysis of 
F88 against the species in its clade and the genome sequence of Fusobacterium 
necrophorum subsp. necrophorum JCM 3718 revealed it to be most closely 
related to Fusobacterium nucleatum subsp. fusiforme ATCC 51190 (89.5 % ANI) 
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and only distantly related to Fusobacterium necrophorum subsp. necrophorum 
JCM 3718 (70.3 % ANI) (Figure 7.3a); the ANI threshold range for species 
affiliation is ≥95 % (Goris et al., 2007; Richter & Rosselló -Mó ra, 2009; Chun et 
al., 2018), confirming F88 belonged to neither Fusobacterium necrophorum nor 
Fusobacterium nucleatum.  16S rRNA gene sequence analysis confirmed F88 
was closely related to Fusobacterium nucleatum subspecies (97.0–99.1 % 
sequence similarity; Fusobacterium nucleatum subsp. nucleatum, 99.1 %). 
However, it shared 99.3 % sequence similarity (1458 nt) with Fusobacterium 
simiae, with this association supported at 100 % by bootstrap analysis (Figure 
7.3b).  Comparison with the (currently unavailable) whole genome sequence of 
Fusobacterium simiae would be required to accurately determine the species 
affiliation of F88.  As the focus of this study was Fusobacterium necrophorum, 
strain F88 was removed from the datasets.  
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Figure 7.1 Phylogenetic (neighbour-joining) tree showing taxonomic 
placement of strains included in this study within the family 
Fusobacteriaceae.  
The tree was generated using an alignment of 374 concatenated proteins selected 
from the whole-genome sequences by PhyloPhlAn 0.99. Arrows point to type strains 
of Fusobacterium necrophorum subsp. necrophorum and Fusobacterium 
necrophorum subsp. funduliforme. Green text = isolates sequenced for this study. 
Designations for all other genomes are as given in the relevant NCBI genome 
records. Bootstrap values are not shown at the nodes as this tree was intended to 
quickly highlight any potential issues with genome assignments, not to provide an 
authoritative phylogeny. 
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Figure 7.2 Representation of contaminating contigs in microbesNG-generated assembly of strain F80 genome. 
The contigs were mapped against the NCBI non-redundant nucleotide database using Centrifuge 1.0.3. The data were visualized 
using   Krona (Ondov et al., 2011).  A third of all contigs were associated with Streptococcus spp., particularly Streptococcus mitis. 
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Figure 7.3 Species assignment of F88.  
(a) The whole-genome nucleotide sequence of F88 was compared with that of its 
closest relatives to generate ANI values (OAT 0.93 output shown). (b) The 16S rRNA 
gene sequence of F88 was extracted from its whole-genome sequence and included 
in a phylogenetic analysis with the 16S rRNA gene sequences of the type strains of its 
closest relatives.  Neighbour-joining tree shown. Values at nodes are bootstrap values 
displayed as a percentage of 1000 replicates; only values >80 % are shown. 
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7.3.2 ANI comparisons of Fusobacterium necrophorum genomes with 
other Fusobacteria 
The type strains of Fusobacterium necrophorum subsp. necrophorum (JCM 3718) 
and Fusobacterium necrophorum subsp. funduliforme (JCM 3724) shared less 
than 82.7 % and 82.6 % ANI, respectively, with the type strains of other 
Fusobacterium species (Figure 7.4).  JCM 3718 shared 97.1 % ANI with JCM 
3724 and formed a cluster with six other strains (BFTR-1, BFTR-2, BL, DAB, DJ-
1, DJ-2) that shared 98.5–99.6 % ANI with JCM 3718 and 97.2–97.4 % ANI with 
JCM 3724.  All other Fusobacterium necrophorum strains shared 98.2–99.8 % 
ANI with JCM 3724.  As all Fusobacterium necrophorum strains shared ≥95 % 
ANI, it could be confirmed they were authentic members of the species (Goris et 
al., 2007; Richter and Rosselló-Móra, 2009; Chun et al., 2018). 
 
7.3.3 Fusobacterium necrophorum pangenome analysis 
The 49 authentic Fusobacterium necrophorum genomes were submitted to Roary 
(minimum identity for BLAST of 95 %).  The analysis showed there to be 1053 
core genes (present in ≥ 99 % –100 % of strains), 276 soft core genes (present in 
≥95 %–< 99 % of strains), 1359 shell genes (i.e. genes present in ≥ 15 % – < 95 
% of strains) and 4131 cloud genes (i.e. genes present in 0 – <15 % of strains). 
In total, 6819 genes were detected in the analysis. Within the core genes, 37436 
SNPs were detected.  The strains fell into two groups, with the majority of strains 
clustering with the type strain of Fusobacterium necrophorum subsp. funduliforme 
(Figure 7.5).  Strains DAB, BFTR-1, BFTR-2, DJ-1, DJ-2 and BL clustered with 
the type strain of Fusobacterium necrophorum subsp. necrophorum, in agreement 
with the results from the ANI analysis (Figure 7.4). 
 
The seven Fusobacterium necrophorum subsp. necrophorum strains shared 1540 
core genes (present in all strains) and 1794 accessory genes (present in one or 
more strains).  The 42 Fusobacterium necrophorum subsp. funduliforme strains 
shared 1253 core genes and 4412 accessory genes.  Of the 6819 genes detected 
in both subspecies by Roary, 1154 were unique to Fusobacterium necrophorum 
subsp. necrophorum and 3485 were unique to Fusobacterium necrophorum 
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subsp. funduliforme at BLASTp cut-off of 95 %.  PCA of accessory genes present 
in 5–95 % of the strains confirmed separation of the two subspecies (Figure 7.6a). 
Although Fusobacterium necrophorum subsp. funduliforme strains clustered on 
the left-hand side of the PCA plot, it appeared there were at least two separate 
clusters within the subspecies that warranted further attention (Figure 7.6b). 
 
PCA of only the accessory genes of Fusobacterium necrophorum subsp. 
funduliforme revealed there to be three clusters within the subspecies.  Cluster A 
contained the type strain of Fusobacterium necrophorum subsp. funduliforme 
(JCM 3724) and strains F1, F21, F39, F40, F70, F1314, LS_1291, F1353 and 
LS_1264, while Cluster B contained F24, F87, Fnf 1007, LS_1195, F1267, F1285, 
F1250, LS_1260, F1330, F1365, F1309, P1_LM and P1_CP (Figure 7.7a).  
Cluster A can clearly be seen in the ANI heatmap in Figure 7.4, while clusters A 
and B are seen in the pangenome analysis in Figure 7.5.  Cluster C was more 
diffuse (Figure 7.7a, b).  Inclusion of additional Fusobacterium necrophorum 
subsp. funduliforme genomes in the analysis may allow separation of Cluster C 
into additional clusters. The three Fusobacterium necrophorum subsp. 
funduliforme clusters shared 790 core genes, but each cluster had its own unique 
genes (Figure 7.8). 
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Figure 7.4 Heatmap summarizing ANI values for Fusobacterium 
necrophorum genomes and related species.  
The data were generated using OAT_cmd 1.30 and imported into R for visualization. 
Green text = genome sequences generated for this study. 
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Figure 7.5 Pangenome analysis of Fusobacterium necrophorum subsp. necrophorum (FNN) and Fusobacterium 
necrophorum subsp. funduliforme (FNF).   
The dendrogram was generated from the core alignment produced by Roary using FastTree (Price et al., 2009).  Image generated using 
phandango (Hadfield et al., 2017) and edited in Illustrator.  Green text, genome sequences generated for this study. 
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Figure 7.6 PCA of accessory genes (present in 5 – 95 % of strains) for 
Fusobacterium necrophorum subsp. necrophorum and Fusobacterium 
necrophorum subsp. funduliforme.   
(a) PCA plot showing separation of data into the two subspecies based on the first 
principal component.  (b) The F. necrophorum subsp. funduliforme strains appeared 
to form two distinct clusters (marked by thick black and green lines).  The cluster 
outlined in green contains the type strain (JCM 3724) of the subspecies. 
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Figure 7.7 PCA of accessory genes (present in 5 – 95 % of strains) for 
Fusobacterium necrophorum subsp. funduliforme.  
(a) PCA including an outlier strain, D12.  (b) PCA with outlier D12 removed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  156 
 
 
Figure 7.8 Venn diagram showing numbers of core and accessory genes 
shared by the three Fusobacterium necrophorum subsp. funduliforme 
clusters identified from PCA of accessory genes.   
Image produced using Venny 2.1.0 (http://bioinfogp.cnb.csic.es/tools/venny/). 
 
7.3.4 Impact of nucleotide changes on amino acid sequence. 
The results of the Clustal Omega alignment of the protein sequences of the LpxI 
protein (described in chapter 6) in 24 isolates are shown in Figure 7.9 and Table 
7.2.  In this case 13 amino acid differences, the products of non-synonymous 
SNPs, were noted in the 24 sequences analysed.  Five of these were close to the 
amino acids identified as important for catalytic activity (see chapter 6).  Of the 
three SNPs that were predicted to cause structural changes in the protein, one 
was close to the active site of the protein and requires further analysis to 
determine impact on enzyme activity and LPS production.  
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Table 7.2 Impact of non-synonymous SNPs on LpxI. 
 
Alternative amino 
acids 
Amino acid 
properties 
Impact Incidences 
Asparagine (N) or 
Aspartic acid (D) 
Amide 
Acidic 
Not close to active 
site 
1 
Methionine (M) or 
Isoleucine(I) 
Hydrophobic 
Hydrophobic 
None 5 
Cysteine (C) or 
Tyrosine (Y) 
Aromatic 
Nucleophilic 
Not close to active 
site 
1 
Lysine (K) or 
Glutamic acid (E) 
Basic 
Acidic 
Both can form salt 
bridges 
1 
Leucine (L) or 
Phenylalanine (F) 
Hydrophobic 
Aromatic 
Both hydrophobic 1 
Serine(S) or  
Arginine (R) 
Nucleophilic 
Basic 
Likely: close to 
active site 
1 
Arginine (R) or 
Glutamine (Q) 
Basic 
Polar 
Unlikely 1 
Isoleucine (I) or 
Valine (V) 
Hydrophobic 
Hydrophobic 
None 1 
Leucine (L) or 
Isoleucine (I) 
Hydrophobic 
Hydrophobic 
None 1 
 
 
Interestingly, the alignment  (Figure 7.9) showed 3 distinct clusters of isolates; 
based on analysis of 10 polymorphisms,  the subsp. funduliforme isolates F1, F21, 
F39, F40, F62, F70, 05310, B35, JCM 3724 and WP1(ATCC 51357) formed one 
cluster (A),  the subsp. funduliforme F5, F11, F24, F30, F42, F52, ARU 01, F59, 
F80, F86, F87, WP2 the second (B + C) and  the subsp. necrophorum isolates  
JCM 3718 and WP3 (DAB, BFTR-1, DJ-1, BFTR-2, DJ-2) the third.  JCM 3718 
and WP3 had a pattern similar to cluster B+C at 8 of 10 sites, but for two sites 
they resembled cluster A.  One polymorphism was noted in JCM 3724 and WP1; 
a change from L to F, that was not present in other isolates and two 
polymorphisms D to N, M to I and I to L were seen only in JCM 3718 and WP3. 
The two subsp. funduliforme clusters were identical to the two main clusters (A 
and B+C) seen in the genomic study.            
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F1         HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFLKLNGIR 120 
F21        HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFLKLNGIR 120 
F39        HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFLKLNGIR 120 
F40        HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFLKLNGIR 120 
F62        HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFLKLNGIR 120 
F70        HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFLKLNGIR 120 
05310      HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFLKLNGIR 120 
B35        HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFLKLNGIR 120 
JCM 3724   HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFFKLNGIR 120 
WP1        HFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAMISFFKLNGIR 120 
F5         YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
F11        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
F24        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 76 
F30        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
F42        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
F52        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
ARU 01     YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
F59        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
F80        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
F86        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
F87        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 120 
WP2        --------------------LFQNLDLDYYGQEILKMLPDRKDETLLFAIISFLKLNGIR 40 
JCM 3718   YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPNRKDETLLFAIISFLKLNGIR 120 
WP3        YFSFYGVKKLILLGKVEKSILFQNLDLDYYGQEILKMLPNRKDETLLFAIISFLKLNGIR 120 
                               *******************:*********:***:****** 
F1           VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
F21          VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
F39          VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
F40          VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
F62          VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
F70          VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
05310        VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
B35          VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
JCM 3724     VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
WP1          VLSQNYLLSSCMVEEKCYTEKIPKEEDDRSIQLGIEAAKILTRLDIGQTVIVKEEAVVAL 180 
F5           VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
F11          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
F24          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 136 
F30          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
F42          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
F52          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
ARU 01       VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
F59          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
F80          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
F86          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
F87          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 180 
WP2          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGMEAAKMLTSLDIGQTVIVKEEAVVAL 100 
JCM 3718     VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGIEAAKMLTSLDIGQTVIVKEEAVVAL 180 
WP3          VLSQNYLLSSYMVEEKCYTEEMPKKEDDRSIQLGIEAAKMLTSLDIGQTVIVKEEAVVAL 180 
             ********** *********::**:*********:****:** ***************** 
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F1           EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F21          EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F39          EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F40          EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F62          EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F70          EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
05310        EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
B35          EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
JCM 3724     EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
WP1          EGIEGTDQAILRAGELAGKNCIIVKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F5           EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F11          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F24          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 196 
F30          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F42          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F52          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
ARU 01       EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F59          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F80          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F86          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
F87          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 240 
WP2          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETIRRAIEIGAKGIVMEA 160 
JCM 3718     EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETLRRAIEIGAKGIVMEA 240 
WP3          EGMEGTDRAILRAGELAGKNCIIIKMARPKQDMRVDIPTVGVETLRRAIEIGAKGIVMEA 240 
             **:****:***************:********************:*************** 
 
Figure 7.9 Clustal Omega analysis of the LpxI protein.   
Amino acids 1-60 and 241-267 were identical and are not included. WP1= 
WP_005958282.1; ATCC 51357, WP2 = WP_005964136.1, WP3 = 
WP_035902054.1; DAB, BFTR-1, DJ-1, BFTR-2, DJ-2. *  = active site.  An * (asterisk) 
indicates positions which have a single, fully conserved residue. A : (colon) indicates 
conservation between amino acids with strongly similar properties (conservative 
replacements). A . (full stop) indicates conservation between amino acids with weakly 
similar properties. A gap indicates non-conserved amino acids.  Two clusters were 
noted, highlighted in green and black, and other individual amino acid changes are 
highlighted in red.  
 
 
Having noted the clustering of isolates with respect to the amino acid sequence of 
LpxI, similar analyses were completed on a number of other proteins. Figure 7.10 
shows the Clustal Omega alignment of the Galactose periplasmic binding protein 
(see chapter 5, Fig. 5.4); in 5 representative isolates, only 6 amino acid changes 
and one deletion were noted. Four amino acid differences were seen between 
JCM 3718 and the other isolates, ARU 01 and isolate F5 had a single amino acid 
deletion, and ARU 01 had an amino acid different to all other isolates. One 
difference was noted where isolate F5 and JCM 3718 differed from the other 
isolates; hence the changes in this protein did not demonstrate the same 
clustering as LpxI and the protein was similar in both subspecies. All changes 
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were conservative replacements and hence unlikely to cause significant changes 
in protein structure or function. 
 
A small section of the Leukotoxin protein was analysed in 13 isolates; it was clear 
that JCM 3718, the only subsp. necrophorum analysed was significantly different 
at 34 sites from the other isolates (highlighted in red in Figure 7.10). Conservative, 
semi-conservative and non-conservative replacements were seen.  The sequence 
from JCM 3718 was used as the interrogator in a BLASTp analysis and matched 
with more than 98 % identity 6 uncharacterised F. necrophorum isolates, 2 subsp. 
necrophorum isolates, BTFR-1 and BTFR-2 suggesting these changes were likely 
to be subsp. necrophorum specific. Polymorphisms, conservative, semi-
conservative and non-conservative, were seen at 65 locations in the other isolates 
differentiating two clusters F1, F21, F39, F40 and JCM 3724 from F5, F11, F24, 
F30, F42, F52 and ARU 01; these results define clusters identical to those 
obtained for LpxI.   
 
Analysis of the Elongation factor Tu in 5 representative isolates was highly 
conserved. There was only one amino acid change (R to K; a conservative 
replacement) in JCM 3718 and a difference in the isolate F5 that appeared to 
produce a shorter protein: this was at the start of the protein and may represent a 
sequencing, assembly or annotation issue, although one similarly shortened 
sequence was found in the NCBI database following a BLASTp analysis.  
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Aru01_00496        MKKMGIILGALVLAAGLVGCGEKKEA-APAENAVRMGLTAYKFDDNFIALFRQAFQAEAD 59 
F5_01730           MKKMGIILGALVLAAGLVGCGEKKEA-APAENAVRMGLTAYKFDDNFIALFRQAFQAEAD 59 
JCM3718_01896      MKKMGIVLGALVLAAGLVGCGEKKEAAAPAENAVRMGLTAYKFDDNFIALFRQAFQAEAD 60 
F1_00295           MKKMGIILGALVLAAGLVGCGEKKEAAAPAENAVRMGLTAYKFDDNFIALFRQAFQAEAD 60 
JCM3724_01150      MKKMGIILGALVLAAGLVGCGEKKEAAAPAENAVRMGLTAYKFDDNFIALFRQAFQAEAD 60 
                   ******:******************* ********************************* 
 
Aru01_00496        AVGNQVALQMVDSQNDAAKQNENLDVLLEKGIDTLAINLVDPAGVDVVLEKIKAKELPVV 119 
F5_01730           AVGDQVALQMVDSQNDAAKQNEQLDVLLEKGIDTLAINLVDPAGVDVVLEKIKAKELPVV 119 
JCM3718_01896      AVGDQVALQMVDSQNDAAKQNEQLDVLLEKGIDTLAINLVDPAGVDVVLEKIKAKELPVV 120 
F1_00295           AVGNQVALQMVDSQNDAAKQNEQLDVLLEKGIDTLAINLVDPAGVDVVLEKIKAKELPVV 120 
JCM3724_01150      AVGNQVALQMVDSQNDAAKQNEQLDVLLEKGIDTLAINLVDPAGVDVVLEKIKAKELPVV 120 
                   ***:******************:************************************* 
 
Aru01_00496        FYNRKPSDEALASYDKAYYVGIDPNAQGIAQGKLIEKAWQANPALDLNGDGVIQFAMLKG 179 
F5_01730           FYNRKPSEEALASYDKAYYVGIDPNAQGIAQGKLIEKAWQANPALDLNGDGVIQFAMLKG 179 
JCM3718_01896      FYNRKPSEEALASYDKAYYVGIDPNAQGVAQGKLIEKAWQANPALDLNGDGVIQFAMLKG 180 
F1_00295           FYNRKPSDEALASYDKAYYVGIDPNAQGIAQGKLIEKAWQANPALDLNGDGVIQFAMLKG 180 
JCM3724_01150      FYNRKPSEEALASYDKAYYVGIDPNAQGIAQGKLIEKAWQANPALDLNGDGVIQFAMLKG 180 
                   *******:********************:******************************* 
 
Aru01_00496        EPGHPDAEARTVYSIKTLNEDGIKTEELHLDTAMWDTAQAKDKMDAWLSGPNADKIEVVI 239 
F5_01730           EPGHPDAEARTVYSIKTLNEDGIKTEELHLDTAMWDTAQAKDKMDAWLSGPNADKIEVVI 239 
JCM3718_01896      EPGHPDAEARTVYSIKTLNEDGIKTEELHLDTAMWDTAQAKDKMDAWLSGPNADKIEVVI 240 
F1_00295           EPGHPDAEARTVYSIKTLNEDGIKTEELHLDTAMWDTAQAKDKMDAWLSGPNADKIEVVI 240 
JCM3724_01150      EPGHPDAEARTVYSIKTLNEDGIKTEELHLDTAMWDTAQAKDKMDAWLSGPNADKIEVVI 240 
                   ************************************************************ 
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Aru01_00496        CNNDGMALGAIESMKAFGKSLPVFGVDALPEAITLIEKGEMAGTVLNDAKGQAKATFQVA 299 
F5_01730           CNNDGMALGAIESMKAFGKSLPVFGVDALPEAITLIEKGEMAGTVLNDAKGQAKATFQVA 299 
JCM3718_01896      CNNDGMALGAIESMKAFGKSLPVFGVDALPEAITLIEKGEMAGTVLNDAKGQAKATFQVA 300 
F1_00295           CNNDGMALGAIESMKAFGKSLPVFGVDALPEAITLIEKGEMAGTVLNDAKGQAKATFQVA 300 
JCM3724_01150      CNNDGMALGAIESMKAFGKSLPVFGVDALPEAITLIEKGEMAGTVLNDAKGQAKATFQVA 300 
                   ************************************************************ 
 
Aru01_00496        MNLGQGKEATEGTDIQMENKIVLVPSIGIDKENVAEYK 337 
F5_01730           MNLGQGKEATEGTDIQMENKIVLVPSIGIDKENVAEYK 337 
JCM3718_01896      MNLGEGKEATEGTDIQMENKIVLVPSIGIDKENVAEYK 338 
F1_00295           MNLGQGKEATEGTDIQMENKIVLVPSIGIDKENVAEYK 338 
JCM3724_01150      MNLGQGKEATEGTDIQMENKIVLVPSIGIDKENVAEYK 338 
                   ****:********************************* 
 
 
Figure 7.10 Clustal Omega analysis of the Galactose binding periplasmic protein.  
Five strains were examined; ARU 01 (Aru01), F1, F5, JCM 3718, JCM 3724. Amino acid changes are highlighted in red. Conservative 
replacements are indicated by a colon (:), a dash (-) in the sequence denotes a deletion.
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1*         IGGNLYFLSSEGLLVGKTGVINAGTFHAISPKKEEYEKAFKDAQNSKVFDGIVPQQDGSI 
JCM 3724   IGGNLYFLSSEGLLVGKTGVINAGTFHAISPKKEEYEKAFKDAQNSKVFDGIVPQQDGSI 
5*         IGGNLYFLSSEGLLVGKTGVINAGTFRAISPKKEEYEKAFKDAQNSKVFDGIVPQQDGSI 
ARU 01     IGGNLYFLSSEGLLVGKTGVINAGTFRAISPKKEEYEKAFKDAQNSKVFDGIVPQQDGSI 
JCM 3718   IGGNLYFLSSEGMAVGKNGVINAGSFHSIIPKQDDFKKALEEAKHGKVFNGIIPV-DGKV 
           ************: ***.******:*::* **:::::**:::*::.***:**:*  **.: 
 
1*         KIPLNPNGSITVEGKINAVEDIGLYAADIRLKDTARLKTGITEFKNLVNINE-TIHAGLT 
JCM 3724   KIPLNPNGSITVEGKINAVEDIGLYAADIRLKDTARLKTGITEFKNLVNINE-TIHAGLT 
5*         KIPLNPNGSITVEGKINAVDEIGLYAADIKLPETGALKTGVTDFHQLVNIKDSNVNAGLS 
ARU 01     KIPLNPNGSITVEGKINAVDEIGLYAADIKLPETGALKTGVTDFHQLVNIKDSNVNAGLS 
JCM 3718   KIPLNPNGSITVEGKINAVEGIGLYAADIRLKDTAILKTGITDFKNLVNISD-RINSGLT 
           *******************: ********:* :*. ****:*:*::****.:  :::**: 
 
1*         GDLTAVKTKSGDIILSAHVDSPQKAVGENSTVGKRIEEYVKGNTKANIESDAVLEADGNI 
JCM 3724   GDLTAVKTKSGDIILSAHVDSPQKAVGENSTVGKRIEEYVKGNTKANIESDAVLEADGNI 
5*         GDLKATKTGTGDIILSAKVEEAGHELE-SSTIYEQIGRNFKGKIKANIETSGSIEAEGHA 
ARU 01     GDLKATKTGTGDIILSAKVEEAGHELE-SSTIYEQIGRNFKGKIKANIETSGSIEAEGHA 
JCM 3718   GDLKATKTKSGDIILSAHIDSPQKAMGKNSTVGKRIEEYVKGNTKANIESDAVLEADGNI 
           ***.*.** :*******:::.  : :  .**: ::* . .**: *****:.. :**:*:  
 
1*         KISARATNGTFVKKEGEKEIYNTPLSLSDVEASVRVNKGKVIGKNVSITAEAKNFYDATL 
JCM 3724   KISARATNGTFVKKEGEKEIYNTPLSLSDVEASVRVNKGKVIGKNVSITAEAKNFYDATL  
5*         KIHAEASNGKLTKKDGEKEVYAPEFSLAEVEASVKVNKGKIKGKKVDISAEAKNYYDTPI 
ARU 01     KIHAEASNGKLTKKDGEKEVYAPEFSLAEVEASVKVNKGKIKGKKVDISAEAKNYYDTPI 
JCM 3718   KISAKATNGRFIKKEGEKETYNTPLSLSDVEASVRVNKGKVIGKNVDITAEAKNFYDATL 
           ** *.*:** : **:**** *   :**::*****:*****: **:*.*:*****:**: : 
 
1*         VTKLAKHSFSFVTGSLSPINLNGFLGLLTSKSSVVIGKDAKVEAREGSANIHSYSGVRAT 
JCM 3724   VTKLAKHSFSFVTGSLSPINLNGFLGLLTSKSSVVIGKDAKVEAREGSANIHSYSGVRAT 
5*         LTKVGKIAFSVGTGSLSPINMNGALGLLKSKASVFIGKDATVESTEGEANIRSYSGVRAS 
ARU 01     LTKVGKIAFSVGTGSLSPINMNGALGLLKSKASVFIGKDATVESTEGEANIRSYSGVRAS 
JCM 3718   VTKLAKHSFSFVTGSISPINLNGFLGLLTSKSSVVIGKDAKVEATEGKANIHSYSGVRAT 
           :**:.* :**. ***:****:** ****.**:**.*****.**: **.***:*******: 
 
Figure 7.11 Clustal Omega alignment of a part of the Leukotoxin protein. 
1* results from F1, F21, F39, F40; 5* results from F5, F11, F24, F30, F42, F52.  An * 
(asterisk) indicates positions which have a single, fully conserved residue. A : (colon) 
indicates conservation between amino acids with strongly similar properties 
(conservative replacements). A . (full stop) indicates conservation between amino 
acids with weakly similar properties. A gap indicates non-conserved amino acids. Two 
clusters were noted, highlighted in green and black, and other individual amino acid 
changes are highlighted in red.  
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F5_02091           ----------------------------------MLSDLGLAQKVDFDKIDVAPEERERG 26 
Aru01_00001        MAKEKYERSKPHVNIGTIGHVDHGKTTTTAAISKVLSDLGLAQKVDFDKIDVAPEERERG 60 
F1_00113           MAKEKYERSKPHVNIGTIGHVDHGKTTTTAAISKVLSDLGLAQKVDFDKIDVAPEERERG 60 
JCM3724_02077      MAKEKYERSKPHVNIGTIGHVDHGKTTTTAAISKVLSDLGLAQKVDFDKIDVAPEERERG 60 
JCM3718_01095      MAKEKYERSKPHVNIGTIGHVDHGKTTTTAAISKVLSDLGLAQKVDFDKIDVAPEEKERG 60 
                                                     :*********************:*** 
 
F5_02091           ITINTAHIEYETEARHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI 86 
Aru01_00001        ITINTAHIEYETEARHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI 120 
F1_00113           ITINTAHIEYETEARHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI 120 
JCM3724_02077      ITINTAHIEYETEARHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI 120 
JCM3718_01095      ITINTAHIEYETEARHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI 120 
                   ************************************************************ 
 
F5_02091           LLSRQVGVPYIVVYLNKADMVEDEELLELVEMEVRELLSEYGFPGDEIPIVTGSSLGALN 146 
Aru01_00001        LLSRQVGVPYIVVYLNKADMVEDEELLELVEMEVRELLSEYGFPGDEIPIVTGSSLGALN 180 
F1_00113           LLSRQVGVPYIVVYLNKADMVEDEELLELVEMEVRELLSEYGFPGDEIPIVTGSSLGALN 180 
JCM3724_02077      LLSRQVGVPYIVVYLNKADMVEDEELLELVEMEVRELLSEYGFPGDEIPIVTGSSLGALN 180 
JCM3718_01095      LLSRQVGVPYIVVYLNKADMVEDEELLELVEMEVRELLSEYGFPGDEIPIVTGSSLGALN 180 
                   ************************************************************ 
 
F5_02091           GEQKWVDKIMELMKAVDEYIPTPERAVDQPFLMPIEDVFTITGRGTVVTGRVERGVVKVG 206 
Aru01_00001        GEQKWVDKIMELMKAVDEYIPTPERAVDQPFLMPIEDVFTITGRGTVVTGRVERGVVKVG 240 
F1_00113           GEQKWVDKIMELMKAVDEYIPTPERAVDQPFLMPIEDVFTITGRGTVVTGRVERGVVKVG 240 
JCM3724_02077      GEQKWVDKIMELMKAVDEYIPTPERAVDQPFLMPIEDVFTITGRGTVVTGRVERGVVKVG 240 
JCM3718_01095      GEQKWVDKIMELMKAVDEYIPTPERAVDQPFLMPIEDVFTITGRGTVVTGRVERGVVKVG 240 
                   ************************************************************ 
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F5_02091           EEVEIVGIKATTKTTCTGVEMFRKLLDQGQAGDNIGALLRGTKKEEVERGQVLAKPGSIH 266 
Aru01_00001        EEVEIVGIKATTKTTCTGVEMFRKLLDQGQAGDNIGALLRGTKKEEVERGQVLAKPGSIH 300 
F1_00113           EEVEIVGIKATTKTTCTGVEMFRKLLDQGQAGDNIGALLRGTKKEEVERGQVLAKPGSIH 300 
JCM3724_02077      EEVEIVGIKATTKTTCTGVEMFRKLLDQGQAGDNIGALLRGTKKEEVERGQVLAKPGSIH 300 
JCM3718_01095      EEVEIVGIKATTKTTCTGVEMFRKLLDQGQAGDNIGALLRGTKKEEVERGQVLAKPGSIH 300 
                   ************************************************************ 
 
F5_02091           PHTNFSGEVYVLTKEEGGRHTPFFTGYRPQFYFRTTDITGAVTLPEGVEMVMPGDNITMT 326 
Aru01_00001        PHTNFSGEVYVLTKEEGGRHTPFFTGYRPQFYFRTTDITGAVTLPEGVEMVMPGDNITMT 360 
F1_00113           PHTNFSGEVYVLTKEEGGRHTPFFTGYRPQFYFRTTDITGAVTLPEGVEMVMPGDNITMT 360 
JCM3724_02077      PHTNFSGEVYVLTKEEGGRHTPFFTGYRPQFYFRTTDITGAVTLPEGVEMVMPGDNITMT 360 
JCM3718_01095      PHTNFSGEVYVLTKEEGGRHTPFFTGYRPQFYFRTTDITGAVTLPEGVEMVMPGDNITMT 360 
                   ************************************************************ 
 
F5_02091           VELIHPIAMETGLRFAIREGGRTVASGVVSEITK 360 
Aru01_00001        VELIHPIAMETGLRFAIREGGRTVASGVVSEITK 394 
F1_00113           VELIHPIAMETGLRFAIREGGRTVASGVVSEITK 394 
JCM3724_02077      VELIHPIAMETGLRFAIREGGRTVASGVVSEITK 394 
JCM3718_01095      VELIHPIAMETGLRFAIREGGRTVASGVVSEITK 394 
                   ********************************** 
 
Figure 7.12 Clustal Omega analysis of the Elongation factor Tu.  
Five isolates were studied: ARU 01 (Aru01), F1, F5, JCM 3718 and JCM 3724. 
 
  166 
JCM3718_01643      MAKKMQTMDGNQAAAYASYAFTEVAGIYPITPSSPMAEYTDEWASRGMKNIFGVPVKLVE 60 
F1_00215           MKKRMKTMDGNQAAA---YAFTEVAGIYPITPSSPMAEYVDEWASKGMKNIFDVPVKLVE 57 
Aru01_00063        MKKRMKTMDGNQAAAYASYAFTEVAGIYPITPSSPMAEYVDEWASKGMKNIFDVPVKLVE 60 
F5_00952           MKKRMKTMDGNQAAAYASYAFTEVAGIYPITPSSPMAEYVDEWASKGMKNIFDVPVKLVE 60 
JCM3724_00851      MKKRMKTMDGNQAAAYASYAFTEVAGIYPITPSSPMAEYVDEWASKGMKNIFDVPVKLVE 60 
                   * *:*:*********   *********************.*****:******.******* 
 
JCM3718_01643      MQSEAGAAGSVHGSLQAGALTTTYTASQGLLLKIPNMYKIAGELLPGVIHVSARALSAQA 120 
F1_00215           MQSEAGAAGTVHGSLQAGALTTTYTASQGLLLKIPNMYKIAGELLPGVIHVSARSLSVQA 117 
Aru01_00063        MQSEAGAAGTVHGSLQAGALTTTYTASQGLLLKIPNMYKIAGELLPGVIHVSARSLSVQA 120 
F5_00952           MQSEAGAAGTVHGSLQAGALTTTYTASQGLLLKIPNMYKIAGELLPGVIHVSARSLSVQA 120 
JCM3724_00851      MQSEAGAAGTVHGSLQAGALTTTYTASQGLLLKIPNMYKIAGELLPGVIHVSARSLSVQA 120 
                   *********:********************************************:**.** 
 
JCM3718_01643      LSIFGDHQDIYAARQTGFAMLATNSVQEVMDLAGVAHLTAIKTRVPFMHFFDGFRTSHEI 180 
F1_00215           LSIFGDHQDIYATRQTGFTMLASGSVQEVMDMGTIAHLTAIKSRVPVLHFFDGFRTSHEI 177 
Aru01_00063        LSIFGDHQDIYATRQTGFTMLASGSVQEVMDMGTIAHLTAIKSRVPVLHFFDGFRTSHEI 180 
F5_00952           LSIFGDHQDIYATRQTGFTMLASGSVQEVMDMGTIAHLTAIKSRVPVLHFFDGFRTSHEI 180 
JCM3724_00851      LSIFGDHQDIYATRQTGFTMLASGSVQEVMDMGTIAHLTAIKSRVPVLHFFDGFRTSHEI 180 
                   ************:*****:***:.*******:. :*******:***.:************ 
 
JCM3718_01643      QKVEVMDYEVFKSLVDYEAIQAFRDRALNPEHPVTRGTAQNDDIYFQAREAQNKFYDAVP 240 
F1_00215           QKIELMDYDVCKRLVDYDAIQAFRDRALNPEHPVTRGTAQNDDIYFQAREAQNKFYDAVP 237 
Aru01_00063        QKIELMDYDVCKRLVDYDAIQAFRDRALNPEHPVTRGTAQNDDIYFQAREAQNKFYDAVP 240 
F5_00952           QKIELMDYDVCKRLVDYDAIQAFRDRALNPEHPVTRGTAQNDDIYFQAREAQNKFYDAVP 240 
JCM3724_00851      QKIELMDYDVCKRLVDYDAIQAFRDRALNPEHPVTRGTAQNDDIYFQAREAQNKFYDAVP 240 
                   **:*:***:* * ****:****************************************** 
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JCM3718_01643      DVTAHYMAEISKVTGRDYKPFNYYGAADAERIIVAMGSVCEAAEEVIDYLNAKGEKVGMV 300 
F1_00215           DIAAYYMEEISKETGREYKPFKYRGAADATRILIAMGSICPAAEETVDYLVEKGEKVGLL 297 
Aru01_00063        DVAAYYMEEISKETGREYKPFKYRGAADATRILIAMGSICPAAEETVDYLVEKGEKVGLL 300 
F5_00952           DVAAYYMEEISKETGREYKPFKYRGAADATRILIAMGSICPAAEETVDYLVEKGEKVGLL 300 
JCM3724_00851      DIAAYYMEEISKETGREYKPFKYRGAADATRILIAMGSICPAAEETVDYLVEKGEKVGLL 300 
                   *::*:** **** ***:****:* ***** **::****:* ****.:***  ******:: 
 
JCM3718_01643      KVHLYRPFSEKYFFDVFPKSVKRIAVLDRTKEPGSLGEPLLLDVKSLFYGKENAPLIVGG 360 
F1_00215           TVHLYRPFSEKYFFAVLPKTVEKIAVLERTKEPGAPGEPLLLDVKGLFYGKDRAPIIVGG 357 
Aru01_00063        TVHLYRPFSEKYFFAVLPKTVEKIAVLERTKEPGAPGEPLLLDVKGLFYGKDRAPIIVGG 360 
F5_00952           TVHLYRPFSEKYFFAVLPKTVEKIAVLERTKEPGAPGEPLLLDVKGLFYGKDRAPIIVGG 360 
JCM3724_00851      TVHLYRPFSEKYFFAVLPKTVEKIAVLERTKEPGAPGEPLLLDVKGLFYGKDRAPIIVGG 360 
                   .************* *:**:*::****:******: *********.*****:.**:**** 
 
JCM3718_01643      RYGLSSKDTTPAQIVAVFDNLKAEQPKDLFTVGIVDDVTFTSLEVGAPVVVSDPSTKACL 420 
F1_00215           RYGLSSKDTTPAQIKAALDNLKLEHPKTNFTIGIIDDVTFTSLEVGERLMVSDPSTKACL 417 
Aru01_00063        RYGLSSKDTTPAQIKAVLDNLKLEHPKTNFTIGIIDDVTFTSLEVGERLMVSDPSTKACL 420 
F5_00952           RYGLSSKDTTPAQIKAVLDNLKLEHPKTNFTIGIIDDVTFTSLEVGERLMVSDPSTKACL 420 
JCM3724_00851      RYGLSSKDTTPAQIKAALDNLKLEHPKTNFTIGIIDDVTFTSLEVGERLMVSDPSTKACL 420 
                   ************** *.:**** *:**  **:**:***********  ::********** 
 
JCM3718_01643      FYGLGADGTVGANKNSIKIIGDKTDLYAQGYFAYDSKKSGGVTRSHLRFGKNPIKSTYLV 480 
F1_00215           FYGLGADGTVGANKNSIKIIGDKTDLYAQGYFAYDSKKSGGVTRSHLRFGKNPIKSTYLV 477 
Aru01_00063        FYGLGADGTVGANKNSIKIIGDKTDLYAQGYFAYDSKKSGGVTRSHLRFGKNPIKSTYLV 480 
F5_00952           FYGLGADGTVGANKNSIKIIGDKTDLYAQGYFAYDSKKSGGVTRSHLRFGKNPIKSTYLV 480 
JCM3724_00851      FYGLGADGTVGANKNSIKIIGDKTDLYAQGYFAYDSKKSGGVTRSHLRFGKNPIKSTYLV 480 
                   ************************************************************ 
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JCM3718_01643      STPNFVACSVPAYLNQYDMTSGLREGGKFLLNCVWDKEEALQRIPNNVKRDIARANGKLY 540 
F1_00215           SSPSFVACSVPAYLNQYDMTSGLKEGGKFLLNCVWDKEEALQRIPNNIKRDLAKANGKLY 537 
Aru01_00063        SSPSFVACSVPAYLNQYDMTSGLKEGGKFLLNCVWDKEEALQRIPNNIKRDLAKANGKLY 540 
F5_00952           SSPSFVACSVPAYLNQYDMTSGLKEGGKFLLNCVWDKEEALQRIPNNIKRDLAKANGKLY 540 
JCM3724_00851      SSPSFVACSVPAYLNQYDMTSGLKEGGKFLLNCVWDKEEALQRIPNNIKRDLAKANGKLY 540 
                   *:*.*******************:***********************:***:*:****** 
 
JCM3718_01643      IINATKLAHDIGLGQRTNTIMQSAFFKLAEIIPFEDAQQYMKDYAKKSYAKKGDDIVQLN 600 
F1_00215           IINATKLAQEIGLGQRTNTIMQAAFFKLAEIIPFEEAQQYMKDYAYKSYGKKGDDIVQLN 597 
Aru01_00063        IINATKLAQEIGLGQRTNTIMQAAFFKLAEIIPFEEAQQYMKDYAYKSYGKKGDDIVQLN 600 
F5_00952           IINATKLAQEIGLGQRTNTIMQAAFFKLAEIIPFEEAQQYMKDYAYKSYGKKGDDIVQLN 600 
JCM3724_00851      IINATKLAQEIGLGQRTNTIMQAAFFKLAEIIPFEEAQQYMKDYAYKSYGKKGDDIVQLN 600 
                   ********::************:************:********* ***.********** 
 
JCM3718_01643      YQAIDIGASGLVEIEVDPAWKDLEVETKVEEAKDCSCSSCDCSAVEKFVERIAKPVNAIK 660 
F1_00215           YRAIDVGASGLVELEVDPAWKDLEVVDSIKEEKENDTCNCKTTSLKTFVQKIVEPINAIR 657 
Aru01_00063        YRAIDVGASGLVELEVDPAWKDLEVVDSIKEEKENDTCNCKTTSLKTFVQKIVEPINAIR 660 
F5_00952           YRAIDVGASGLVELEVDPAWKDLEVVDSIKEEKENDTCNCKTTSLKTFVQKIVEPINAIR 660 
JCM3724_00851      YRAIDVGASGLVELEVDPAWKDLEVVDSIKEEKENDTCNCKTTSLKTFVQKIVEPINAIR 660 
                   *:***:*******:***********  .::* *: . ..*. ::::.**::*.:*:***: 
 
 
JCM3718_01643      GYDLPVSAFNGYEDGTFENGTSAFEKRGVAVDVPLWDSTKCIQCNQCSYVCPHAVIRPFL 720 
F1_00215           GYDLPVSAFMGREDGTFENGTASFEKRGVAVEVPEWIADNCIQCNQCSYVCPHAAIRPFL 717 
Aru01_00063        GYDLPVSAFMGREDGTFENGTASFEKRGVAVEVPEWIADNCIQCNQCSYVCPHAAIRPFL 720 
F5_00952           GYDLPVSAFMGREDGTFENGTASFEKRGVAVEVPEWIADNCIQCNQCSYVCPHAAIRPFL 720 
JCM3724_00851      GYDLPVSAFMGREDGTFENGTASFEKRGVAVEVPEWIADNCIQCNQCSYVCPHAAIRPFL 720 
                   ********* * *********::********:** * : :**************.***** 
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JCM3718_01643      VSEEEKAASPVAFDTLKAMGKGLDGLTYRIQVSPLDCVGCGSCVNVCPAPGKAITMQPIA 780 
F1_00215           ITEEEKKASPVEFVTKKAVGKGLEDVNYRIQVTPLDCVGCGSCVNVCPAPGKALIMKPIA 777 
Aru01_00063        ITEEEKKASPVEFVTKKAVGKGLEDVSYRIQVTPLDCVGCGSCVNVCPAPGKALIMKPIA 780 
F5_00952           ITEEEKKASPVEFVTKKAVGKGLEDVSYRIQVTPLDCVGCGSCVNVCPAPGKALIMKPIA 780 
JCM3724_00851      ITEEEKKASPVEFVTKKAVGKGLEDVSYRIQVTPLDCVGCGSCVNVCPAPGKALIMKPIA 780 
                   ::**** **** * * **:****:.:.*****:********************: *:*** 
 
JCM3718_01643      MSMDAEEDKKADYLFNKVEYRSNLMSIDTVKGSQFAQPLFEFHGACPGCGETPYLKAITQ 840 
F1_00215           ESLDLEEDKKASYLYTSVPYRSDRMPTSTVKGSQFSQPLFEFNGACPGCGETPYLKVISQ 837 
Aru01_00063        ESLDLEEDKKASYLYTSVPYRSDRMPTSTVKGSQFSQPLFEFNGACPGCGETPYLKVISQ 840 
F5_00952           ESLDLEEDKKASYLYTSVPYRSDRMPTSTVKGSQFSQPLFEFNGACPGCGETPYLKVISQ 840 
JCM3724_00851      ESLDLEEDKKASYLYTSVPYRSDRMPTSTVKGSQFSQPLFEFNGACPGCGETPYLKVISQ 840 
                    *:* ******.**:..* ***: *  .*******:******:*************.*:* 
 
JCM3718_01643      LFGDRMMIANATGCSSIYSGSAPATPYTTNSCGEGPSWASSLFEDNAEFGMGMHVAVEAL 900 
F1_00215           MFGDRMMVSNASGCSSVYSGSAPSTPYTKNCHGEGPAWASSLFEDNAEYGFGMHIGVEAL 897 
Aru01_00063        MFGDRMMVSNASGCSSVYSGSAPSTPYTKNCHGEGPAWASSLFEDNAEYGFGMHIGVEAL 900 
F5_00952           MFGDRMMVSNASGCSSVYSGSAPSTPYTKNCHGEGPAWASSLFEDNAEYGFGMHIGVEAL 900 
JCM3724_00851      MFGDRMMVSNASGCSSVYSGSAPSTPYTKNCHGEGPAWASSLFEDNAEYGFGMHIGVEAL 900 
                   :******::**:****:******:****.*. ****:***********:*:***:.**** 
Figure 7.13 Clustal Omega analysis of the Pyruvate synthase.  
Five isolates were studied: ARU 01 (Aru01), F1, F5, JCM 3718 and JCM 3724. The changes seen in JCM 3718 are underscored in red. An * 
(asterisk) indicates positions which have a single, fully conserved residue. A : (colon) indicates conservation between amino acids with strongly 
similar properties (conservative replacements). A . (full stop) indicates conservation between amino acids with weakly similar properties. A gap 
indicates non-conserved amino acids. 
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The results of the analysis of the Pyruvate synthase of 5 representative isolates 
showed that whilst 4 isolates, ARU 01, F1, F5 and JCM 3724 shared greater than 
99.75 % identity, JCM 3718 shared only 80 % identity with the other strains.  This 
is highlighted in Figure 7.12 where all but 2 of the 139 amino acid differences, 
which were a mixture of conservative, semi-conservative and non-conservative 
replacements) were seen only in JCM 3718.  One unique change was seen in the 
isolate F1.  One polymorphism (V or I) was seen to differentiate JCM 3718, ARU 
01 and isolate F5 from isolate F1 and JCM 3724: potentially discrimination clusters 
A and B+C.  A BLASTp search using the sequence from JCM 3718 as the 
interrogator, identified 5 subsp. necrophorum strains; BTFR-1, BTFR-2, ATTC 
51357, DJ-2 and B35 with 100 % coverage and more than 98.5 % identity.  This 
strongly suggests a significant difference in protein sequence between the two 
subspecies with respect to this protein.   
 
Figure 7.13 illustrates the Clustal Omega analysis of the DNA polymerase III 
subunit tau from 5 representative isolates.  In this case fifteen amino acid 
differences were noted, all but one of which were unique to JCM 3718; these were 
a mixture of conservative, semi-conservative and non-conservative replacements.  
A BLAST search using the sequence from JCM 3718 as interrogator identified 6 
subsp. necrophorum strains: BTFR-1, BTFR-2, DJ1, DJ2, DAB and B35 with 100 
% identity, implying the differences were subspecies specific.  One polymorphism 
(N or D) resulting in a conservative replacement differentiated JCM 3718, JCM 
3724 and F1 from ARU 01 and F5; again, discriminating cluster A from B+C.  
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JCM3718_01085      MLEEWIRKDIQKKKKSGTYLFYGEDSSRLKKAVLSFAKALCCVEEEDYYCDSCPVCRRIQ 60 
Aru01_00178        MLEEWIRKDIQKKKKSGTYLFYGEDSSRLEKAVLSFAKALCCVEEENYYCDSCPVCQRIQ 60 
F5_01504           MLEEWIRKDIQKKKKSGTYLFYGEDSSRLEKAVLSFAKALCCVEEENYYCDSCPVCQRIQ 60 
F1_00103           MLEEWIRKDIQKKKKSGTYLFYGEDSSRLEKAVLSFAKALCCVEEEDYYCDSCPVCQRIQ 60 
JCM3724_01536      MLEEWIRKDIQKKKKSGTYLFYGEDSSRLEKAVLSFAKALCCVEEEDYYCDSCPVCQRIQ 60 
                   *****************************:****************:*********:*** 
 
JCM3718_01085      KGVYADVHVLEDLDIESIREAESSFHESSYEGERKIFILPNIQDLRKESANALLKSIEEP 120 
Aru01_00178        KGVYADVHVLEHLNIEDIREAESSFHETSYEGERKIFILPNIQDLRKESANALLKSIEEP 120 
F5_01504           KGVYADVHVLEHLNIEDIREAESSFHETSYEGERKIFILPNIQDLRKESANALLKSIEEP 120 
F1_00103           KGVYADVHVLEHLNIEDIREAESSFHETSYEGERKIFILPNIQDLRKESANALLKSIEEP 120 
JCM3724_01536      KGVYADVHVLEHLNIEDIREAESSFHETSYEGERKIFILPNIQDLRKESANALLKSIEEP 120 
                   ***********.*:**.**********:******************************** 
 
JCM3718_01085      GENTFFLLWTTRKNILSTIRSRSIQVFVPRAGYQELGVSKECYEFFEGNEQDILQCLEEK 180 
Aru01_00178        GENTFFLLWTTRKNILSTIRSRSIQVFVPRAGYQELGVSKECYEFFEGNEQDILQCLEEK 180 
F5_01504           GENTFFLLWTTRKNILSTIRSRSIQVFVPRAGYQELGVSKECYEFFEGNEQDILQCLEEK 180 
F1_00103           GENTFFLLWTTRKNILSTIRSRSIQVFVPRAGYQELGVSKECYEFFEGNEQDILQCLEEK 180 
JCM3724_01536      GENTFFLLWTTRKNILSTIRSRSIQVFVPRAGYQELGVSKECYEFFEGNEQDILQCLEEK 180 
                   ************************************************************ 
 
JCM3718_01085      LDWKEHQSYKNIQKNIKEYMDTKQLSSKVKVYRSLIDFLEVKENISVAEVLWFVEELVNS 240 
Aru01_00178        LDWKEHQSYKNIQKNIKEYTDTKQIAAKIKVYQSLIDFLEVKDNISVAEVLWFVEELVNS 240 
F5_01504           LDWKEHQSYKNIQKNIKEYTDTKQIAAKIKVYQSLIDFLEVKDNISVAEVLWFVEELVNS 240 
F1_00103           LDWKEHQSYKNIQKNIKEYTDTKQIAAKIKVYQSLIDFLEVKDNISVAEVLWFVEELVNS 240 
JCM3724_01536      LDWKEHQSYKNIQKNIKEYTDTKQIAAKIKVYQSLIDFLEVKDNISVAEVLWFVEELVNS 240 
                   ******************* ****:::*:***:*********:***************** 
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JCM3718_01085      PCERKDFARLFHYCLLQDRYQGKIEEKLLLSKMLNFPINNKVLFANLFLK 290 
Aru01_00178        PCERKDFARLFHYCLLQARYQGKMEEKLLLSKMLNFPINNKVLFANLFLK 290 
F5_01504           PCERKDFARLFHYCLLQARYQGKMEEKLLLSKMLNFPINNKVLFANLFLK 290 
F1_00103           PCERKDFARLFHYCLLQARYQGKMEEKLLLSKMLNFPINNKVLFANLFLK 290 
JCM3724_01536      PCERKDFARLFHYCLLQARYQGKMEEKLLLSKMLNFPINNKVLFANLFLK 290 
                   ***************** *****:************************** 
                     
Figure 7.14 Clustal Omega analysis of the DNA polymerase III subunit tau.  
Five isolates were analysed, ARU 01 (Aru01), F1, F5, JCM 3718 and JCM 3724. An * (asterisk) indicates positions which have a single, fully 
conserved residue. A : (colon) indicates conservation between amino acids with strongly similar properties (conservative replacements). A . (full 
stop) indicates conservation between amino acids with weakly similar properties. A gap indicates non-conserved amino acids.  Individual amino 
acid changes are highlighted in red.  
 
 
 
 
JCM3718_00247      MKIEFLDGNVQEFQEACNMFVIAKSISNSLAKKAVAAKIDGELYDMSYILDHDAKVEFIM 60 
Aru01_01113        MKIEFLDGNVQEFQEACNMFVIAKSISNSLAKKAVAAKIDGELYDMSYILDHDAKVEFIM 60 
F5_00354           MKIEFLDGNVQEFQEACNMFVIAKSISNSLAKKAVAAKIDGELYDMSYILDHDAKVEFIM 60 
F1_01307           MKIEFLDGNVQEFQEACNMFVIAKSISNSLAKKAVAAKIDGELYDMSYILDHDAKVEFIM 60 
JCM3724_01407      MKIEFLDGNVQEFQEACNMFVIAKSISNSLAKKAVAAKIDGELYDMSYILDHDAKVEFIM 60 
                   ************************************************************ 
 
JCM3718_00247      PESEEGVEVIRHSAAHLMAQAVIRLFPGTKVTIGPSIENGFYYDFDPKEQFTEEDLLKIE 120 
Aru01_01113        PESEEGVEVIRHSAAHLMAQAVIRLFPGTKVTIGPSIENGFYYDFDPKEQFTEEDLLKIE 120 
F5_00354           PESEEGVEVIRHSAAHLMAQAVIRLFPGTKVTIGPSIENGFYYDFDPKEQFTEEDLLKIE 120 
F1_01307           PESEEGVEVIRHSAAHLMAQAVIRLFPGTKVTIGPSIENGFYYDFDPKEQFTEEDLLKIE 120 
JCM3724_01407      PESEEGVEVIRHSAAHLMAQAVIRLFPGTKVTIGPSIENGFYYDFDPKEQFTEEDLLKIE 120 
                   ************************************************************ 
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JCM3718_00247      EEMKKLSKEDIKVERFMMSREEAIEYFEKLGEHYKVEIIKDIAKGEQLSFYRQGEFVDLC 180 
Aru01_01113        EEMKRLSKEDIKVERFMMSREEAIEYFEKLGEHYKVEIIKDIAKGEQLSFYRQGEFVDLC 180 
F5_00354           EEMKRLSKEDIKVERFMMSREEAIEYFEKLGEHYKVEIIKDIAKGEQLSFYRQGEFVDLC 180 
F1_01307           EEMKRLSKEDIKVERFMMSREEAIEYFEKLGEHYKVEIIKDIAKGEQLSFYRQGEFVDLC 180 
JCM3724_01407      EEMKRLSKEDIKVERFMMSREEAIEYFEKLGEHYKVEIIKDIAKGEQLSFYRQGEFVDLC 180 
                   ****:******************************************************* 
 
JCM3718_00247      RGPHVPSTGHIKAIKLKSVAGAYWRGDSKNKMLQRIYGYAFATEKDLKDFLQLMEEAEKR 240 
Aru01_01113        RGPHVPSTGHIKAIKLKSVAGAYWRGDSKNKMLQRIYGYAFATEKDLKDFLKLMEEAEKR 240 
F5_00354           RGPHVPSTGHIKAIKLKSVAGAYWRGDSKNKMLQRIYGYAFATEKDLKDFLKLMEEAEKR 240 
F1_01307           RGPHVPSTGHIKAIKLKSVAGAYWRGDSKNKMLQRIYGYAFATEKDLKDFLKLMEEAEKR 240 
JCM3724_01407      RGPHVPSTGHIKAIKLKSVAGAYWRGDSKNKMLQRIYGYAFATEKDLKDFLKLMEEAEKR 240 
                   ***************************************************:******** 
 
JCM3718_00247      DHRKLGKELELFFLSEYGPGFPFFLPKGMVLRNTLIDLWRAEHEKAGYVQIDTPIMLNRE 300 
Aru01_01113        DHRKLGKELELFFLSEYGPGFPFFLPKGMVLRNTLIDLWRAEHEKAGYVQIDTPIMLNRE 300 
F5_00354           DHRKLGKELELFFLSEYGPGFPFFLPKGMVLRNTLIDLWRAEHEKAGYVQIDTPIMLNRE 300 
F1_01307           DHRKLGKELELFFLSEYGPGFPFFLPKGMVLRNTLIDLWRAEHEKAGYVQIDTPIMLNRE 300 
JCM3724_01407      DHRKLGKELELFFLSEYGPGFPFFLPKGMVLRNTLIDLWRAEHEKAGYVQIDTPIMLNRE 300 
                   ************************************************************ 
 
JCM3718_00247      LWEISGHWFNYRENMYTSSIDDVDFAIKPMNCPGGVLAFKYQQHSYRDLPARVAELGKVH 360 
Aru01_01113        LWEISGHWFNYRENMYTSSIDDVDFAIKPMNCPGGVLAFKYQQHSYRDLPARVAELGKVH 360 
F5_00354           LWEISGHWFNYRENMYTSSIDDVDFAIKPMNCPGGVLAFKYQQHSYRDLPARVAELGKVH 360 
F1_01307           LWEISGHWFNYRENMYTSSIDDVDFAIKPMNCPGGVLAFKYQQHSYRDLPARVAELGKVH 360 
JCM3724_01407      LWEISGHWFNYRENMYTSSIDDVDFAIKPMNCPGGVLAFKYQQHSYRDLPARVAELGKVH 360 
                   ************************************************************ 
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JCM3718_00247      RHEFSGALHGLFRVRAFTQDDSHIFMTEEQIESEIIGVVNLIDKFYSKLFGFQYSIELST 420 
Aru01_01113        RHEFSGALHGLFRVRAFTQDDSHIFMTEEQIESEIIGVVNLIDKFYSKLFGFQYSIELST 420 
F5_00354           RHEFSGALHGLFRVRAFTQDDSHIFMTEEQIESEIIGVVNLIDKFYSKLFGFQYSIELST 420 
F1_01307           RHEFSGALHGLFRVRAFTQDDSHIFMTEEQIESEIIGVVNLIDKFYSKLFGFQYSIELST 420 
JCM3724_01407      RHEFSGALHGLFRVRAFTQDDSHIFMTEEQIESEIIGVVNLIDKFYSKLFGFQYSIELST 420 
                   ************************************************************ 
 
JCM3718_00247      RPEKSIGTDEIWEKAEAALAGALHHLGREFKINEGDGAFYGPKLDFKIKDAIGRTWQCGT 480 
Aru01_01113        RPEKSIGTDEIWEKAEAALAGALHHLGREFKINEGDGAFYGPKLDFKIKDAIGRTWQCGT 480 
F5_00354           RPEKSIGTDEIWEKAEAALAGALHHLGREFKINEGDGAFYGPKLDFKIKDAIGRTWQCGT 480 
F1_01307           RPEKSIGTDEIWEKAEAALAGALHHLGREFKINEGDGAFYGPKLDFKIKDAIGRTWQCGT 480 
JCM3724_01407      RPEKSIGTDEIWEKAEAALAGALHHLGREFKINEGDGAFYGPKLDFKIKDAIGRTWQCGT 480 
                   ************************************************************ 
 
JCM3718_00247      IQLDFNLPERFDVTYVGEDGEKHRPVMIHRVIYGSIERFIGILIEHYAGAFPMWLAPVQI 540 
Aru01_01113        IQLDFNLPERFDVTYVGEDGEKHRPVMIHRVIYGSIERFIGILIEHYAGAFPMWLAPVQI 540 
F5_00354           IQLDFNLPERFDVTYVGEDGEKHRPVMIHRVIYGSIERFIGILIEHYAGAFPMWLAPVQI 540 
F1_01307           IQLDFNLPERFDVTYVGEDGEKHRPVMIHRVIYGSIERFIGILIEHYAGAFPMWLAPVQI 540 
JCM3724_01407      IQLDFNLPERFDVTYVGEDGEKHRPVMIHRVIYGSIERFIGILIEHYAGAFPMWLAPVQI 540 
                   ************************************************************ 
 
JCM3718_00247      KVLTINDDCVSYAKEVVEALKGQGIRAELDDRSESIGYKIREANGRYKIPMQVIIGKNEI 600 
Aru01_01113        KVLTINDDCVSYAKEIVEKLKEQGIRAELDDRSESIGYKIREANGRYKIPMQVIIGKNEI 600 
F5_00354           KVLTINDDCVSYAKEIVEKLKEQGIRAELDDRSESIGYKIREANGRYKIPMQVIIGKNEI 600 
F1_01307           KVLTINDDCVSYAKEIVEKLKEQGIRAELDDRSESIGYKIREANGRYKIPMQVIIGKNEI 600 
JCM3724_01407      KVLTINDDCVSYAKEIVEKLKEQGIRAELDDRSESIGYKIREANGRYKIPMQVIIGKNEI 600 
                   ***************:** ** ************************************** 
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JCM3718_00247      EKREVNIRRFGSQAQESMDLNAFLSLVVEEAKIRFQD 637 
Aru01_01113        EKKEVNIRRFGSQAQESMDLNAFLAMVKEEAKIRFQE 637 
F5_00354           EKKEVNIRRFGSQAQESMDLNAFLAMVKEEAKIRFQE 637 
F1_01307           EKQEVNIRRFGSQAQESMDLNAFLAMVKEEAKIRFQD 637 
JCM3724_01407      EKQEVNIRRFGSQAQESMDLNAFLAMVKEEAKIRFQD 637 
                   **:*********************::* ********: 
 
 
Figure 7.15 Clustal Omega analysis of Threonine--tRNA ligase 2.  
Five isolates were investigated: ARU 01 (Aru01), F1. F5, JCM 3718 and JCM 3724
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The analysis of the Threonine--tRNA ligase 2 (Figure 7.14) showed that ARU 01 
and F5 shared 100 % identity, likewise, JCM 3724 shared 100 % identity with F1 
and greater than 99.6 % identity with ARU 01 and F5; JCM 3718 shared about 
98.5 % identity with each of the other isolates.  JCM 3718 had 8 unique amino 
acid changes, 3 of which were non-conservative, and one polymorphism (K or Q) 
was noted to differentiate ARU 01 and F5 from JCM 3724 and F1, potentially 
discriminating cluster A from B+C; at the same site JCM 3718 had a different 
amino acid (R).  The sequence of JCM 3718 was used in a BLASTp search as 
interrogator and detected 6 isolates with 100 % identity; the subsp. necrophorum 
strains BL.  BTFR-1, 2 with no recorded speciation and 2 subsp. necrophorum 
suggesting the differences seen were likely to be subspecies specific. 
 
 Discussion 
      
Whole genome sequencing (WGS) was not an original aim, but during the project 
the cost of WGS significantly dropped to the point at which it was more cost 
effective to sequence whole genomes than to sequence individual genes.  Hence, 
whole genome sequencing was performed on the type culture strains JCM 3718, 
JCM 3724, ARU 01 and 17 clinical isolates.  The data was combined with all data 
available in databases (this included F. necrophorum, Fusobacteria sp. (not 
speciated) and other authenticated Fusobacterial species) and analysed by Dr 
Lesley Hoyles (see acknowledgment).  
 
One of the clinical isolates in this study, F88, was shown to resemble 
Fusobacterium hwasookii, the four subspecies of Fusobacterium nucleatum, 
Fusobacterium periodonticum, Fusobacterium massiliens and Fusobacterium 
russii rather than F. necrophorum.  Although it shared 99.3 % sequence similarity 
(1458 nt) with Fusobacterium simiae, further analysis was hampered by the lack 
of whole genome sequence data for a reference strain.  This issue had not been 
detected in biochemical tests or by microbesNG; the isolate was removed from 
the dataset.  This highlights the value of WGS in speciation.  Within the genomes, 
contaminants were identified, for example in isolate F80, by analysis of the 
Fusobacterium necrophorum assemblies against the nt (NCBI non-redundant 
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nucleotide) database (created 3 March 2018) of Centrifuge 1.0.3.  Any potentially 
contaminated data was removed from the dataset.  In this way, all the data 
generated in the current project and that harvested from databases was 
authenticated prior to further analyses. 
 
The analyses of the selected, authenticated 49 genomes of F. necrophorum  
demonstrated the presence of  1053 core genes (present in ≥ 99 % – 100 % of 
strains), 276 soft core genes (present in ≥ 95 % – < 99 % of strains), 1359 shell 
genes (present in ≥15 % – < 95 % of strains) and 4131 cloud genes (present in 0 
– <15 % of strains); a total of 6819 genes were detected.  An analysis of the core 
genes detected 37436 SNPs.  As expected, based on sub-speciation analysis, 
most of the strains clustered with the type strain of Fusobacterium necrophorum 
subsp. funduliforme; these shared 1253 core genes and 4412 accessory genes. 
The clinical isolates sequenced as part of this project, with the e xception of F88 
and F80 were authenticated as Fusobacterium necrophorum subsp. funduliforme. 
Strains DAB, BFTR-1, BFTR-2, DJ-1, DJ-2 and BL clustered with JCM 3718, the 
type strain of Fusobacterium necrophorum subsp. necrophorum; these shared 
1540 core genes and 1794 accessory genes.  The sub-speciation was confirmed 
by PCA of accessory genes present. Interestingly, PCA of the accessory genes of 
Fusobacterium necrophorum subsp. funduliforme revealed there to be three 
clusters, A, B and C, within the subspecies.  Cluster A contained the type strain of 
Fusobacterium necrophorum subsp. funduliforme (JCM 3724) and isolates F1, 
F21, F39, F40, F70, F1314, LS_1291, F1353 and LS_1264, while Cluster B 
contained isolates F24, F87, Fnf 1007, LS_1195, F1267, F1285, F1250, LS_1260, 
F1330, F1365, F1309, P1_LM and P1_CP; cluster C was more diffuse.  Each 
cluster had its own unique genes whilst all three shared 790 core genes.  
 
The relevance of these clusters to pathogenicity, clinical profile, 
ecological/environmental niche or geographical location has yet to be explored.  
One of the preliminary aims was to define differences between the Lemierre’s 
strain and less pathogenic isolates.  From the genomic data presented thus far, 
ARU 01 clustered with 5 clinical isolates F11, F30, F42, F52 and F87 whilst at the 
protein level, it was found in cluster B+C along with the majority of clinical isolates.  
At the start of 2019, the whole genome sequences of two further Lemierre’s 
isolates became available; a limited analysis (data not shown) showed one 
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belonged to cluster A whilst the other belonged to cluster B+C (Lyster et al., 2019); 
this suggested that Lemierre’s disease was not simply a product of a distinct, more 
virulent strain.  The availability of the two new Lemierre’s strains should enable a 
more in-depth comparative analysis that may reveal new insights.  
 
For the clinical isolates collected in this study no clinical data was available; except 
that these were from throat swabs of patients with persistent sore throats. 
Similarly, many of the sequences lodged in databases do not have further 
available information.  Clearly at the genomic level there is scope for more in-
depth research; this was outside the timescale of the current project.  It was 
obvious that there were significant differences between subsp. necrophorum and 
funduliforme that could be used to develop a new, robust assay for identification 
of the two sub-species.  The relevance of the 3 clusters of F. necrophorum subsp 
funduliforme is yet to be determined, but it would be profitable to review these for 
the presence/absence of known or potential virulence genes.  Although the three 
Fusobacterium necrophorum subsp. funduliforme clusters (A, B and C) shared 
790 core genes, each cluster had its own unique genes (Figure 7.8); this would 
enable targeted assays to be developed.  However, in a clinical environment, 
techniques reliant on the presence/absence of genes may be prone to 
misinterpretation whilst those based on sequence variations within a gene, or a 
number of genes would be more reliable. 
 
 
A small study of the outcome of non-synonymous SNPs, on protein sequences, 
was undertaken to understand the impact on protein structure and, potentially, 
function.  The alignment of LpxI sequences showed 3 distinct clusters of isolates; 
based on analysis of 10 polymorphic sites, F. necrophorum subsp. funduliforme 
isolates F1, F21, F39, F40, F62, F 70, 05310, B35. JCM 3724, WP1(ATCC 51357) 
formed one cluster defined at the genomic level as cluster A: F5, F11, F24, F30, 
F42, F52, ARU 01, F59, F80, F86, F87, WP2 the second cluster defined as 
clusters B+C at the genomic level  and  a cluster of the F. necrophorum subsp 
necrophorum  isolates JCM 3718 and WP3 (DAB, BFTR-1, DJ-1, BFTR-2, DJ-2). 
The subsp. necrophorum cluster had two unique changes and then shared 8 of 
10 sites with the cluster B+C and 2 with cluster A.  From the data, clusters B and 
C could not be separated.  Only one of the polymorphisms caused a change that 
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could affect the active site of the enzyme; further in silico and biochemical studies 
need to be performed to assess the effect. 
 
In contrast, in an analysis of a small portion of the Leukotoxin protein, the amino 
acid sequence of JCM 3718 and other subsp. necrophorum isolates were 
significantly different from the subsp. funduliforme isolates.  These differences 
included non-conservative amino acid changes that could affect both protein 
structure and function.  Two clusters, A [F1, F21, F39, F40 and JCM 3724], and 
B+C [F5, F11, F24, F30, F42, F52 and ARU 01] that were differentiated based on 
the analysis of 65 non-synonymous SNPs were noted; identical to those obtained 
for LpxI.  These results suggest that the two subsp. funduliforme clusters (A and 
B+C) split and diverged and that all strains/isolates represented today are derived 
from 2 original variants.  The amino acid differences included non-conservative 
amino acid changes that could affect both protein structure and function.  Further 
studies are required to determine the likely impact of these polymorphisms on the 
function of this known virulence factor.  The conservation of 65 polymorphisms in 
the two subsp. funduliforme clusters is suggestive of 2 evolutionary distinct strains. 
 
In the 900 amino acids of Pyruvate kinase 139 amino acid polymorphisms were 
seen; of these, all but 2 were unique to subspecies necrophorum re-iterating the 
differences between the two subspecies.  These were a mixture of conservative, 
semi-conservative and non-conservative amino acid replacements.  The subsp. 
funduliforme isolates shared 99.75 % identity and only one polymorphism (V or I; 
a conservative replacement) was seen to differentiate JCM 3718, ARU 01 and 
isolate F5 (cluster B+C) from isolate F1 and JCM 3724 (cluster A).  By contrast, 
analysis of the Galactose binding periplasmic protein highlighted only 6 amino 
acid differences, all conservative replacements, of which 4 were unique to the 
subsp. necrophorum.  The Elongation factor Tu was also highly conserved with 
only one conservative amino acid change (R to K) in JCM 3718.  
 
Due to the degenerate nature of the genetic code, many genetic polymorphisms 
do not result in a change in the encoded amino acid: synonymous SNPs.  Amino 
acid conservation may be of greater importance in those proteins whose presence 
is vital to the functioning of the organism, however, care should be taken to 
determine their likely impact; changes that impact on protein structure or affect the 
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active site/binding site of a protein are more likely to be deleterious.  Most of the 
non-synonymous changes that differentiated the subsp. funduliforme isolates 
involved amino acids of similar properties unlikely to impact structure or function.  
However, those differentiating the two subspecies, funduliforme and necrophorum 
were a mixture of conservative, semi-conservative and non-conservative 
replacements. 
 
The similarity between the encoded proteins in JCM 3724 and the clinical isolates  
F1, F21, F39, F40 is of interest as the type strain was originally isolated from a 
bovine liver abscess in 1985 (https://www.jcm.riken.jp/cgi-bin/jcm/jcm number 
?JCM=3724) whereas the clinical samples were collected from patients with 
recurrent sore throats  within the last decade.  The conservation of 65 non-
synonymous SNPs in the portion of the Leukotoxin protein suggests a strong 
relationship between these strains: further research could reveal the dynamics of 
their evolution. 
 
Of course, there are many more changes seen at the genomic than at the protein 
level as synonymous SNPs, including those involving the third nucleotide of a 
codon that do not change the encoded amino acid, are not represented in the 
protein studies.  Organisms also have a codon bias and hence a change from a 
codon to one not, or rarely used by the organism could result in either a reduction 
in transcription or no transcription at all leading to lower levels of proteins or fore-
shortened proteins (Sharp and Li, 1987).  Although from a functional standpoint 
the impact of non-synonymous SNPs on amino acid sequence has been thought 
to be key, synonymous SNPs may change mRNA structure and stability (Kudla et 
al., 2009; Goodman et al., 2013; Firnberg et al., 2014), alter protein or nucleic acid 
binding sites (Li et al., 2012), increase or decrease the rate of translation 
(Sørensen and Pedersen, 1991) and impact protein folding and solubility (Rosano 
and Ceccarelli, 2009; Zhang et al., 2009).  Indeed, Agashe et al., (2016) were able 
to demonstrate that synonymous SNPs in the fae gene of Methylobacterium 
extorquens decreased both enzyme production and organism fitness.  Genetic 
engineering of point mutations in the N-terminal region of the gene (including four 
synonymous mutations) impacted transcription levels, enzyme production, and/or 
enzyme activity.  
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There is much future work required to determine the impact of both the 
synonymous and non-synonymous SNPs on the functioning of F. necrophorum. 
Clearly the genomic data is a valuable resource for future work.  In chapter 8, 
analysis of the data generated was used to unravel the biochemical pathways 
involved in sialic acid uptake/metabolism/catabolism/cell surface expression, in F. 
necrophorum.  
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Chapter 8  
 
8 Sialylation pathways in F. necrophorum; the utility of in silico analysis 
of WGS data 
 Introduction 
The processes involved in sialic acid utilisation can be broken down into uptake, 
de novo synthesis, polysialic acid (PSA) capsule biosynthesis and export, O-
acetylation, LPS sialylation, surface expression and catabolism (Figure 8.1); 
organisms may possess none, some or all of these processes.  Sialic acid 
metabolism and surface expression is complex with some organisms able to 
scavenge sialic acid from the host: in human blood the concentration of free sialic 
acid is 16 mg/L (Uslu et al., 2003).  In biofilms, production of sialidases by one 
partner frees sialic acids from host glycoconjugates that can be utilised by other 
partners.  Swords et al., (2004) demonstrated that Haemophilus influenzae 
scavenged sialic acids from the environment that it then was able to use to 
sialylate lipooligosaccharides (LOS).  Growth in a sialic acid fee medium resulted 
in significant reduction of cell surface expression of sialic acid and a decrease in 
biofilm formation.  The data supported the hypothesis that sialylated LOS 
glycoforms promote biofilm formation and persistence in vivo. 
In 2014, Yoneda et al.,  demonstrated that F. nucleatum could both catabolise and 
synthesise sialic acid.  They concluded that surface sialylation was a general 
ability of F. nucleatum and F. periodonticum, the two major fusobacterial species 
in the oral cavity whereas sialic acid catabolism was probably minimal.  They 
reported that the FN1470 – FN1476 operon encoded the nan operon: this 
comprised specific TRAP transporters (FN1472 and FN1473), the catabolic 
enzymes NanA, K, and E (FN1474– FN1476), an operon transcription regulator 
(FN1471) and a sialic acid mutarotase NanM (FN1470) that facilitated the 
transport of exogenous sialic acid.  
Although the nan operon responded to the addition of exogenous sialic acid, the 
authors suggested that sialic acid probably did not play a major role in energy 
generation.  Consistent with evidence of cell surface sialylation, albeit patchy in 
nature, the authors identified the FN1682 – FN1686 operon as the neu operon 
responsible for de novo sialic acid synthesis; this contained genes with roles in 
lipopolysaccharide (LPS) synthesis/modification.  The neu operon contained a 
candidate neuB orthologue (FN1684), a gene encoding a protein with both NeuA 
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and NeuB domains (FN1686) and at least two other genes with predicted roles in 
LPS or cell surface modification.  There was no candidate for neuC in this operon; 
this suggests that de novo sialic acid synthesis in F. nucleatum would require 
either an alternative source of N-acetylmannosamine (ManNAc) or a novel UDP-
N-acetylglucosamine 2-epimerase with little homology to NeuC orthologs.  
Nevertheless, this work did suggest that, F. nucleatum subsp. nucleatum was 
capable of both sialic acid catabolism and synthesis. 
 
 
 
 
.  
 
 
 
 
 
 
 
 
 
  Figure 8.1 Overview of the major pathways for sialic acid utilization in  
  bacterial pathogens.  
This figure summarizes the major pathways and mechanisms discussed in 
https://mic.microbiologyresearch.org/content/journal/micro/10.1099/mic.0.2007/009480-
0#tab2 (see text for a description of each pathway) Sialic acid is shown as Neu5Ac. The light-
green dotted line represents the pathways (mostly not defined) by which the LPS is exposed 
on the outer membrane. Abbreviations: IM, inner membrane; OM, outer membrane; 
Neu5Ac, N-acetylneuraminic or sialic acid; ManNAc, N-acetylmannosamine; GlcNAc, N-
acetylglucosamine; GlcN, glucosamine; Fru, fructose; PSA, polysialic acid; PEP, 
phosphoenolpyruvate; Lst, Neisseria LPS sialyltransferase; NanC,  Neu5Ac-specific porin; 
Kps, E. coli PSA capsule export system; SatABCD, H. ducreyi Neu5Ac ABC (ATP-binding 
casstte) transporter; SiaPQM, Neu5Ac TRAP (tripartite ATP-independent periplasmic) 
transporter; NanT, Neu5Ac transporter; SiaB and NeuA, respectively  CMP-Neu5Ac 
synthetases /deacetylase; Lic3A, Lic3B sialyltransferases; SOAT,  Neu5Ac O-
acetyltransferase; NeuC,  UDP-GlcNAc 2-epimerase; NeuB, Neu5Ac synthase; 
NeuS,  polysialyltransferase; NeuO, PSA O-acetyltransferase; NeuD, Neu5Ac O-
acetyltransferase; NanA, Neu5Ac aldolase; NanK, ManNAc kinase; NanE, ManNAc-6P 
epimerase; NagB, GlcNAc-6P deacetylase; NagA, GlcN-6P deaminase.  
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In 2016, Lewis and colleagues performed bioinformatics analysis on 31 genomes 
to determine whether de novo sialic acid synthesis was conserved amongst all  
four subspecies of F. nucleatum (animalis, nucleatum, vincentii and 
polymorphum).  NeuA, NeuB and NeuC amino acid sequences from strain F. 
nucleatum subsp. polymorphum ATCC10953 and relevant sequences from E. coli 
were used to interrogate the translated proteins encoded by fusobacterial 
genomes using BLASTP.  Two of four strains of subsp. polymorphum possessed 
all three enzymes needed for de novo sialic acid synthesis (encoded by neuA, 
neuB and neuC).  Two of the six strains ssp vincentii encoded genes required for 
de novo sialic acid synthesis that were nearly identical to those found in the ssp 
polymorphum strains.  Of the remaining strains, several encoded one or more 
putative homologues of these enzymes; their amino acid sequences shared 
limited identity to those of F. nucleatum ATCC10953 or E. coli UTI89 pathways. 
However, in a number of sequenced strains there was no evidence that a 
complete sialic acid pathway existed.  High performance liquid chromatography 
(HPLC) and mass spectrometry demonstrated that high levels of Neu5Ac were 
produced by F. nucleatum subsp. polymorphum ATCC10953.  The authors 
hypothesised that sialic acids were used by F. nucleatum to evade the immune 
system and could aid dissemination through the host bloodstream.  
In 2017, Vinogradov et al.,  isolated lipopolysaccharide from F. nucleatum strain 
10953 and identified a trisaccharide repeating unit of the O-antigen with the 
following structure:    
where Ac indicates 4-N-acetylation of ∼30% FucNAc4N residues. 
 
Additionally, they showed, using a chemical stain-based methodology that, in a 
bacterial smear, some but not all the F. nucleatum cells expressed cell surface 
sialic acid.  
 The aims of this study were to: 
1. determine, using bioinformatics the likely biosynthetic pathways for sialic 
catabolism, sialylation and de novo synthesis in F. necrophorum and a range 
of other Fusobacterium sp. 
2. investigate any polymorphisms that could be associated with 
virulence/pathogenicity. 
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As little was known about sialic acids in F. necrophorum, research was undertaken 
to understand the metabolic pathways concerned.  Although no information was 
available on sialic acid catabolism or de novo synthesis in F. necrophorum, the 
work presented in chapter 5 suggested that sialic acid was present both on the 
cell surface and intracellularly.  A comparative study of sialic acid pathways was 
undertaken using sequences derived in the current study (chapter 7, section 7.2.1) 
and those lodged in available databases.  
 
 Methods 
To identify candidate proteins, amino acid sequences were downloaded from 
Uniprot; identification was by gene or protein name.  BLASTP searches were 
performed to verify protein identity.  Genomic data was generated as described in 
chapter 7, section 7.2.1.  Searches of the translated protein sequences were 
performed manually using search terms such as gene name, protein name and/or 
conserved amino acid sequences. 
For the generation of Table 8.2, annotated amino acid sequence data (from 
microbesNG) were interrogated using gene names, enzyme names or short 
segments of conserved sequences (see table for details). 
 
 Results 
8.3.1 Interrogation of the Uniprot database  
The Uniprot database (www.uniprot.org) for Fusobacterium necrophorum was 
interrogated using gene and enzyme names and/or conserved amino acid motifs 
and candidate proteins were subjected to BLASTP analysis to check identity. 
Whilst nanA, nanE, nanK, nanT, nagA, nagB, neuA, siaA, siaP, siaT and MurJ 
were identified; neuB, neuC, neuD and, neuS were absent (Table 8.1).   
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Table 8.1 Candidate proteins for sialic acid pathways of F. necrophorum 
 
Gene F. necrophorum 
candidate 
Enzyme specificity  
nanA A0A017H2Y7 N-acetylneuraminate lyase 
nanE A0A017H4J6 N-acetylmannosamine-6-phosphate 2-
epimerase 
nanK A0A162IIB5 N-acetylmannosamine kinase 
nanM A0A2X3KQ65 N-acetylneuraminate epimerase 
nanT No candidate Sialic acid transporter 
nagA J5TYX7 N-acetylglucosamine-6-phosphate 
deacetylase 
nagB A0A017H7C7 Glucosamine-6-phosphate deaminase 
neuA A0A2X3MEE5 N-acylneuraminate cytidylyltransferase 
neuB No candidate N-acetyl neuramic acid synthetase 
neuC No candidate UDP-N-acetyl-D-glucosamine 2-epimerase 
neuS No candidate Poly-alpha-2,8 sialosyl sialyltransferase 
siaA A0A017H790 Lipooligosaccharide sialyltransferase 
SiaP J5W387 Sialic acid-binding periplasmic protein 
SiaT J5U0J4 Sialic acid TRAP transporter, permease 
protein 
murJ(mviN ) J5W1X4 Lipid II flippase 
 
 
Lewis et al., (2016) had demonstrated probable de novo synthesis of sialic acids 
in some isolates of F. nucleatum, the information in that paper was used to 
highlight genes utilised by F. nucleatum to synthesise sialic acid.  Each protein 
sequence was retrieved from Uniprot, subjected to BLASTP to verify identity and 
was then used to interrogate the F. necrophorum proteome.  Potential 
homologues were then subjected to BLASTP to verify identity.  The results (Table 
8.1) showed that two key enzymes for de novo synthesis, NeuB and NeuC, were 
not present in the F. necrophorum sequences available on Uniprot.  In the case of 
NeuB, BLASTP identified as the closest match a hypothetical protein with 27 % 
identity with only 12 % coverage.  This protein had homologues (30 %) only in 
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Fusobacterium sp.  In the case of NeuC, UDP-N-acetyl-D-glucosamine 2-
epimerase, the only match detected was to an unrelated enzyme, nucleotidyl 
transferase, with 34 % identity 13 % coverage.  This nucleotidyl transferase was 
similar (40 %) to nucleotidyl transferases in other bacteria.  Thus, there was no 
compelling evidence for de novo sialic acid synthesis.  However, based on the 
bioinformatics data collected from Uniprot, F. necrophorum possessed the genes 
required for scavenging and catabolising sialic acid, LPS sialylation and 
expression on the cell surface; Figure 8.2 shows the proposed pathway for sialic 
acid utilisation in F. necrophorum. 
 
 
Figure 8.2 Proposed major pathways for sialic acid utilization  
in F. necrophorum. 
 
Subsequent to this primary study, novel genome data was generated from a range 
of clinical and type strains of F. necrophorum (see Chapter 7 section 7.2.7), this 
was combined with available data on Fusobacterium sp.  The translated gene 
products were interrogated for the presence/absence of enzymes/proteins 
required for sialic acid uptake, catabolism, metabolism, sialylation of LPS and 
transfer to the cell surface.  The data was interrogated, by keywords or sequence, 
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for the presence/absence of SiaA (lipo-oligosaccharide sialyltransferase), NagA 
(N-acetylglucosamine-6-phosphate deacetylase), NagB (glucosamine-6 
phosphate deaminase), NeuA (N-acylneuraminate cytidylyltransferase), NeuB (N-
acetyl neuramic acid synthetase), NeuC (UDP-N-acetyl-D-glucosamine 2-
epimerase), NanA (N-acetylneuraminate lyase), NanE(N-acetylmannosamine-6-
phosphate 2-epimerase) NanK (N-acetylmannosamine kinase (annotated as 
glucoside kinase in the data)), NanM (N-acetylneuraminate epimerase), 
NanT(Sialic acid transporter), NeuO (Polysialic acid O-acetyltransferase), NeuS 
(Poly-α -2,8 sialosyl sialyltransferase), SiaM (sialic acid TRAP transporter large 
permease protein), SiaQ (sialic acid TRAP transporter small permease protein), 
SiaT(sialic acid TRAP transporter permease protein), SiaP (sialic acid-binding 
periplasmic protein) (Table 8.1).  
 
Analysis of the data from F. necrophorum subsp. funduliforme (41 isolates) 
showed that all isolates possessed the murJ, nagA, neuA, nanA, nanE, nanK, 
nanM, siaT and siaP genes.  Almost all possessed nagB (40/41).  In most isolates 
2-4 copies of siaP and siaT were found within the genome; one copy of each gene 
was found within the operon shown in Figure 8.3.  There was no evidence for the 
presence of neuB, neuC, nanT, neuO, neuS in any of the F. necrophorum subsp. 
funduliforme isolates; most also lacked siaM (40/41) and siaQ (39/41).  The most 
obvious variation was in the presence/absence of siaA; 14 of the 41 isolates 
possessed the siaA gene.  This gene encodes an enzyme that is key in the 
sialylation of lipooligosaccharides prior to cell surface expression.  Of the two 
control strains, ARU 01 did not have the gene whilst JCM 3724 was shown to 
possess it. Of the clinical strains sequenced in the current study (see chapter 8), 
6 had the gene whilst 8 did not.  By comparison, in the F. necrophorum subsp 
necrophorum isolates there were some significant differences.  All isolates (7) had 
the murJ, nagA, nagB, nanA, nanE, siaP and siaT genes and lacked neuB, neuC, 
nanT, neuO, neuS and siaM.  Only 4/7 isolates had the neuA gene, 2/7 lacked 
nanK, and 6/7 possessed the siaQ genes.  With respect to siaA, 3/7 isolates were 
positive for this gene.  This data suggests that lipooligosaccharide sialylation, and 
hence the potential for surface expression of sialic acid in subsp. funduliforme and 
subsp. necrophorum is different, but there are also differences in some strains 
within each subspecies.  Whether there are links between virulence and sialic acid 
expression is as yet unclear.  It would have been predicted that ARU 01, the isolate 
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from the Lemierre’s case would be more virulent than those isolates from clinical 
samples from patients with persistent sore throat.  Since ARU 01 lacked siaA and 
the gene was polymorphic within the clinical isolates, 6/14 possessed the gene, 
sialic acid expression does not seem to be directly involved in virulence.  
 
An analysis (Table 8.2) of a limited range of other Fusobacterium species, F. 
equinum, F. gonidiaformans, F. hwasookii, F. mortiferum, F. naviforme, F. 
necrogenes. F. nucleaum (4 isolates), F. perfoetens, F. periodonticum, F. russii, 
F. ulcerans, and F. varium, showed that none possessed siaA, neuB or nanT.  
Only F. naviforme lacked murJ, F. naviforme and F. periodonticum lacked nagA, 
3 strains lacked nagB (F. naviforme, F. periodonticum and F. nucleatum (2 
isolates)).  Seven strains lacked neuA, two of the four F. nucleatum isolates had 
neuC, three strains (F. naviforme, F. periodonticum and one F. nucleatum isolates 
lacked nanA.  NanE was absent from 2 strains (F. equinum and F. periodonticum), 
five strains lacked nanK (F. naviforme, F. perfoetens, F. periodonticum, F. 
ulcerans, and F. varium), nanM was absent from 3 strains (F. naviforme, one 
isolate of F. nucleatum and F. periodonticum).  Neu O was present in 3 strains (F. 
hwasookii, one isolate of F. nucleatum and F. ulcerans), neuS was present in F. 
hwasookii, 2 isolates of F. nucleatum, F. perfoetens, F. periodonticum, and F. 
ulcerans.  siaM was present in F. naviforme and F. perfoetens and siaQ was found 
in F. mortiferum, F. russii, F. ulcerans, and F. varium, siaT was absent from F. 
necrogenes and siaP was absent from F. necrogenes and one isolate of F. 
nucleatum.  The data imply that sialic acid pathways are both complex and 
different in different strains, subspecies and even isolates from a single 
subspecies. 
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Table 8.2 Analysis of gene encoded proteins in sialic acid pathways  
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 (Continued from page 192.) 
Key: fund = funduliforme, necr = necrophorum, equi = equinum, gona = gonidiaformans, hwas = 
hwasookii, morti = mortiferum, navif = naviforme, nec = necrogenes. Nucl = nucleaum, perfo = 
perfoetens, perid = periodonticum, russi = russii, ulcer = ulcerans, variu = varium.  
Red=absent, green= present 
SiaA- glycosyltransferase 52 (sialyltransferase) was searched by key word and with conserved 
sequences “MKKEYIC” and “QDHMLLSYI”. NanK was searched with conserved sequences 
“FQKKIEEELQ” and “GGGII” and key words mannosamine kinase and glucoside kinase.  All other 
genes were searched by gene and protein name. 
 
 
 
An analysis of the gene organisation (Figure 8.3), demonstrated similar 
organisation, nanM- catabolite control protein A/exuR -siaP-siaT-nanK-nanA- 
nanE, in F. necrophorum (subsp. funduliforme and subsp. necrophorum), F. 
hwasookii, F. nucleatum, F. equinum and F. gonidiaformans.  The structure was 
similar in F. russii except that the tabA gene, found just outside the cluster in the 
preceding organisms, had been relocated between the nanK and nanA genes.  F. 
ulcerans had the first four genes (nanM-catabolite control protein A/exuR -siaP-
siaT) in a cluster whereas F. varium had the genes, cephalosporin-C deacetylase- 
glucokinase- tabA between siaT and nanA.  
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Figure 8.3 Comparison of the gene order in Fusobacteria sp. 
exuR = HTH-type transcriptional repressor; tabA Toxin-antitoxin biofilm protein; in other 
species this is found just outside the operon. 
 
During the study, it was noted that N, N’-diacetyllegionaminic acid synthase, was 
present in one of the F. necrophorum subsp. funduliforme isolate, 3 of 4 of the F. 
nucleatum isolates, F. varium and F. ulcerans.  This enzyme, that was originally 
isolated from Legionella pneumophila and Campylobacter jejuni, is involved in the 
biosynthesis of a sialic acid-like derivative legionaminic acid that is incorporated 
into virulence-associated cell surface glycoconjugates such as lipopolysaccharide 
(LPS), capsular polysaccharide, pili and flagella.  Clearly, this requires further 
investigation. 
 
 Discussion 
Initial work using lectins (see section 5.3.2 (Table 5.2)) suggested that sialic acid 
was present in F. necrophorum.  However, the organism does not possess a gene 
for sialidase and hence cannot cleave sialic acid from glyconjugates in the 
environment (from the host or other bacteria).  An in-depth bioinformatics study 
showed that the organism possessed nanM that encodes N-acetylneuraminate 
epimerase which converts α-N-acetylneuranimic acid (Neu5Ac) to the beta-
Gene cluster organisation; 
F. necrophorum (subsp. funduliforme and subsp. necrophorum) F. hwasookii, 
F. nucleatum, F. equinum, F. gonidiaformans; 
nanM- catabolite control protein A/ exuR -siaP-siaT-nanK-nanA- nanE;  
F. russii; 
NanM-catabolite control protein A/exuR -siaP-siaT, nanK, tabA, nanA, nanE;  
F. ulcerans; 
nanM-catabolite control protein A/exuR -siaP-siaT  
F. varium; 
nanM-catabolite control protein A/exuR -siaP-siaT- cephalosporin-C 
deacetylase- glucokinase- tabA-nanA-nanE 
F. mortiferum, F. naviforme, F. necrogenes, F. perfoetens, F. periodonticum; 
no obvious structure.  
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anomer; this has been reported to enable those bacteria that lack sialidase activity 
to compete for and take up the extracellular Neu5Ac present in the host (Severi et 
al. 2008).  There was evidence for the presence of the genes required uptake, 
catabolism and O-acetylation of sialic acids in almost all F. necrophorum 
funduliforme isolates tested: indeed, the pattern of presence/absence of genes 
was highly conserved.  The pattern was significantly different in F. necrophorum 
subsp. necrophorum; 6/7 of which had the siaQ gene that was absent in subsp. 
funduliforme, 3/7 lacked neuA that subsp. funduliforme possessed and 2/7 lacked 
nanK that was present in subsp. funduliforme.  Interestingly, the gene (siaA) 
required for sialylation of lipooligosaccharides was present in only 14/41 isolates 
of F. necrophorum subsp. funduliforme and 3/7 of the subsp. necrophorum 
isolates.  These results imply that the ability to express surface sialic acid is 
variable in isolates of Fusobacterium necrophorum; there was no obvious 
correlation between known pathogenicity, host specificity or subspecies.  A study 
of a limited number of genomes of other Fusobacterium sp. showed a much more 
diverse pattern; none had siaA whilst 9/15 possessed the neuS gene that encodes 
a polysialic acid O-acetyltransferase capable of sialylating LPS.  Two of the four 
F. nucleatum isolates had the neuC gene that would enable de novo sialic acid 
synthesis as described by Yoneda et al., (2014).  Clearly more work is required to 
unravel the complexity of sialylation, sialic acid synthesis, metabolism and 
catabolism in Fusobacterium sp. 
The importance of sialylation has been reported for a number of organisms, 
though some of the findings seem contradictory.  Vogel et al., (1999) showed, 
using an infant rat model system of meningococcal disease that LPS sialylation 
was only of minor importance for resistance of serogroup B and C to attack by 
complement.  Jones et al., (2003) investigated the recognition of meningococcal 
sialylated LPS by sialic acid binding lectins, siglecs, expressed on myeloid cells. 
Using a mouse model, they showed that bacteria with sialylated LPS were 
recognized and phagocytosed by two siglecs, Sn and siglec-5.  This suggested 
that sialylation was detrimental to the organism in meningococcal disease. 
However, in 2003,  Bouchet et al.,  reported that in capsule deficient strains of 
Haemophilus influenzae, sialylation of LPS was a significant virulence factor in 
development of otitis media in a chinchilla model.  Sialylation of LPS of H. 
influenzae was required to enable the organism to evade the innate immune 
response of the host; mutant strains with non-sialylated LPS were more sensitive 
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to killing by human serum than the sialylated strains (Severi et al., 2005). 
Sialylation of LPS of non-capsular H. influenzae has a role in biofilm formation and 
has been suggested to be important to both commensal behaviour and virulence 
(Jurcisek et al., 2005; Swords et al., 2004; Greiner et al., 2004).  This data implies 
a positive impact of sialylation.  
The presence of terminal NeuAc (sialic acid) in the O-antigen units of LPS 
produces a structure that is similar to those found in human glycosphingolipids 
and protects the bacteria from host response through molecular mimicry 
(Heikema et al., 2013; Spinola et al., 2012; Bax et al., 2011; Pawlak et al., 2017).  
Bugla-Ploskonska et al., (2010) hypothesised that sialic acid (NeuAc)-containing    
lipopolysaccharides (LPS) of Salmonella O48 strains could camouflage the 
bacterial surface from the immunological response of the host resulting in down-
regulation of complement activation.  However, their experimental results 
indicated that the presence of sialic acid in LPS did not play a major role in 
determining resistance to the bactericidal activity of complement or block the 
activation of the alternative pathway of complement; this work questioned the role 
of sialic acid in virulence.  
Zaric et al., (2017) demonstrated that highly sialylated LPS from Porphyromonas 
gingivalis had significantly lower inflammatory potential than a less sialylated form 
but that a reduction in endotoxicity was not mediated by sialic acid carried on LPS. 
They also suggested that interactions of sialylated LPS with the CD33 receptor 
were inhibited by endogenously expressed sialic acid of the host.  Further proof 
of the role of host, free sialic acid in bacterial: host interactions was demonstrated 
by Hsu et al., (2016) who showed that pre-treatment of rats with free sialic acid 
reduced the detrimental effects -induced by LPS on systemic and renal 
haemodynamics, renal ROS production and renal function, and LPS-activated 
TLR4/gp91/Caspase3 mediated apoptosis signalling.  This implies that LPS plays 
a crucial role in renal infection.  For organisms such as F. necrophorum that are 
reliant on host endogenous sialic acid or sialic acid liberated by bacterial 
sialidases to provide the building blocks for sialylation, the free sialic acid available 
would also inhibit adverse interactions of the sialylated bacteria with host lectins. 
Of course, the surface sialylation of bacteria may play an important role in 
bacteria: bacteria interaction, specifically in biofilm formation.  In a study of H. 
infuenzae in Chinchilla otitus, Jurcisek et al., (2005) suggested that 
lipooligosaccharide sialylation was indispensable in biofilm formation.  Future 
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metagenomic analyses of biofilms and subsequent pathway analyses may 
improve our understanding of the role of sialic acid. 
Given the reported role of sialic acids in pathogenicity, it was surprising that the 
results of the current study did not show significant differences between the ARU 
01 control strain that was originally isolated from a patient with Lemierre’s disease 
and the clinical isolates (from London).  However, a polymorphism was seen in 
lipooligosaccharide sialylation; ARU 01 and eight of the clinical isolates lacked 
siaA that encodes the sialyltransferase that sialylates LPS whilst the six other 
clinical isolates possessed this gene.  Analysis of the siaA of two newly reported 
isolates from the blood of Lemierre’s patients (Lyster et al., 2019) demonstrated 
that one isolate had the siaA whereas the other did not.  This polymorphism was 
seen not only in subsp. funduliforme but also subsp. necrophorum.  There were 
also differences between the two type cultures, (JCM 3724 and JCM 3718); 
sialylation was seen in JCM 3724 subsp funduliforme whilst JCM 3718 subsp. 
necrophorum lacked the gene.  It is as yet unclear why sialylation of LPS is 
polymorphic in Fusobacterium sp., or whether it plays any role in pathogenesis 
and/or biofilm formation.  Given that it was impossible to identify Lemierre’s 
isolates based on the analyses performed, there was no obvious link to 
pathogenicity; however, it is possible that sialylation could play a role in tissue 
specific adhesion/homing.  It would be important to collect and analyse new 
isolates and correlate the results with in-depth information on the isolate 
pathogenicity, location of the organism and presence co-infecting organisms using 
metagenomics.  The impact of host free sialic acid on the binding between sialic 
acid containing LPS and lectins/adhesins of the host requires further research. 
Bioinformatics does not provide proof of expression of genes and hence results 
should be couched in terms of “potential to express”; all work should be backed 
up by biochemical analyses.  
An intriguing finding of the analyses was that the F. necrophorum could be split 
into 2 clusters based on the presence or absence of siaA; these corresponded to 
the two major clusters seen in the WGS and protein analyses in chapter 7 (section 
7.3.3).  This supports the idea that there are at least 2 evolutionary distinct types 
of subsp. funduliforme. 
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Chapter 9 
 
9 General Discussion 
 
 Discussion 
The original aims of the project were to investigate biofilm formation and, to ensure 
strict growth conditions and reproducibility, this work relied heavily on the 
availability of an anaerobic cabinet in the laboratory of our collaborators.  
However, within 20 months, changes within the NHS brought about closure of that 
facility and work continued in less than ideal conditions, all work presented in the 
thesis used gas jars and mineral oil overlay to establish anerobic growth 
conditions.  Nevertheless, interesting results were obtained for the biofilm studies; 
F. necrophorum was shown to form mono and dual species biofilm and in dual 
culture the organism showed enhanced resistance to the antibiotics penicillin and 
ciprofloxacin.  Whilst F. necrophorum is considered to be easy to treat, formation 
of biofilm could lead to resistance that would endanger the patient.  In the related 
organism F. nucleatum, biofilm production is recognised to play an important role 
not only in dental plaque formation but also, in rare cases, in cardiac disease and 
colorectal cancer (reviewed by Kolenbrander, 2011; Persson and Imfeld, 2008; 
Cordero and Varela-Calviño, 2018; Brennan and Garrett, 2019).  As glycans have 
been implicated in cell adhesion between different microbes and between 
microbial and eukaryotic cells, the research was re-focused to investigate the 
potential role of glycans and lectins in biofilm formation (reviewed by Cross and 
Ruhl, 2018; Moran et al., 2011; Szymanski and Wren, 2005).  This study involved 
biochemical and molecular studies that did not require the strict growth conditions 
needed to continue the physiological biofilm work. 
A study undertaken to investigate one bacterial adhesion, the Galactose binding 
protein, showed that this protein did not bind to human red blood cells but did bind 
to desialylated sheep red blood cells.  This suggested that the specificity was to 
unsubstituted beta galactosyl residues found on many bacterial cells and supports 
a role for this lectin in biofilm formation.  This glycan is found on some types of 
eukaryotic cells, though the galactose is usually substituted with fucose or sialic 
acid residues that would preclude binding.  The lectin-based studies of the cell 
surface and cell extracts showed the presence of glucose, galactose and N-
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acetylglucosamine; although there were difficulties in visualising cell surface 
binding no significant differences were noted between the subspecies 
funduliforme and necrophorum or between the clinical isolates and the Lemierre’s 
strain ARU 01.  The results with Sambucus nigra, the lectin that detected sialic 
acid, were difficult to interpret; however, such issues had been noted with similar 
studies in F. nucleatum where “patchy and variable expression” was noted 
(Vinogradov, 2017).  Further work was then undertaken to examine key pathways 
for lipid A biosynthesis and sialic acid cell surface expression.  
Although lipidA had been described in the organism one gene, lpxH, was absent; 
all other key genes/enzymes required for lipid A synthesis were detected and 
characterised using bioinformatics.  Data mining, protein studies and molecular 
modelling were used to identify and characterise an alternative enzyme LpxI that 
had been shown to replace LpxH in Caulobacter crescentus (Metzger et al., 2012).  
However, biochemical studies were not carried out as the substrates had been 
synthesised by the authors of the paper and were not available to purchase. 
Nevertheless, it is clear that all Fusobacterium sp. utilise LpxI to complete the lipid 
A pathway.   
During the 7 years of this project, there were dramatic changes in molecular 
technologies and the accessibility and affordability of genome sequencing 
technology.  Hence, for studies of the sialic acid pathway, it was decided to 
sequence the whole genomes of the strains and isolates under study rather than 
using PCR and Sanger sequencing to investigate the genes of interest.  At the 
time of the study it was estimated that each PCR assay (with replicates) and 
subsequent gene sequencing cost £10 whereas genome sequencing cost £50 per 
genome; hence whole genome sequencing was cost-effective if more than 5 
genes were to be studied.  The genome sequencing generated far more data than 
was required, and limited genome analysis was carried out (with the help of Dr 
Lesley Hoyles).  The results highlighted significant differences between the two 
subspecies that will be used in future work to develop a simple PCR based 
identification.  More interestingly, gene analysis of the subsp. fundulifome, from 
data generated in this study and that available in databases worldwide, 
determined that the subspecies comprised 3 clusters (A, B and C): A was distinct 
from B and C which showed a close relationship to each other.  A number of 
clinical strains from the current study were found in each cluster.   
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This work was then extended to investigate the presence and impact of non-
synonymous snps on a small range of encoded proteins.  For some proteins, for 
example the Elongaton factor Tu, few amino acid replacements were seen, and 
these were conservative or semi-conserative changes unlikely to affect protein 
structure and function.  However, in other proteins there were numerous 
replacements: 65 in the case of a small part of Leukotoxin.  Based on the 
sequence data, the isolates and strains of subsp. funduliforme could be split into 
2 clusters; one corresponded to cluster A seen in the genome study whilst the 
other corresponded to clusters B and C which could not be differentiated.  Analysis 
of the alignments of the subsp necrophorum demonstrated more changes, some 
similar to cluster A, some to cluster B+C and other unique changes, many of which 
were non-conservative.  The data that was compiled from the current study and 
from data available worldwide suggested 2 major ancestral lines leading to the 
distinct clusters noted.  Future studies are required to determine whether there is 
any correlation between these clusters and bacterial pathogenesis; current 
studies suggest that the Lemierre’s strains were not differentiated from the other 
clinical isolates based on this clustering.  The recent submission of 2 new 
Lemierre’s strains to available databases will enable more in-depth studies into 
any differences between these and the clinical isolates sequenced.  It should be 
noted that a preliminary study suggested that one of the new strains was cluster 
A whilst the other was cluster B+C based on protein analysis.  
The analysis of sialic acid pathway genes in F. necrophorum demonstrated that 
all isolates and strains lacked the genes required for de novo synthesis of sialic 
acid; in agreement with the literature, these genes were found in some but not all 
F. nucleatum strains (Lewis et al., 2016).  There were also differences that 
characterised the subsp. necrophorum strains, for example 6/7 had siaQ that was 
absent in subsp. funduliforme and 3/7 lacked neuA.  Interestingly, the key gene 
required for surface expression of sialic acid, siaA was present in some but not all 
strains and isolates of both subspecies of F. necrophorum, but absent from other 
Fusobacteria that possessed an alternative gene for surface sialylation.  In subsp. 
funduliforme, the presence/absence of siaA defined the same 2 clusters (A and 
B+C) noted in chapter 7.  This supports the suggestion that at least 2 distinct 
lineages of subsp. funduliforme are present worldwide and that these could be 
differentiated based on the ability to express of sialic acid on their surfaces.  The 
correlation between surface sialic acid and pathogenicity in bacteria is currently 
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controversial and this area is worthy of further investigation.  However, as these 
bacteria are reliant on uptake of available sialic acid from the environment, great 
care should be taken in the research methodology to standardise the free sialic 
acid present.  Additionally, to understand the in vivo role of sialic acid expression 
would require an understanding of “local” environmental levels.  It is clear that the 
organism can only sialylate in the presence of free sialic acid in the host; this would 
preclude the detection of the bacterial sialic acid by the immune system whose 
receptors would be blocked by the endogenous sialic acid present. 
 
 Future Work 
Utilise the genome sequencing information to suggest genes suitable for inclusion 
in a PCR based sub-speciation/ group differentiation assay.  Are the sub-groups 
noted in the genomic studies associated with specific/different clinical 
presentation/ patient profile? 
  
Analyse the two new strains from Lemierre’s patients that have been lodged in 
public databases: is there any evidence of unique genes/snps differentiating 
Lemierre’s strains from those causing sore throats? 
  
Provide strain F88 to collaborators to review the phenotypic characteristics of this 
strain that has been identified as F. siminae by genomic analysis. 
  
Further investigate the large numbers of snps seen in the Leucotoxin gene; 
increase the analysis from a fragment of the gene to the whole gene.  Does the 
distribution of snps reveal information about the potential toxicity of the molecule? 
Extend the study of specific metabolic pathways to understand the glycosylation 
potential of these organisms. 
  
Investigate the expression of mRNA encoding genes of interest and the impact of 
environmental conditions on gene expression. 
 
 Conclusion 
Much of the work presented is based on bioinformatics and the results and their 
implications must be verified by cell biology and/or biochemistry.  Nevertheless, 
the results do demonstrate the potential, or lack of potential, of the organism to 
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express certain proteins.  A number of novel discoveries have been made during 
this work: 
1- F. necrophorum produces mono and dual species biofilms the formation of 
which affects antibiotic sensitivity. 
2- The Galactose binding protein is specific for unsubstituted terminal beta 
galactosyl residues. 
3- LpxI is used as an alternative to LpxH in the lipid A pathway. 
4- There are many differences between the genomes of subsp. necrophorum 
and funduliforme that could be used to set up a PCR based species specific 
test. 
5- Three clusters (A, B and C) in the subsp. funduliforme were identified using 
genome sequencing, assembly and analysis. 
6- Two clusters (A and B+C) in the subsp. funduliforme were identified by 
proteomic analysis. 
7- Detailed analysis of the sialic acid pathways highlighted difference between 
species and subspecies and the differentiation of the subsp. funduliforme 
into 2 clusters (A, and B+C) based on the presence/absence of siaA. 
8- Genome sequences of type culture strains, ARU 01 and 17 clinical strains 
have been deposited into public databases to enable further research.  
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Appendices 
 
Appendix I: Biochemical tests 
These tests include Gram staining and tests for catalase, oxidase, indole and 
lipase. 
 
i-1 Gram stain and Microscopic appearance 
Gram staining was carried out using the method of Halebain et al., (1981), with 
slight modifications.  A colony was smeared onto a drop of distilled water on a 
glass slide.  The smear was left to air-dry at room temperature, after which it was 
heat fixed by passing through a blue flame several times.  The slide was then 
covered with crystal violet solution for 30-60 seconds, this was followed by adding 
iodine solution to the slide and incubating for 30-60 seconds.  The slide was rinsed 
briefly with tap water, until the water was clear.  The slide was quickly rinsed with 
decolouriser solution (approximately 10 seconds), and then rinsed with tap water. 
The slide was covered with safranin solution for 30 seconds, and then rinsed 
under tap water until the water was clear.  The slide was gently blotted dry and 
the sample examined under a light microscope. F. necrophorum should appear 
as a Gram-negative pleomorphic rod, sometimes with long, tapered filaments 
present. 
 
i-2 Catalase test 
The catalase test is used to show the presence or absence of the enzyme 
catalase, an important enzyme which protects cells from oxidative damage by 
reactive oxygen species (ROS), which catalyses the release of oxygen form 
hydrogen peroxide (H2O2).  
Using a clean dry glass slide, a small amount of a bacterial colony was transferred 
onto the slide using a sterile toothpick.  A drop of 3 % hydrogen peroxide (H2O2) 
(Sigma Aldrich Ltd, Dorset, UK) was placed onto the slide and mixed.  A positive 
result was a rapid production of oxygen within 5 -10 seconds, seen as bubbles, 
and a negative result was recorded when only a few scattered bubbles, or no 
bubbles were produced. F. necrophorum strains are catalase negative. 
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i-3 Oxidase test 
This test is to identify bacteria that produce cytochrome c oxidase, an enzyme 
involved in the bacterial electron transport chain.  When this enzyme is present, it 
oxidises the reagent (tetramethyl-p-phenylenediamine dihydrochloride) to a purple 
(indophenol) colour end product.  The reagent remains reduced and colourless 
when the enzyme is not present. 
 
A filter paper was placed in a petri-dish and soaked with 1 % (w/v) solution of 
oxidase reagent (N, N, N’, N’- tetramethyl-p-phenylenediamine dihydrochloride 
(TMPD) (Sigma, Gillingham, UK), made up with sterile distilled water.  Using a 
sterile toothpick, a small amount of bacterial colony to be tested was smeared 
onto the filter paper.  The inoculated area was observed for colour change to dark 
blue or purple within 10 - 30 seconds.  Purple colonies were positive for 
cytochrome oxidase, or negative if no colour change was observed.  F. 
necrophorum strains are oxidase negative. 
 
 
i-4 Spot Indole test 
This test is used to determine the ability of an organism to split the amino acid 
tryptophan to generate the compound indole.  A number of different intracellular 
enzymes known as tryptophanase are involved in the conversion that produces 
three end products, one of which is indole.  The indole released then reacts with 
cinnamaldehyde to produce a blue-green compound, the absence of the enzyme 
shows no colour production. 
 A piece of filter paper in a petri-dish was saturated with reagent (1 % para-
dimethylamino cinnamaldehyde) from a vial of Bactodrop Spot Indole test 
(Remel™; Thermo Scientific, DE, USA).  A toothpick was used to take a small 
portion of the bacterial colony from an agar plate and smeared onto the filter 
paper.  A development of a blue-green colour within 30 seconds indicated a 
positive result for indole production from tryptophan.  Pink or no colour change 
was seen if negative.  F. necrophorum strains are indole positive. 
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i-5 Lipase test 
The lipase test is used to identify organisms that are capable of producing the 
exoenzyme lipase.  The presence of lipase activity is detected by distinct halo 
zone around the colony (with the help of a lamp). 
11.175 grams of L.D. Egg Yolk agar base (HiMedia, Mumbai, India) was 
suspended in 250 ml of sterile distilled water, this was heated to boiling to dissolve 
completely and then sterilised by autoclaving at 121 ºC for 15 minutes.  This was 
then allowed to cool to 50 ºC and about 25 ml of sterile Egg Yolk emulsion (LabM, 
Lancashire, UK) was added aseptically, mixed well and poured into sterile Petri-
dishes.  The set agar was streaked with F. necrophorum isolates and incubated 
anaerobically in an anaerobic jar with AnaeroGen™ sachet (Oxoid Ltd., 
Basingstoke, UK) for 48 hours at 37 ºC, as described in the methods section (see 
chapter 2).  The agar plates were then examined for lipase production.  Plates 
with isolates negative for lipase were kept for up to 7 days to confirm presumptive 
identification, since lipase reaction may be delayed.  Lipase breaks down free fats 
present in the egg yolks, resulting an iridescent, “oil on water” sheen on the 
surface of the colonies.  Some of the F. necrophorum tested were positive and 
some negative for lipase.  
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Appendix II: DNA Sequence [16S rRNA] 
ii-1 ARU planktonic 
tgGGCgtAagCGCgtCtagGCGGCAAGGAAAGTCTGATGTGAAAATGCGgagctCaacT
CCGTATGGCGttgGAAACTGCCTTACTAGAGTACTGGAGagGTAGGCGGAACTAC
AAgtGTAGAGGTGAAATTCGTaGaTATTTGTAGGAATGCCGATGGGGAAGCCAGC
CTACTGGACAGATACTGACGCTAAAGCGCGAAAGCGTGGGTAGCAAACAGGATT
AGATACCCTggtaGTCCACGCTGTAAACGATGATTACtaggTGTTGGGGGTCAAACC
TCAGCGCCCAAGCTAACGCGATAAGTAATCCGCCTGGGGagTACGTACGCAAGT
ATGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGa 
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ii-2 3718 planktonic 
acTaGGtntGGGGTCcatTcnnngggttcCgtgCcntannna 
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ii-3 3724 planktonic 
cGCGcgTAgGCGGtTTTTTaAgTCTGATGTGAaancccacgGcTCanccgnGgagG
gtcaTTGnannctg 
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ii-4 ARU biofilm 
CntaTCGganTtatTGGgCGTaAGCGCGTCTAGGCGGCAAGGAAAGTCTGAT
GTGAAAATGCGGAGCTCAACTCCGTATGGCGTTGGAAACTGCCTTACTAG
AGTACTGGAGAGGTAGGCGGAACTACAAGTGTAGAGGTGAAATTCGTAG
ATATTTGTAGGAATGCCGATGGGGAAGCCAGCCTACTGGACAGATACTG
ACGCTAAAGCGCGAAAGCGTGGGTAGCAAACAGGATTAGATACCCTGGT
AGTCCACGCTGTAAACGATGATTACTAGGTGTTGGGGGTCAAACCTCAGC
GCCCAAGCTAACGCGATAAGTAATCCGCCTGGGGAGTACGTACGCAAGT
ATGAAACTCAAAGGAATTGACGGGGGCCCGCACAAgaa 
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ii-5 3718 Biofilm 
tTaTTcGGattatTGGgCGTAaGCGCGCGTagGCGGTTTTTtaAGTCTGATGTG
AAAGCCCACGGCTCAACCGTGGAGGGTCATTGGAAACTGGAAAACTTGA
GTGCAGAAGAGGAAAGTGGAATTCCATGTGTAGCGGTGAAATGCGCAGA
GATATGGAGGAACACCAGTGGCGAAGGCGACTTTCTGGTCTGTAACTGA
CGCTGATGTGCGAAAGCGTGGGGATCAAACAGGATTAGATACCCTGGTA
GTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGGGGGTTTCCGCCCCT
TAGTGCTGCAGCTAACGCATTAAGCACTCCGCCTGGGGAGTACGACCGC
AAGGTTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAgaa 
 
 
 
 
 
 
 
  209 
ii-6 3724 Biofilm 
cgGgatntTGGgcgTAaGCGCgnntagGCGgnnnntaaGTCTGATGTGaaatgcnnag
CTCAActc 
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ii-7 Positive control  
tCCatGTGTAnngGTGAAATgcgtaGATAtttggaGGAacgcCgntggggaaancgGCC 
 
 
 
Figure I.  BLAST search results of sequenced purified PCR products of 
planktonic cells and biofilms compared to those in the GenBank database. 
These revealed all the strains as F. necrophorum. Strains tested were: ARU 01, 
JCM 3718 and JCM 3724. 
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Appendix III: BLAST data analysis for galactose binding primers  
with F. necrophorum DNA samples. 
 
iii-1 ARU 01-gal binding primer: 
TATTCGCATATTGGGGCTGTATGGAGTGGAGAAAAAAGAAGCAGCTCCCGCTGAAAATGC 
AGTAAGAATGGGATTAACCGCTTATAAATTCGATGACAACTTCATTGCATTGTTCAGACA 
AGCTTTTCAAGCAGAAGCGGATGCCGTGGGAAATCAAGTTGCCTTACAAATGGTTGACTC 
TCAAAATGATGCAGCAAAACAAAATGAAAACTTGGATGTATTATTAGAAAAAGGAATCGA 
CACCTTGGCAATCAATTTGGTTGACCCGGCCGGTGTTGATGTCGTATTGGAAAAAATCAA 
AGCAAAAGAATTGCCGGTTGTTTTCTATAATAGAAAACCTTCGGATGAAGCATTGGCTTC 
TTATGATAAAGCTTACTATGTAGGAATTGACCCAAATGCACAGGGAATTGCTCAAGGAAA 
ATTGATTGAAAAAGCATGGCAAGCAAATCCTGCTTTGGATTTAAACGGAGATGGAGTGAT 
TCAATTCGCTATGTTGAAAGGAGAACCGGGACATCCGGATGCAGAAGCAAGAACCGTTTA 
TTCCATTAAAACTTTAAATGAAGATGGAATAAAAACAGAAGAATTACACTTAGATACAGC 
TATGTGGGATACTGCACAAGCAAAAGACAAAATGGATGCATGGTTGTCAGGACCGAATGC 
GGATAAAATTGAAGTGGTTATCTGTAATAACGACGGAATGGCTTTAGGAGCTATCGAATC 
TATGAAAGCCTTCGGAAAATCATTACCGGTATTTGGAGTGGATGCTTTACCGGAAGCAAT 
CACTTTGATTGAAAAGGGAGAAATGGCAGGAACCGTTTTAAATGATGCAAAAGGTCAAGC 
AAAAGCAACTTTCCAAGTAGCTATGAACTTAGGGCAAGGAAAAGAAGCAACAGAAGGAAC 
AGATATTCAAATGGAAAATAAAATTGTATTGGTGCCTTAGTATCGGGACCCAAGTGGGCA 
ATACTTCGGTTATCCTTAAAATCCAAATATTTCTAGATCTCCTTATCAACCATTTATTTC 
TATTC 
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iii-2 JCM 3718 – gal binding primer: 
AAGATCACAGGTAGACTAGATAGCTCGCATAATGCGCGGGGAGAAGAAAGAGCAGCAGCT 
CCCGCTGAAAATGCAGTAAGAATGGGATTAACTGCTTATAAATTTGATGATAACTTCATT 
GCATTGTTCAGACAAGCTTTTCAAGCAGAAGCGGATGCTGTAGGAGATCAAGTTGCTCTA 
CAAATGGTTGACTCTCAAAATGATGCAGCAAAACAAAATGAACAATTGGATGTGTTATTA 
GAAAAAGGAATTGACACCTTAGCAATCAATTTGGTTGACCCGGCCGGTGTCGATGTTGTA 
TTGGAAAAAATCAAAGCAAAAAAATTGCCAGTTGTTTTCTATAATCGAAAACCTTCAGAG 
GAAGCGTTGGCTTCTTATGACAAAGCTTACTATGTAGGAATTGATCCAAATGCACAAGGA 
GTTGCTCAAGGAAAATTAATTGAAAAAGCATGGCAAGCAAATCCTGCTTTGGATTTAAAC 
GGAGACGGAGTGATTCAATTCGCTATGTTAAAAGGAGAACCCGGACATCCAGATGCAGAA 
GCAAGAACTGTTTACTCCATTAAAACTTGAATGAAGATGGAATTTAACAGAAAATTACAT 
TTAATACAGCTATGTGGGATACTGCATAAGCAAAGGATAAATGGATGCATGGTGTCAGGA 
CCGAATGCCGATAAATTTAATTGATATCTGTATAATGACGGATTTCTTTAGGACTATTG 
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iii-3 JCM 3724 – gal binding primer: 
AATTTCATGTGCGGCTAGTAGCGATGTGGAGAAGAAGAAGCGGCAGCTCCTGCTGAAAAT 
GCAGTAAGAATGGGATTAACCGCTTATAAATTCGATGACAACTTCATTGCATTGTTCAGA 
CAAGCTTTTCAAGCAGAAGCGGATGCCGTGGGAAATCAAGTTGCCTTACAAATGGTTGAC 
TCTCAAAATGATGCAGCAAAACAAAATGAACAATTGGATGTGTTATTAGAAAAAGGAATT 
GACACCTTGGCAATCAATTTGGTTGACCCGGCCGGTGTCGATGTTGTATTGGAAAAAATC 
AAAGCAAAAGAATTGCCGGTTGTTTTCTATAATCGAAAACCTTCAGAGGAAGCATTGGCT 
TCTTATGACAAAGCTTACTATGTAGGAATTGACCCAAATGCACAAGGAATTGCTCAAGGA 
AAATTGATTGAAAAAGCATGGCAAGCAAATCCTGCTTTGGATTTAAACGGAGATGGAGTG 
ATTCAATTCGCTATGTTGAAAGGAGAACCGGGACATCCGGATGCGGAAGCAAGAACCGTT 
TACTCCATTAAAACTTTAAATGAAGATGGAATAAAAACAGAAGAATTACACTTAGATACA 
GCTATGTGGGATACCGCACAAGCAAAGGATAAAATGGATGCATGGTTGTCAGGACCGAAT 
GCGGATAAAATTGAAGTGGTTATCTGTAATAACGACGGAATGGCTTTAGGAGCTATCGAA 
TCTATGAGAGCCTTCGGAAAATCATTACCGGTATTTGGAGTGGATGCTTTACCGGAAGCA 
ATCACTTTGATTGAAAAGGGAGAAATGGCGGGAACCGTTTTAAATGATGCAAAAGGTCAA 
GCAAAAGCAACTTTCCAAGTAGCTATGAACTTAGGGCAAGGAAAGAAGCACGGAAGGAAC 
AGATATTCAAATGGAGAATAAATTGTATTGTGCCCTAGTATCGGCCCAA 
 
Figure II. Nucleotide sequences of purified F. necrophorum samples with gal 
binding primer used for identification of the presence of galactose binding 
gene in F. necrophorum species. 
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Appendix IV: Haemagglutination Assays 
iv-1 Haemagglutination assay of human blood cells with commercial anti-
sera. 
Figure III: Heamagglutination assays – Anti-B monoclonal 
antibody with blood type A, B, O and AB a) Anti-B with blood type 
A; b) Anti-B antibody with blood type B; c) Anti-B antibody with 
blood type O and d) Anti-B antibody with blood type AB. a) and 
c) indicates no haemagglutination, images b) and d) shows 
grape-like clusters of cells showing that haemagglutination has 
occurred. 
A B 
C D 
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Figure IV: Haemagglutination assays showing results of F. necrophorum bacterial cells tested with neuraminidase treated sheep 
erythrocytes.  A) ARU 01; B) JCM 3718 and C) JCM 3724 F. necrophorum cells with neuraminidase treated sheep erythrocytes. The  
results showed that F. necrophorum bacterial cells tested all agglutinated with the neuraminidase treated red blood cells. 
A B C 
iv-2 Haemagglutination assay of F. necrophorum cells with sheep red blood cells treated with neuraminidase. 
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Table I: Haemagglutination between human and sheep red cells and F. 
necrophorum 
    ARU 01; JCM 3718; JCM 3724 
 
 
 
 
Agglutinin 
 
             Human Red Cells 
                                                   
Sheep Red Cells 
A B 0 AB Native 
 
Desialylated 
ARU 01 0 0 0 0 0 3 
JCM 3718 0 0 0 0 0 2+ 
JCM 3724 0 0 0 0 0 2 
Anti-A 4 0 0 4 0 0 
Anti-B 0 3+ 0 3+ 0 0 
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Appendix V: Q-RT-PCR for gene expression 
 
Table II: Real-time PCR results of the first gene (LpxA) of lipid A pathway, 
showing the melt curve and quantitation analysis of F. necrophorum 
samples:  
ARU 01; JCM 3718; JCM 3724; F21 and NC (no template control). 
 
Lpx A   
   
Strains 
CT 
Values 
Melting 
Temperature 
ARU 01 17.82 81.3 
JCM 3718 11.74 82 
JCM 3724 16.54 81.7 
F5 7.46 82 
F21 9.5 82 
F24 8.49 82 
F30 23.2 82 
Neg Control 26.44 89 
Pos Control 13.45 82 
 
 
 
Table III: Real-time PCR results of the second gene (LpxC) of lipid A 
pathway, showing the melt curve and quantitation analysis of F. 
necrophorum samples: 
ARU 01; JCM 3718; JCM 3724; F21 and NC (no template control). 
 
Lpx C   
   
Strains 
CT 
Values 
Melting 
Temperature 
ARU 01 17.05 81.2 
JCM 3718 17.43 81.2 
JCM 3724 17.23 81.3 
F5 7.53 81.5 
F21 8.98 81.5 
F24 9.29 81.5 
F30 8.91 81.5 
Neg Control 25.44 87.0 
Pos Control 14.10                                  81.5 
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Table IV:  Real-time PCR results of the third gene (LpxD) of lipid A pathway, 
showing the melt curve and quantitation analysis of F. necrophorum 
samples:  
ARU 01; JCM 3718; JCM 3724; F21 and NC (no template control). 
 
Lpx D   
   
Strains CT Values 
Melting 
Temperature 
ARU 01 19.59 82.2 
JCM 3718 19.34 82 
JCM 3724 18.88 82.3 
F5 9.56 82.5 
F21 9.03 82.5 
F24 11.37 82.5 
F30 9.97 82.5 
Neg Control 26.25 89 
Pos Control 14.63 82.5 
 
 
 
Table V:  Real-time PCR results of the fourth gene (LpxB) of lipid A pathway, 
showing the melt curve and quantitation analysis of F. necrophorum 
samples:  
ARU 01; JCM 3718; JCM 3724; F21, PC (positive control) and NC (no template 
control). 
 
Lpx B   
   
Strains CT Values 
Melting 
Temperature 
ARU 01 18.29 79.7 
JCM 3718 12.21 80.2 
JCM 3724 18.8 80.2 
F5 9.13 80 
F21 10.36 80.3 
F24 10.81 80 
F30 9.16 80.3 
Neg Control 26.24 88.8 
Pos Control 15.08 80.3 
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Appendix VI: Formulae for estimation of biofilm assays 
 
To ensure reproducibility and repeatability of the all biofilm assays, coefficient of 
variation (CV) was calculated for replicate assays (Feiler et al., 2014).  Standard 
deviation mean values and CV were determined for data generated from all biofilm 
assays to determine extent of dispersion between resultant OD values (replicates) 
using the equation; 
 
CV (%) = σ/μ × 100; Where σ is the standard deviation and μ is the mean value. 
CV % was subsequently set at ≤ 10 %. 
 
Percentage efficacy of an antibiotic/antimicrobial (also known as antibiotic activity) 
and residual biofilm biomass for biofilm inhibition and eradication was determined 
for all MIC replicate assays using the formula; 
 
Antibiotic/Antimicrobial efficacy (%) = [(A – B) / A] × 100 
and 
Residual biofilm biomass (%) = 100 – Antibiotic/Antimicrobial efficacy (%) 
Where A = absorbance of control (antibiotic free culture), B = absorbance of test 
sample (bacteria with antibiotic).  uuuPercentage inhibition (PI) and percentage 
reduction (PR) of biofilms by an antibiotic/antimicrobial which can also be defined 
as the efficacy of that antibiotic/antimicrobial were calculated using the formula; 
 
Antibiotic/Antimicrobial efficacy (%) = [(A – B) / A] × 100, 
or 
PI/PR = 100 – Residual biofilm biomass (%)  
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Appendix VII: Rpm (speed) to g (RCF) 
 
Table VI: Conversion Table- Speed (rpm) to Relative centrifugal  
force (g) for Eppendorf centrifuge used in the project. 
 
The radius of this centrifuge is 10 cm and is used with 15 ml tubes. 
 
 
 
  
    Speed          RCF 
   (RPM)          (g) 
1000  112 
1500  252 
2000  447 
2500  699 
3000  1006 
3500  1370 
4000  1789 
4500  2264 
5000  2795 
5500  3382 
6000  4025 
6500  4724 
7000  5478 
7500  6289 
8000  7155 
8500  8078 
9000  9056 
9500  10090 
10000  11180 
10500  12326 
11000  13528 
11500  14786 
12000  16099 
13000  18894 
13500  20376 
14000   21913   
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Table VII: Conversion Table - Speed (rpm) to Relative centrifugal 
force (g) for Eppendorf centrifuge used in the project. 
 
The radius of this centrifuge is 8 cm and is used with 1.5 ml microfuge tubes.  
  Speed           RCF 
   (RPM)          (g) 
1000  89 
1500  201 
2000  358 
2500  559 
3000  805 
3500  1096 
4000  1431 
4500  1811 
5000  2236 
5500  2706 
6000  3220 
6500  3779 
7000  4383 
7500  5031 
8000  5724 
8500  6462 
9000  7245 
9500  8072 
10000  8944 
10500  9861 
11000  10822 
11500  11828 
12000  12879 
13000  15115 
13500  16300 
14000   17530    
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Appendix VIII 
 
Permission granted from the copyright holder for the use of Figure 8.1. 
Order License ID: 1040238-1. 
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